Literature for peptidase M02.006: angiotensin-converting enzyme-2

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Pharma

(Topics flags: A Assay, S Structure, T Target, P Specificity, K Knockout, E Expression, V Review, M Mutation, I Inhibitor, U Therapeutic. To select only the references relevant to a single topic, click the link above. See explanation.)

    2025
  1. Chau,L.F., Lillico,S., Opriessnig,T., Blake,R., Tardy,L., Lee,C.H., Maxwell,S., Warren,C., Thornton,E., Mclaughlin,C.L., McLachlan,G., Tait-Burkard,C., Fletcher,S., Anderson,S., Brown,S., Gibbard,L., Tzelos,T., MacMillan-Christensen,D., Baillie,J.K., Dorward,D.A., Griffiths,D.J. and Grey,F.
    Human ACE2 transgenic pigs are susceptible to SARS-CoV-2 and develop COVID-19-like disease
    Nat Commun16, 766-766. PubMed  Europe PubMed DOI
  2. Chen,J., Zhang,W., Li,Y., Liu,C., Dong,T., Chen,H., Wu,C., Su,J., Li,B., Zhang,W., Hu,B., Jia,J., Ma,C.B., Zhu,Y., He,X., Li,A., Pan,K., Lin,H., Guo,Z., Li,C., Zhang,L., Yan,H., Zhou,P., Peng,W. and Shi,Z.L.
    Bat-infecting merbecovirus HKU5-CoV lineage 2 can use human ACE2 as a cell entry receptor
    Cell PubMed  Europe PubMed DOI
  3. Chhabra,K.H., Shoemaker,R., Herath,C.B., Thomas,M.C., Filipeanu,C.M. and Lazartigues,E.
    Molecular Dissection of the Role of ACE2 in Glucose Homeostasis
    Physiol Rev PubMed  Europe PubMed DOI  V
  4. Jiang,S. and Wu,F.
    Global surveillance and countermeasures for ACE2-using MERS-related coronaviruses with spillover risk
    Cell188, 1465-1468. PubMed  Europe PubMed DOI
  5. Lu,J., Tang,Y., Li,H., Chen,X., Qin,P., Xu,J., Li,W. and Chen,L.
    Identifying Exifone as a Dual-Target Agent Targeting Both SARS-CoV-2 3CL Protease and the ACE2/S-RBD Interaction Among Clinical Polyphenolic Compounds
    Int J Mol Sci26, PubMed  Europe PubMed DOI  V
  6. Lusvarghi,S., Vassell,R., Williams,B., Baha,H., Neerukonda,S.N. and Weiss,C.D.
    Capture of fusion-intermediate conformations of SARS-CoV-2 spike requires receptor binding and cleavage at either the S1/S2 or S2' site
    PLoS Pathog21, e1012808-e1012808. PubMed  Europe PubMed DOI
  7. Ma,C.B., Liu,C., Park,Y.J., Tang,J., Chen,J., Xiong,Q., Lee,J., Stewart,C., Asarnow,D., Brown,J., Tortorici,M.A., Yang,X., Sun,Y.H., Chen,Y.M., Yu,X., Si,J.Y., Liu,P., Tong,F., Huang,M.L., Li,J., Shi,Z.L., Deng,Z., Veesler,D. and Yan,H.
    Multiple independent acquisitions of ACE2 usage in MERS-related coronaviruses
    Cell PubMed  Europe PubMed DOI
  8. Noettger,S., Zech,F., Nchioua,R., Pastorio,C., Jung,C., Jacob,T., Stenger,S. and Kirchhoff,F.
    Role of N-linked glycosylation sites in human ACE2 in SARS-CoV-2 and hCoV-NL63 infection
    J Virole0220224-e0220224. PubMed  Europe PubMed DOI
  9. Okal,E.F., Romero,P.A. and Heinzelman,P.
    Droplet microfluidic screening to engineer angiotensin-converting enzyme 2 (ACE2) catalytic activity
    J Biol Eng19, 12-12. PubMed  Europe PubMed DOI
  10. Park,Y.J., Liu,C., Lee,J., Brown,J.T., Ma,C.B., Liu,P., Gen,R., Xiong,Q., Zepeda,S.K., Stewart,C., Addetia,A., Craig,C.J., Tortorici,M.A., Alshukairi,A.N., Starr,T.N., Yan,H. and Veesler,D.
    Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses
    Cell PubMed  Europe PubMed DOI
  11. Tang,C., Lupala,C.S., Wang,D., Li,X., Tang,L.H. and Li,X.
    Structural and Energetic Insights into SARS-CoV-2 Evolution: Analysis of hACE2-RBD Binding in Wild-Type, Delta, and Omicron Subvariants
    Int J Mol Sci26, PubMed  Europe PubMed DOI
  12. Tang,X., Lu,L., Li,X. and Huang,P.
    Bridging Cancer and COVID-19: The Complex Interplay of ACE2 and TMPRSS2
    Cancer Med14, e70829-e70829. PubMed  Europe PubMed DOI  V
  13. Wang,N., Ji,W., Jiao,H., Veit,M., Sun,J., Wang,Y., Ma,X., Wang,Y., Wang,Y., Li,X.X., Zhang,X., Chen,J., Wei,J., Xu,Y., Guo,D., Zhai,X., Merits,A., Li,C., Rey,F.A., Dobrikov,G.M., Gao,G.F., Zhang,S., Bi,Y. and Su,S.
    A MERS-CoV-like mink coronavirus uses ACE2 as entry receptor
    Nature PubMed  Europe PubMed DOI
  14. Xing,L., Liu,Z., Wang,X., Liu,Q., Xu,W., Mao,Q., Zhang,X., Hao,A., Xia,S., Liu,Z., Sun,L., Zhang,G., Wang,Q., Chen,Z., Jiang,S., Sun,L. and Lu,L.
    Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target
    Cell PubMed  Europe PubMed DOI
  15. 2024
  16. Al-Saigh,N.N., Harb,A.A. and Abdalla,S.
    Receptors Involved in COVID-19-Related Anosmia: An Update on the Pathophysiology and the Mechanistic Aspects
    Int J Mol Sci25, PubMed  Europe PubMed DOI  V
  17. Ayyubova,G., Gychka,S.G., Nikolaienko,S.I., Alghenaim,F.A., Teramoto,T., Shults,N.V. and Suzuki,Y.J.
    The Role of Furin in the Pathogenesis of COVID-19-Associated Neurological Disorders
    Life (Basel)14, PubMed  Europe PubMed DOI
  18. Bach,M.L., Laftih,S., Andresen,J.K., Pedersen,R.M., Andersen,T.E., Madsen,L.W., Madsen,K., Hinrichs,G.R., Zachar,R., Svenningsen,P., Lund,L., Johansen,I.S., Hansen,L.F., Palarasah,Y. and Jensen,B.L.
    ACE2 and TMPRSS2 in human kidney tissue and urine extracellular vesicles with age, sex, and COVID-19
    Pflugers Arch PubMed  Europe PubMed DOI
  19. Bader,M., Steckelings,U.M., Alenina,N., Santos,R.A.S. and Ferrario,C.M.
    Alternative Renin-Angiotensin System
    Hypertension81, 964-976. PubMed  Europe PubMed DOI  V
  20. Broer,A., Hu,Z., Kukulowicz,J., Yadav,A., Zhang,T., Dai,L., Bajda,M., Yan,R. and Broer,S.
    Cryo-EM structure of ACE2-SIT1 in complex with Tiagabine
    J Biol Chem107687-107687. PubMed  Europe PubMed DOI
  21. Ding,J., Zhang,Q., Jiang,J., Zhou,N., Yu,Z., Wang,Z., Meng,X., Daggumati,L., Liu,T., Wang,F., Lu,Z., Yang,X., Yang,Z., Zhang,H., Thorek,D.L.J., Du,P. and Zhu,H.
    Preclinical Evaluation and Pilot Clinical Study of (18)F-Labeled Inhibitor Peptide for Noninvasive Positron Emission Tomography Mapping of Angiotensin Converting Enzyme 2
    ACS Pharmacol Transl Sci7, 1758-1769. PubMed  Europe PubMed DOI
  22. Elgazzaz,M., Filipeanu,C. and Lazartigues,E.
    The 2023 Lewis K. Dahl Memorial Lecture: Angiotensin-Converting Enzyme 2 Posttranslational Modifications-Implications for Hypertension and SARS-CoV-2 Infection
    Hypertension81, 1438-1449. PubMed  Europe PubMed DOI  V
  23. Ghahramani,M., Shahsavani,M.B., Khaleghinejad,S.H., Niazi,A., Moosavi-Movahedi,A.A. and Yousefi,R.
    Efficient Expression in the Prokaryotic Host System, Purification and Structural Analyses of the Recombinant Human ACE2 Catalytic Subunit as a Hybrid Protein with the B Subunit of Cholera Toxin (CTB-ACE2)
    Protein J43, 24-38. PubMed  Europe PubMed DOI
  24. Guo,Y.T., Jiang,J.B., Qiao,G.R., Luo,R.H., Zhou,X., Hua,R., Zheng,C.B. and Liu,Z.
    Pleiotropy of positive selection in ancient ACE2 suggests an alternative hypothesis for bat-specific adaptations to host coronaviruses
    Proc Natl Acad Sci U S A121, e2321619121-e2321619121. PubMed  Europe PubMed DOI
  25. Han,H., Luo,R.H., Long,X.Y., Wang,L.Q., Zhu,Q., Tang,X.Y., Zhu,R., Ma,Y.C., Zheng,Y.T. and Zou,C.G.
    Transcriptional regulation of SARS-CoV-2 receptor ACE2 by SP1
    elife13, PubMed  Europe PubMed DOI
  26. Heindl,M.R., Rupp,A.L., Schwerdtner,M., Bestle,D., Harbig,A., De Rocher,A., Schmacke,L.C., Staker,B., Steinmetzer,T., Stein,D.A., Moulton,H.M. and Bottcher-Friebertshauser,E.
    ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells
    J Virol98, e0010224-e0010224. PubMed  Europe PubMed DOI  K
  27. Li,H.Z., Pike,A.C.W., Lotsaris,I., Chi,G., Hansen,J.S., Lee,S.C., Rodstrom,K.E.J., Bushell,S.R., Speedman,D., Evans,A., Wang,D., He,D., Shrestha,L., Nasrallah,C., Burgess-Brown,N.A., Vandenberg,R.J., Dafforn,T.R., Carpenter,E.P. and Sauer,D.B.
    Structure and function of the SIT1 proline transporter in complex with the COVID-19 receptor ACE2
    Nat Commun15, 5503-5503. PubMed  Europe PubMed DOI
  28. Li,R., Li,F. and Yuan,L.
    ACE2 Regulates Glycolipid Metabolism in Multiple Tissues
    Front Biosci (Landmark Ed)29, 17-17. PubMed  Europe PubMed DOI  V
  29. Li,Z., Chen,X., Ma,C., Du,X. and Zhang,Y.
    Angiotensin converting enzyme 2 does not facilitate porcine epidemic diarrhea virus entry into porcine intestinal epithelial cells and inhibits it-induced inflammatory injury by promoting STAT1 phosphorylation
    Virus Res340, 199300-199300. PubMed  Europe PubMed DOI
  30. Liao,Y., Zhang,Y., Li,H., Hu,H., Li,M. and Liao,C.
    ACE2: the node connecting the lung cancer and COVID-19
    Am J Cancer Res14, 1466-1481. PubMed  Europe PubMed DOI  V
  31. Luo,D., Bai,M., Zhang,W. and Wang,J.
    The possible mechanism and research progress of ACE2 involved in cardiovascular injury caused by COVID-19: a review
    Front Cardiovasc Med11, 1409723-1409723. PubMed  Europe PubMed DOI
  32. Mizutani,S., Mizutani,H., Mizutani,E., Arita,H. and Kajiyama,H.
    The Fate of Angiotensin II in Placental Tissue and Blood
    Horm Metab Res56, 477-481. PubMed  Europe PubMed DOI
  33. Mondal,A., Das,S., Das,M., Chakraborty,S. and Sengupta,A.
    YAP1-mediated dysregulation of ACE-ACE2 activity augments cardiac fibrosis upon induction of hyperglycemic stress
    Biochim Biophys Acta Gen Subj1868, 130666-130666. PubMed  Europe PubMed DOI
  34. Niu,S., Zhao,Z., Liu,Z., Rong,X., Chai,Y., Bai,B., Han,P., Shang,G., Ren,J., Wang,Y., Zhao,X., Liu,K., Tian,W., Wang,Q. and Gao,G.F.
    Structural basis and analysis of hamster ACE2 binding to different SARS-CoV-2 spike RBDs
    J Virol98, e0115723-e0115723. PubMed  Europe PubMed DOI
  35. Paiardi,G., Ferraz,M., Rusnati,M. and Wade,R.C.
    The accomplices: Heparan sulfates and N-glycans foster SARS-CoV-2 spike:ACE2 receptor binding and virus priming
    Proc Natl Acad Sci U S A121, e2404892121-e2404892121. PubMed  Europe PubMed DOI
  36. Saulnier,N.M., Thorne,D.M., Bablu,F.E., Suzuki,A.M., Khan,R.L., Oliveira,K.X. and Suzuki,Y.J.
    Characterizations of angiotensin-converting enzyme-2 (ACE2) peptidase activity
    Arch Biochem Biophys761, 110167-110167. PubMed  Europe PubMed DOI
  37. Su,C., Li,C., Hu,X., Wang,J., Liu,L., Zhang,X. and Tong,Y.
    Association Between ACE2 and Lung Diseases
    Infect Drug Resist17, 1771-1780. PubMed  Europe PubMed DOI  V
  38. Tanriverdi,O., Alkan,A., Karaoglu,T., Kitapli,S. and Yildiz,A.
    COVID-19 and Carcinogenesis: Exploring the Hidden Links
    Cureus16, e68303-e68303. PubMed  Europe PubMed DOI  V
  39. Teng,F., Gang,O. and Freimuth,P.
    Overexpression of human ACE2 protein in mouse fibroblasts stably transfected with the intact ACE2 gene
    Virology592, 109988-109988. PubMed  Europe PubMed DOI
  40. Wan,T.T., Li,Y., Li,J.X., Xiao,X., Liu,L., Li,H.H. and Guo,S.B.
    ACE2 activation alleviates sepsis-induced cardiomyopathy by promoting MasR-Sirt1-mediated mitochondrial biogenesis
    Arch Biochem Biophys752, 109855-109855. PubMed  Europe PubMed DOI
  41. Wang,Z., Fan,H. and Wu,J.
    Food-Derived Up-Regulators and Activators of Angiotensin Converting Enzyme 2: A Review
    J Agric Food Chem72, 12896-12914. PubMed  Europe PubMed DOI
  42. Xiong,Q., Ma,C., Liu,C., Tong,F., Huang,M. and Yan,H.
    ACE2-using merbecoviruses: Further evidence of convergent evolution of ACE2 recognition by NeoCoV and other MERS-CoV related viruses
    Cell Insight3, 100145-100145. PubMed  Europe PubMed DOI  V
  43. Xu,W., Langhans,S.A., Johnson,D.K., Stauff,E., Kandula,V.V.R., Kecskemethy,H.H., Averill,L.W. and Yue,X.
    Radiotracers for Molecular Imaging of Angiotensin-Converting Enzyme 2
    Int J Mol Sci25, PubMed  Europe PubMed DOI  V
  44. Yang,H., Zhou,J.N., Zhang,X.M., Ling,D.D., Sun,Y.B., Li,C.Y., Zhou,Q.Q., Shi,G.N., Wang,S.H., Lin,X.S., Fan,T., Wang,H.Y., Zeng,Q., Jia,Y.L., Xi,J.F., Jin,Y.G., Pei,X.T. and Yue,W.
    Nanoengineered Red Blood Cells Loaded with TMPRSS2 and Cathepsin L Inhibitors Block SARS-CoV-2 Pseudovirus Entry into Lung ACE2(+) Cells
    Adv Matere2310306-e2310306. PubMed  Europe PubMed DOI
  45. Zhang,H., Wang,Z., Nguyen,H.T.T., Cornejo Pontelli,M., Qi,W., Rao,L., Liu,Z., Whelan,S.P.J. and Zhu,J.
    Facilitating and restraining virus infection using cell-attachable soluble viral receptors
    Proc Natl Acad Sci U S A121, e2414583121-e2414583121. PubMed  Europe PubMed DOI
  46. Zhang,W., Shi,K., Hsueh,F.C., Mendoza,A., Ye,G., Huang,L., Perlman,S., Aihara,H. and Li,F.
    Structural basis for mouse receptor recognition by bat SARS2-like coronaviruses
    Proc Natl Acad Sci U S A121, e2322600121-e2322600121. PubMed  Europe PubMed DOI
  47. Zhou,L., Chen,S., Wei,Y., Sun,Y., Yang,Y., Lin,B., Li,Y. and Wang,C.
    Glycyrrhizic acid restores the downregulated hepatic ACE2 signaling in the attenuation of mouse steatohepatitis
    Eur J Pharmacol967, 176365-176365. PubMed  Europe PubMed DOI
  48. Zorad,S., Skrabanova,M., Zilkova,M., Cente,M., Turic Csokova,N., Kovacech,B., Cizkova,D. and Filipcik,P.
    Angiotensin I and II Stimulate Cell Invasion of SARS-CoV-2: Potential Mechanism via Inhibition of ACE2 Arm of RAS
    Physiol Res73, 27-35. PubMed  Europe PubMed DOI
  49. 2023
  50. Bednash,J.S., Johns,F., Farkas,D., Elhance,A., Adair,J., Cress,K., Yount,J.S., Kenney,A.D., Londino,J.D. and Mallampalli,R.K.
    Inhibiting the Deubiquitinase UCHL1 Reduces SARS-CoV-2 Viral Uptake by ACE2
    Am J Respir Cell Mol Biol68, 566-576. PubMed  Europe PubMed DOI  K
  51. Beyer,D., Vaccarin,C., Deupi,X., Mapanao,A.K., Cohrs,S., Sozzi-Guo,F., Grundler,P.V., van der Meulen,N.P., Wang,J., Tanriver,M., Bode,J.W., Schibli,R. and Muller,C.
    A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides
    EJNMMI Res13, 32-32. PubMed  Europe PubMed DOI
  52. Bhullar,K.S., Fan,H., Nael,M.A., Elokely,K.M. and Wu,J.
    ACE2 Activation by Tripeptide IRW (Ile-Arg-Trp) Depends on the G Protein-Coupled Receptor 30 Signaling Cascade
    J Agric Food Chem71, 8071-8082. PubMed  Europe PubMed DOI  K
  53. Bradley,T., Geanes,E., McLennan,R. and LeMaster,C.
    Autoantibodies against Angiotensin-converting enzyme 2 and immune molecules are associated with COVID-19 disease severity
    Res Sq PubMed  Europe PubMed DOI
  54. Brevini,T., Maes,M., Webb,G.J., John,B.V., Fuchs,C.D., Buescher,G., Wang,L., Griffiths,C., Brown,M.L., Scott,W.E., III, Pereyra-Gerber,P., Gelson,W.T.H., Brown,S., Dillon,S., Muraro,D., Sharp,J., Neary,M., Box,H., Tatham,L., Stewart,J., Curley,P., Pertinez,H., Forrest,S., Mlcochova,P., Varankar,S.S., Darvish-Damavandi,M., Mulcahy,V.L., Kuc,R.E., Williams,T.L., Heslop,J.A., Rossetti,D., Tysoe,O.C., Galanakis,V., Vila-Gonzalez,M., Crozier,T.W.M., Bargehr,J., Sinha,S., Upponi,S.S., Fear,C., Swift,L., Saeb-Parsy,K., Davies,S.E., Wester,A., Hagstrom,H., Melum,E., Clements,D., Humphreys,P., Herriott,J., Kijak,E., Cox,H., Bramwell,C., Valentijn,A., Illingworth,C.J.R., Dahman,B., Bastaich,D.R., Ferreira,R.D., Marjot,T., Barnes,E., Moon,A.M., Barritt,A.S., Gupta,R.K., Baker,S., Davenport,A.P., Corbett,G., Gorgoulis,V.G., Buczacki,S.J.A., Lee,J.H., Matheson,N.J., Trauner,M., Fisher,A.J., Gibbs,P., Butler,A.J., Watson,C.J.E., Mells,G.F., Dougan,G., Owen,A., Lohse,A.W., Vallier,L. and Sampaziotis,F.
    FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
    Nature615, 134-142. PubMed  Europe PubMed DOI
  55. Dang,F., Bai,L., Dong,J., Hu,X., Wang,J., Paulo,J.A., Xiong,Y., Liang,X., Sun,Y., Chen,Y., Guo,M., Wang,X., Huang,Z., Inuzuka,H., Chen,L., Chu,C., Liu,J., Zhang,T., Rezaeian,A.H., Liu,J., Kaniskan,H.U., Zhong,B., Zhang,J., Letko,M., Jin,J., Lan,K. and Wei,W.
    USP2 inhibition prevents infection with ACE2-dependent coronaviruses in vitro and is protective against SARS-CoV-2 in mice
    Sci Transl Med15, eadh7668-eadh7668. PubMed  Europe PubMed DOI  I
  56. Ferreira-Duarte,M., Oliveira,L.C.G., Quintas,C., Esteves-Monteiro,M., Duarte-Araujo,M., Sousa,T., Casarini,D.E. and Morato,M.
    ACE and ACE2 catalytic activity in the fecal content along the gut
    Neurogastroenterol Motile14598-e14598. PubMed  Europe PubMed DOI
  57. Gupta,P. and Rani,V.
    The Surging Mechanistic Role of Angiotensin Converting Enzyme 2 in Human Pathologies: A Potential Approach for Herbal Therapeutics
    Curr Drug Targets24, 1046-1054. PubMed  Europe PubMed DOI  V
  58. Harman,M.A.J., Stanway,S.J., Scott,H., Demydchuk,Y., Bezerra,G.A., Pellegrino,S., Chen,L., Brear,P., Lulla,A., Hyvonen,M., Beswick,P.J. and Skynner,M.J.
    Structure-Guided Chemical Optimization of Bicyclic Peptide (Bicycle) Inhibitors of Angiotensin-Converting Enzyme 2
    J Med Chem66, 9881-9893. PubMed  Europe PubMed DOI  I
  59. Jami,G., Ataee,M., Esmaeili,V., Chamani,S., Rezaei,A. and Naghizadeh,A.
    Characterization of the angiotensin-converting enzyme 2 (ACE2), the main receptor for the SARS-CoV-2 virus
    Am J Clin Exp Immunol12, 24-44. PubMed  Europe PubMed
  60. Kamthe,D.D., Sarangkar,S.D., Dalvi,M.S., Gosavi,N.A. and Nikam,V.S.
    Angiotensin converting enzyme 2 level and its significance in COVID-19 and other diseases patients
    Eur J Clin Invest53, e13891-e13891. PubMed  Europe PubMed DOI
  61. Kralova,E., Hadova,K., Cinakova,A., Krenek,P. and Klimas,J.
    Pioglitazone Alters Ace/Ace 2 Balance to Favour Ace2 Independently Of Glycaemia Levels in Diabetic Rat Heart
    Pharmazie78, 122-127. PubMed  Europe PubMed DOI
  62. Kunvariya,A.D., Dave,S.A., Modi,Z.J., Patel,P.K. and Sagar,S.R.
    Exploration of multifaceted molecular mechanism of angiotensin-converting enzyme 2 (ACE2) in pathogenesis of various diseases
    Heliyon9, e15644-e15644. PubMed  Europe PubMed DOI  V
  63. Li,Z., Hasson,A., Daggumati,L., Zhang,H. and Thorek,D.L.J.
    Molecular Imaging of ACE2 Expression in Infectious Disease and Cancer
    Viruses15, PubMed  Europe PubMed DOI  V
  64. Magazine,R., Chogtu,B. and Bhat,A.
    Role of Angiotensin Converting Enzyme-2 and its modulation in disease: exploring new frontiers
    Med Pharm Rep96, 146-153. PubMed  Europe PubMed DOI  V
  65. Meyers,W.M., Hong,R.J., Sin,W.C., Kim,C.S. and Haas,K.
    A cell-based assay for rapid assessment of ACE2 catalytic function
    Sci Rep13, 14123-14123. PubMed  Europe PubMed DOI
  66. Mohammed,M., Ogunlade,B., Elgazzaz,M., Berdasco,C., Lakkappa,N., Ghita,I., Guidry,J.J., Sriramula,S., Xu,J., Restivo,L., Mendiola Pla,M.A., Bowles,D.E., Beyer,A.M., Yue,X., Lazartigues,E. and Filipeanu,C.M.
    Nedd4-2 upregulation is associated with ACE2 ubiquitination in hypertension
    Cardiovasc Res119, 2130-2141. PubMed  Europe PubMed DOI
  67. Pan,Y.
    Angiotensin-converting enzyme 2 G8790A polymorphisms are associated with COVID-19 severity
    J Infect Dev Ctries17, 819-825. PubMed  Europe PubMed DOI  V
  68. Reveret,L., Leclerc,M., Emond,V., Tremblay,C., Loiselle,A., Bourassa,P., Bennett,D.A., Hebert,S.S. and Calon,F.
    Higher angiotensin-converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer's disease
    Acta Neuropathol Commun11, 159-159. PubMed  Europe PubMed DOI
  69. Shovlin,C.L. and Vizcaychipi,M.P.
    Vascular inflammation and endothelial injury in SARS-CoV-2 infection: The overlooked regulatory cascades implicated by the ACE2 gene cluster
    QJM116, 629-634. PubMed  Europe PubMed DOI
  70. Song,X., Hu,W., Yu,H., Zhao,L., Zhao,Y., Zhao,X., Xue,H.H. and Zhao,Y.
    Little to no expression of angiotensin-converting enzyme-2 on most human peripheral blood immune cells but highly expressed on tissue macrophages
    Cytometry A103, 136-145. PubMed  Europe PubMed DOI
  71. Wang,C.W., Chuang,H.C. and Tan,T.H.
    ACE2 in chronic disease and COVID-19: gene regulation and post-translational modification
    J Biomed Sci30, 71-71. PubMed  Europe PubMed DOI  V
  72. Wang,Z., Fan,H., Bao,X. and Wu,J.
    Angiotensin-Converting Enzyme 2 Activation Is Not a Common Feature of Angiotensin-Converting Enzyme Inhibitory Peptides
    J Agric Food Chem71, 8867-8876. PubMed  Europe PubMed DOI
  73. Wei,L., Chen,Y., Feng,X., Yao,J., Zhang,L., Zhou,X., Yan,G., Qiu,H., Wang,C. and Lu,H.
    Elucidation of N-/O-glycosylation and site-specific mapping of sialic acid linkage isomers of SARS-CoV-2 human receptor angiotensin-converting enzyme 2
    Analyst148, 5002-5011. PubMed  Europe PubMed DOI
  74. Wrobel,A.G.
    Mechanism and evolution of human ACE2 binding by SARS-CoV-2 spike
    Curr Opin Struct Biol81, 102619-102619. PubMed  Europe PubMed DOI  V
  75. Xiao,Y., Chang,L., Ji,H., Sun,H., Song,S., Feng,K., Nuermaimaiti,A., Halemubieke,S., Mei,L., Lu,Z., Yan,Y. and Wang,L.
    Posttranslational modifications of ACE2 protein: Implications for SARS-CoV-2 infection and beyond
    J Med Virol95, e29304-e29304. PubMed  Europe PubMed DOI
  76. Zhang,W., Golynker,I., Brosh,R., Fajardo,A., Zhu,Y., Wudzinska,A.M., Ordonez,R., Ribeiro-Dos-Santos,A.M., Carrau,L., Damani-Yokota,P., Yeung,S.T., Khairallah,C., Vela Gartner,A., Chalhoub,N., Huang,E., Ashe,H.J., Khanna,K.M., Maurano,M.T., Kim,S.Y., tenOever,B.R. and Boeke,J.D.
    Mouse genome rewriting and tailoring of three important disease loci
    Nature623, 423-431. PubMed  Europe PubMed DOI
  77. Zhou,G. and Liu,J.
    Prognostic value of elevated plasma angiotensin-converting enzyme 2 in cardiometabolic diseases: A review
    Medicine (Baltimore)102, e33251-e33251. PubMed  Europe PubMed DOI
  78. Zhu,Y., Zhang,S., Wang,Z., Wang,Z. and Zhu,S.
    ACE2 Receptor: A Potential Pharmacological Target in COVID-19
    Curr Protein Pept Sci24, 701-710. PubMed  Europe PubMed DOI
  79. 2022
  80. Alfaleh,M.A., Zawawi,A., Al-Amri,S.S. and Hashem,A.M.
    David versus goliath: ACE2-Fc receptor traps as potential SARS-CoV-2 inhibitors
    MAbs14, 2057832-2057832. PubMed  Europe PubMed DOI  V
  81. Alfaro,E., Diaz-Garcia,E., Garcia-Tovar,S., Zamarron,E., Mangas,A., Galera,R., Nanwani-Nanwani,K., Perez-de-Diego,R., Lopez-Collazo,E., Garcia-Rio,F. and Cubillos-Zapata,C.
    Impaired Kallikrein-Kinin System in COVID-19 Patients' Severity
    Front Immunol13, 909342-909342. PubMed  Europe PubMed DOI
  82. Badawi,S., Mohamed,F.E., Alkhofash,N.R., John,A., Ali,A. and Ali,B.R.
    Characterization of ACE2 naturally occurring missense variants: impact on subcellular localization and trafficking
    Hum Genomics16, 35-35. PubMed  Europe PubMed DOI
  83. Baharin,A., Ting,T.Y. and Goh,H.H.
    Post-Proline Cleaving Enzymes (PPCEs): Classification, Structure, Molecular Properties, and Applications
    Plants (Basel)11, PubMed  Europe PubMed DOI  V
  84. Batlle,D., Monteil,V., Garreta,E., Hassler,L., Wysocki,J., Chandar,V., Schwartz,R.E., Mirazimi,A., Montserrat,N., Bader,M. and Penninger,J.M.
    Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity
    Cell185, 1837-1839. PubMed  Europe PubMed DOI
  85. Bauer,M.S., Gruber,S., Hausch,A., Gomes,P.S.F.C., Milles,L.F., Nicolaus,T., Schendel,L.C., Navajas,P.L., Procko,E., Lietha,D., Melo,M.C.R., Bernardi,R.C., Gaub,H.E. and Lipfert,J.
    A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions
    Proc Natl Acad Sci U S A119, e2114397119-e2114397119. PubMed  Europe PubMed DOI
  86. Bhushan,S., Xiao,Z., Gao,K., Mao,L., Chen,J., Ping,W., Hong,W. and Zhang,Z.
    Role and Interaction Between ACE1, ACE2 and Their Related Genes in Cardiovascular Disorders
    Curr Probl Cardiol101162-101162. PubMed  Europe PubMed DOI
  87. Chakraborty,S., Ghosh,S. and Mondal,T.
    Decoding molecular factors shaping human angiotensin converting enzyme 2 receptor usage by spike glycoprotein in lineage B beta-coronaviruses
    Biochim Biophys Acta Mol Basis Dis1868, 166514-166514. PubMed  Europe PubMed DOI
  88. Devaux,C.A. and Camoin-Jau,L.
    An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection
    Front Microbiol13, 1042200-1042200. PubMed  Europe PubMed DOI  V
  89. Fast,L., Agren,R. and Zeberg,H.
    Fluorescence-Based Measurements of Membrane-Bound Angiotensin Converting Enzyme 2 Activity Using Xenopus Laevis Oocytes
    Biosensors (Basel)12, PubMed  Europe PubMed DOI
  90. Govender,N., Khaliq,O., Moodley,J. and Naicker,T.
    Unravelling the Mechanistic Role of ACE2 and TMPRSS2 in Hypertension: A Risk Factor for COVID-19
    Curr Hypertens Rev18, 130-137. PubMed  Europe PubMed DOI  V
  91. Han,P., Li,L., Liu,S., Wang,Q., Zhang,D., Xu,Z., Han,P., Li,X., Peng,Q., Su,C., Huang,B., Li,D., Zhang,R., Tian,M., Fu,L., Gao,Y., Zhao,X., Liu,K., Qi,J., Gao,G.F. and Wang,P.
    Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
    Cell185, 630-640. PubMed  Europe PubMed DOI
  92. Healy,E.F.
    How tetraspanin-mediated cell entry of SARS-CoV-2 can dysregulate the shedding of the ACE2 receptor by ADAM17
    Biochem Biophys Res Commun593, 52-56. PubMed  Europe PubMed DOI
  93. Hong,Q., Han,W., Li,J., Xu,S., Wang,Y., Xu,C., Li,Z., Wang,Y., Zhang,C., Huang,Z. and Cong,Y.
    Molecular basis of receptor binding and antibody neutralization of Omicron
    Nature604, 546-552. PubMed  Europe PubMed DOI
  94. Huang,G., Wang,Y., Qin,L., Huang,B. and Yu,X.
    Association and functional analysis of angiotensin-converting enzyme 2 genetic variants with the pathogenesis of pre-eclampsia
    Front Endocrinol (Lausanne)13, 926512-926512. PubMed  Europe PubMed DOI
  95. Li,L., Liao,H., Meng,Y., Li,W., Han,P., Liu,K., Wang,Q., Li,D., Zhang,Y., Wang,L., Fan,Z., Zhang,Y., Wang,Q., Zhao,X., Sun,Y., Huang,N., Qi,J. and Gao,G.F.
    Structural basis of human ACE2 higher binding affinity to currently circulating Omicron SARS-CoV-2 sub-variants BA.2 and BA.1.1
    Cell185, 2952-2960. PubMed  Europe PubMed DOI
  96. Ling,J., Peng,N. and Luo,L.
    ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma
    J Clin Lab Anal36, e24362-e24362. PubMed  Europe PubMed DOI
  97. Liu,P., Zhang,Y., Li,Z., Huang,J., Wang,T. and Chen,C.
    Structural insights revealed by crystal structure of B38-CAP, an isoenzyme of carboxypeptidase ACE2, the receptor of SARS-CoV-2
    Biochem Biophys Res Commun606, 17-22. PubMed  Europe PubMed DOI
  98. MacGowan,S.A., Barton,M.I., Kutuzov,M., Dushek,O., van der Merwe,P.A. and Barton,G.J.
    Missense variants in human ACE2 strongly affect binding to SARS-CoV-2 Spike providing a mechanism for ACE2 mediated genetic risk in Covid-19: A case study in affinity predictions of interface variants
    PLoS Comput Biol18, e1009922-e1009922. PubMed  Europe PubMed DOI
  99. Mariappan,V., Ranganadin,P., Shanmugam,L., Rao,S.R. and Balakrishna Pillai,A.
    Early shedding of membrane-bounded ACE2 could be an indicator for disease severity in SARS-CoV-2
    Biochimie201, 139-147. PubMed  Europe PubMed DOI
  100. Moreira,G., Casso-Hartmann,L., Datta,S.P.A., Dean,D., McLamore,E. and Vanegas,D.
    Development of a Biosensor Based on Angiotensin-Converting Enzyme II for Severe Acute Respiratory Syndrome Coronavirus 2 Detection in Human Saliva
    Front Sens (Lausanne)3, PubMed  Europe PubMed DOI
  101. Shatizadeh Malekshahi,S., Yavarian,J. and Shafiei-Jandaghi,N.Z.
    Usage of peptidases by SARS-CoV-2 and several human coronaviruses as receptors: A mysterious story
    Biotechnol Appl Biochem69, 124-128. PubMed  Europe PubMed DOI
  102. Sohaei,D., Hollenberg,M., Janket,S.J., Diamandis,E.P., Poda,G. and Prassas,I.
    The therapeutic relevance of the Kallikrein-Kinin axis in SARS-cov-2-induced vascular pathology
    Crit Rev Clin Lab Sci1-16. PubMed  Europe PubMed DOI  V
  103. Song,J., Hu,B., Qu,H., Wang,L., Huang,X., Li,M. and Zhang,M.
    Corrigendum to "Upregulation of angiotensin converting enzyme 2 by shear stress reduced inflammation and proliferation in vascular endothelial cells" [Biochem. Biophys. Res. Commun. 525(3) (2020) 812-818]
    Biochem Biophys Res Commun632, 204-205. PubMed  Europe PubMed DOI
  104. Starr,T.N., Zepeda,S.K., Walls,A.C., Greaney,A.J., Alkhovsky,S., Veesler,D. and Bloom,J.D.
    ACE2 binding is an ancestral and evolvable trait of sarbecoviruses
    Nature603, 913-918. PubMed  Europe PubMed DOI
  105. Wang,Y., Zhang,Y., Zhang,L., Li,M., Zhu,P., Ji,W., Liang,R., Qiin,L., Wu,W., Feng,F. and Jin,Y.
    [Angiotensin-converting enzyme 2 particapates in ozone-induced lung inflammation and airway remodeling in mice]
    Nan Fang Yi Ke Da Xue Xue Bao42, 860-867. PubMed  Europe PubMed DOI
  106. Xiong,Q., Cao,L., Ma,C., Tortorici,M.A., Liu,C., Si,J., Liu,P., Gu,M., Walls,A.C., Wang,C., Shi,L., Tong,F., Huang,M., Li,J., Zhao,C., Shen,C., Chen,Y., Zhao,H., Lan,K., Corti,D., Veesler,D., Wang,X. and Yan,H.
    Close relatives of MERS-CoV in bats use ACE2 as their functional receptors
    Nature612, 748-757. PubMed  Europe PubMed DOI
  107. Xu,J. and Lazartigues,E.
    Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus
    Cell Mol Neurobiol42, 305-309. PubMed  Europe PubMed DOI
  108. Yang,G., Wang,W., Han,S., Xu,S. and Liu,H.
    Effect of microRNA-181b on the biological characteristics and clinical drug resistance of small-cell lung cancer by targeting angiotensin converting enzyme 2
    Thorac Cancer13, 742-749. PubMed  Europe PubMed DOI
  109. Yang,Z., Macdonald-Dunlop,E., Chen,J., Zhai,R., Li,T., Richmond,A., Klaric,L., Pirastu,N., Ning,Z., Zheng,C., Wang,Y., Huang,T., He,Y., Guo,H., Ying,K., Gustafsson,S., Prins,B., Ramisch,A., Dermitzakis,E.T., Png,G., Eriksson,N., Haessler,J., Hu,X., Zanetti,D., Boutin,T., Hwang,S.J., Wheeler,E., Pietzner,M., Raffield,L.M., Kalnapenkis,A., Peters,J.E., Vinuela,A., Gilly,A., Elmstahl,S., Dedoussis,G., Petrie,J.R., Polasek,O., Folkersen,L., Chen,Y., Yao,C., Vosa,U., Pairo-Castineira,E., Clohisey,S., Bretherick,A.D., Rawlik,K., Esko,T., Enroth,S., Johansson,A., Gyllensten,U., Langenberg,C., Levy,D., Hayward,C., Assimes,T.L., Kooperberg,C., Manichaikul,A.W., Siegbahn,A., Wallentin,L., Lind,L., Zeggini,E., Schwenk,J.M., Butterworth,A.S., Michaelsson,K., Pawitan,Y., Joshi,P.K., Baillie,J.K., Malarstig,A., Reiner,A.P., Wilson,J.F. and Shen,X.
    Genetic Landscape of the ACE2 Coronavirus Receptor
    Circulation145, 1398-1411. PubMed  Europe PubMed DOI
  110. Yeung,M.L., Teng,J.L.L. and Yuen,K.Y.
    Response to Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity
    Cell185, 1840-1841. PubMed  Europe PubMed DOI
  111. Yin,W., Xu,Y., Xu,P., Cao,X., Wu,C., Gu,C., He,X., Wang,X., Huang,S., Yuan,Q., Wu,K., Hu,W., Huang,Z., Liu,J., Wang,Z., Jia,F., Xia,K., Liu,P., Wang,X., Song,B., Zheng,J., Jiang,H., Cheng,X., Jiang,Y., Deng,S.J. and Xu,H.E.
    Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody
    Science375, 1048-1053. PubMed  Europe PubMed DOI
  112. Yousif,A., Mir,R., Javid,J., Barnawi,J., Jalal,M.M., Altayar,M.A., Albalawi,S.O. and Abuduhier,F.M.
    Clinical Utility of Amplification Refractory Mutation System-Based PCR and Mutation-Specific PCR for Precise and Rapid Genotyping of Angiotensin-Converting Enzyme 1 (ACE1-rs4646996 D>I) and Angiotensin-Converting Enzyme 2 (ACE2-rs4240157T>C) Gene Variations in Coronary Artery Disease and Their Strong Association with Its Disease Susceptibility and Progression
    Diagnostics (Basel)12, PubMed  Europe PubMed DOI
  113. Zhang,Y., Yan,R. and Zhou,Q.
    ACE2, B(0)AT1, and SARS-CoV-2 spike protein: Structural and functional implications
    Curr Opin Struct Biol74, 102388-102388. PubMed  Europe PubMed DOI  V
  114. Zheng,M.
    ACE2 and COVID-19 Susceptibility and Severity
    Aging Dis13, 360-372. PubMed  Europe PubMed DOI
  115. 2021
  116. Ahsan,T. and Sajib,A.A.
    Repurposing of approved drugs with potential to interact with SARS-CoV-2 receptor
    Biochem Biophys Rep26, 100982-100982. PubMed  Europe PubMed DOI
  117. Al-Benna,S.
    Gene Expression of Angiotensin-Converting Enzyme 2 Receptor in Skin and the Implications for COVID-19
    Adv Skin Wound Care34, 31-35. PubMed  Europe PubMed DOI
  118. Al-Mulla,F., Mohammad,A., Al Madhoun,A., Haddad,D., Ali,H., Eaaswarkhanth,M., John,S.E., Nizam,R., Channanath,A., Abu-Farha,M., Ahmad,R., Abubaker,J. and Thanaraj,T.A.
    ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: A time to implement precision medicine against COVID-19
    Heliyon7, e06133-e06133. PubMed  Europe PubMed DOI
  119. Albashir,A.A.D.
    Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors and Coronavirus Disease 2019 (COVID-19)
    South Med J114, 51-56. PubMed  Europe PubMed DOI  V
  120. Aleksova,A., Gagno,G., Sinagra,G., Beltrami,A.P., Janjusevic,M., Ippolito,G., Zumla,A., Fluca,A.L. and Ferro,F.
    Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review
    Int J Mol Sci22, PubMed  Europe PubMed DOI
  121. Alexandre,J. and Cracowski,J.L.
    Outcome of patients hospitalized for Covid-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: Results of the ACECoV study
    Fundam Clin Pharmacol35, 192-193. PubMed  Europe PubMed DOI
  122. Ali,M.Y., Zaib,S., Jannat,S. and Khan,I.
    Inhibition of Angiotensin-I Converting Enzyme by Ginsenosides: Structure-Activity Relationships and Inhibitory Mechanism
    J Agric Food Chem69, 6073-6086. PubMed  Europe PubMed DOI
  123. Allison,S.
    Soluble ACE2 in SARS-CoV-2 infection
    Nat Rev Nephrol17, 297-297. PubMed  Europe PubMed DOI
  124. Almasi,F. and Mohammadipanah,F.
    Hypothetical targets and plausible drugs of coronavirus infection caused by SARS-CoV-2
    Transbound Emerg Dis68, 318-332. PubMed  Europe PubMed DOI
  125. Aloufi,N., Traboulsi,H., Ding,J., Fonseca,G.J., Nair,P., Huang,S.K., Hussain,S.N.A., Eidelman,D.H. and Baglole,C.J.
    Angiotensin-converting enzyme 2 (ACE2) expression in COPD and IPF fibroblasts- the forgotten cell in COVID-19
    Am J Physiol Lung Cell Mol Physiol320, L152-L157. PubMed  Europe PubMed DOI
  126. Andrews,P.L.R., Cai,W., Rudd,J.A. and Sanger,G.J.
    COVID-19, nausea, and vomiting
    J Gastroenterol Hepatol36, 646-656. PubMed  Europe PubMed DOI
  127. Arce,V.M. and Costoya,J.A.
    SARS-CoV-2 infection in K18-ACE2 transgenic mice replicates human pulmonary disease in COVID-19
    Cell Mol Immunol PubMed  Europe PubMed DOI
  128. Ayipo,Y.O., Yahaya,S.N., Alananzeh,W.A., Babamale,H.F. and Mordi,M.N.
    Pathomechanisms, therapeutic targets and potent inhibitors of some beta-coronaviruses from bench-to-bedside
    Infect Genet Evol93, 104944-104944. PubMed  Europe PubMed DOI  V  I
  129. Badawi,S. and Ali,B.R.
    ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues
    Hum Genomics15, 8-8. PubMed  Europe PubMed DOI  V
  130. Bakhshandeh,B., Sorboni,S.G., Javanmard,A.R., Mottaghi,S.S., Mehrabi,M.R., Sorouri,F., Abbasi,A. and Jahanafrooz,Z.
    Variants in ACE2; potential influences on virus infection and COVID-19 severity
    Infect Genet Evol90, 104773-104773. PubMed  Europe PubMed DOI  V
  131. Berdowska,I. and Matusiewicz,M.
    Cathepsin L, transmembrane peptidase/serine subfamily member 2/4, and other host proteases in COVID-19 pathogenesis - with impact on gastrointestinal tract
    World J Gastroenterol27, 6590-6600. PubMed  Europe PubMed DOI
  132. Bertoglio,F., Meier,D., Langreder,N., Steinke,S., Rand,U., Simonelli,L., Heine,P.A., Ballmann,R., Schneider,K.T., Roth,K.D.R., Ruschig,M., Riese,P., Eschke,K., Kim,Y., Schackermann,D., Pedotti,M., Kuhn,P., Zock-Emmenthal,S., Wohrle,J., Kilb,N., Herz,T., Becker,M., Grasshoff,M., Wenzel,E.V., Russo,G., Kroger,A., Brunotte,L., Ludwig,S., Fuhner,V., Kramer,S.D., Dubel,S., Varani,L., Roth,G., Cicin-Sain,L., Schubert,M. and Hust,M.
    SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface
    Nat Commun12, 1577-1577. PubMed  Europe PubMed DOI
  133. Beumer,J., Geurts,M.H., Lamers,M.M., Puschhof,J., Zhang,J., van der Vaart,J., Mykytyn,A.Z., Breugem,T.I., Riesebosch,S., Schipper,D., van den Doel,P.B., de Lau,W., Pleguezuelos-Manzano,C., Busslinger,G., Haagmans,B.L. and Clevers,H.
    A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses
    Nat Commun12, 5498-5498. PubMed  Europe PubMed DOI
  134. Beyerstedt,S., Casaro,E.B. and Rangel,E.B.
    COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection
    Eur J Clin Microbiol Infect Dis PubMed  Europe PubMed DOI
  135. Bhattacharya,R., Gupta,A.M., Mitra,S., Mandal,S. and Biswas,S.R.
    A natural food preservative peptide nisin can interact with the SARS-CoV-2 spike protein receptor human ACE2
    Virology552, 107-111. PubMed  Europe PubMed DOI
  136. Bitossi,C., Frasca,F., Viscido,A., Oliveto,G., Scordio,M., Belloni,L., Cimino,G., Pietropaolo,V., Gentile,M., d'Ettorre,G., Midulla,F., Trancassini,M., Antonelli,G., Pierangeli,A. and Scagnolari,C.
    SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients
    Microorganisms9, PubMed  Europe PubMed DOI
  137. Blume,C., Jackson,C.L., Spalluto,C.M., Legebeke,J., Nazlamova,L., Conforti,F., Perotin,J.M., Frank,M., Butler,J., Crispin,M., Coles,J., Thompson,J., Ridley,R.A., Dean,L.S.N., Loxham,M., Reikine,S., Azim,A., Tariq,K., Johnston,D.A., Skipp,P.J., Djukanovic,R., Baralle,D., McCormick,C.J., Davies,D.E., Lucas,J.S., Wheway,G. and Mennella,V.
    A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection
    Nat Genet53, 205-214. PubMed  Europe PubMed DOI
  138. Bozgeyik,I.
    Therapeutic potential of miRNAs targeting SARS-CoV-2 host cell receptor ACE2
    Meta Gene27, 100831-100831. PubMed  Europe PubMed DOI
  139. Buitron-Gonzalez,I., Aguilera-Duran,G. and Romo-Mancillas,A.
    In-silico drug repurposing study: Amprenavir, enalaprilat, and plerixafor, potential drugs for destabilizing the SARS-CoV-2 S-protein-angiotensin-converting enzyme 2 complex
    Results Chem3, 100094-100094. PubMed  Europe PubMed DOI  I
  140. Cao,W., Dong,C., Kim,S., Hou,D., Tai,W., Du,L., Im,W. and Zhang,X.F.
    Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction
    Biophys J PubMed  Europe PubMed DOI
  141. Cao,X., Song,L.N. and Yang,J.K.
    ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders
    Clin Sci (Lond)135, 535-554. PubMed  Europe PubMed DOI
  142. Chakraborty,S.
    Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity
    Biochem Biophys Res Commun538, 97-103. PubMed  Europe PubMed DOI
  143. Chen,C., Boorla,V.S., Banerjee,D., Chowdhury,R., Cavener,V.S., Nissly,R.H., Gontu,A., Boyle,N.R., Vandegrift,K., Nair,M.S., Kuchipudi,S.V. and Maranas,C.D.
    Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike RBD and human ACE2
    Proc Natl Acad Sci U S A118, PubMed  Europe PubMed DOI
  144. Choudhary,S., Sreenivasulu,K., Mitra,P., Misra,S. and Sharma,P.
    Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19
    Ann Lab Med41, 129-138. PubMed  Europe PubMed DOI
  145. Cubuk,H. and Ozbil,M.
    Comparison of clinically approved molecules on SARS-CoV-2 drug target proteins: a molecular docking study
    Turk J Chem45, 35-41. PubMed  Europe PubMed DOI  I
  146. Dash,P., Turuk,J., Behera,S.K., Palo,S.K., Raghav,S.K., Ghosh,A., Sabat,J., Rath,S., Subhadra,S., Rana,K., Bhattacharya,D., Kanungo,S., Kshatri,J.S., Mishra,B.K., Dash,S., Parida,A. and Pati,S.
    Sequence analysis of Indian SARS-CoV-2 isolates shows a stronger interaction of mutated receptor binding domain with ACE2 receptor
    Int J Infect Dis PubMed  Europe PubMed DOI
  147. Deng,Q., Rasool,R.U., Russell,R.M., Natesan,R. and Asangani,I.A.
    Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19
    iScience24, 102254-102254. PubMed  Europe PubMed DOI
  148. Du,Y., Shi,R., Zhang,Y., Duan,X., Li,L., Zhang,J., Wang,F., Zhang,R., Shen,H., Wang,Y., Wu,Z., Peng,Q., Pan,T., Sun,W., Huang,W., Feng,Y., Feng,H., Xiao,J., Tan,W., Wang,Y., Wang,C. and Yan,J.
    A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants
    Nat Commun12, 5000-5000. PubMed  Europe PubMed DOI
  149. Egieyeh,S., Egieyeh,E., Malan,S., Christofells,A. and Fielding,B.
    Computational drug repurposing strategy predicted peptide-based drugs that can potentially inhibit the interaction of SARS-CoV-2 spike protein with its target (humanACE2)
    PLoS ONE16, e0245258-e0245258. PubMed  Europe PubMed DOI
  150. Evans,J.P. and Liu,S.L.
    Role of host factors in SARS-CoV-2 entry
    J Biol Chem297, 100847-100847. PubMed  Europe PubMed DOI
  151. Flinn,B., Royce,N., Gress,T., Chowdhury,N. and Santanam,N.
    Dual role for angiotensin-converting enzyme 2 in Severe Acute Respiratory Syndrome Coronavirus 2 infection and cardiac fat
    Obes Rev PubMed  Europe PubMed DOI  V
  152. Forouzesh,N. and Mishra,N.
    An Effective MM/GBSA Protocol for Absolute Binding Free Energy Calculations: A Case Study on SARS-CoV-2 Spike Protein and the Human ACE2 Receptor
    Molecules26, PubMed  Europe PubMed DOI
  153. Freitas,F.C., Ferreira,P.H.B., Favaro,D.C. and Oliveira,R.J.
    Shedding Light on the Inhibitory Mechanisms of SARS-CoV-1/CoV-2 Spike Proteins by ACE2-Designed Peptides
    J Chem Inf Model61, 1226-1243. PubMed  Europe PubMed DOI
  154. Gangadevi,S., Badavath,V.N., Thakur,A., Yin,N., De Jonghe,S., Acevedo,O., Jochmans,D., Leyssen,P., Wang,K., Neyts,J., Yujie,T. and Blum,G.
    Kobophenol A Inhibits Binding of Host ACE2 Receptor with Spike RBD Domain of SARS-CoV-2, a Lead Compound for Blocking COVID-19
    J Phys Chem Lett12, 1793-1802. PubMed  Europe PubMed DOI
  155. Garcia-Escobar,A., Jimenez-Valero,S., Galeote,G., Jurado-Roman,A., Garcia-Rodriguez,J. and Moreno,R.
    The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: new insights for heart failure and COVID19
    Heart Fail Rev PubMed  Europe PubMed DOI  V
  156. Ge,J., Wang,R., Ju,B., Zhang,Q., Sun,J., Chen,P., Zhang,S., Tian,Y., Shan,S., Cheng,L., Zhou,B., Song,S., Zhao,J., Wang,H., Shi,X., Ding,Q., Liu,L., Zhao,J., Zhang,Z., Wang,X. and Zhang,L.
    Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
    Nat Commun12, 250-250. PubMed  Europe PubMed DOI
  157. Ge,S., Lu,J., Hou,Y., Lv,Y., Wang,C. and He,H.
    Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2
    Virology560, 110-115. PubMed  Europe PubMed DOI
  158. Getachew,B. and Tizabi,Y.
    Vitamin D and COVID-19: Role of ACE2, age, gender, and ethnicity
    J Med Virol PubMed  Europe PubMed DOI  V
  159. Glasgow,J., Glasgow,A., Kortemme,T. and Wells,J.A.
    Reply to Liu et al.: Specific mutations matter in specificity and catalysis in ACE2
    Proc Natl Acad Sci U S A118, PubMed  Europe PubMed DOI
  160. Gomez-Zorita,S., Milton-Laskibar,I., Garcia-Arellano,L., Gonzalez,M. and Portillo,M.P.
    An Overview of Adipose Tissue ACE2 Modulation by Diet and Obesity. Potential Implications in COVID-19 Infection and Severity
    Int J Mol Sci22, PubMed  Europe PubMed DOI  V
  161. Gottschalk,G., Knox,K. and Roy,A.
    ACE2: At the crossroad of COVID-19 and lung cancer
    Gene Rep23, 101077-101077. PubMed  Europe PubMed DOI  V
  162. Graier,T., Golob-Schwarzl,N., Weger,W., Benezeder,T., Painsi,C., Salmhofer,W. and Wolf,P.
    Furin Expression in Patients With Psoriasis-A Patient Cohort Endangered to SARS-COV2?
    Front Med (Lausanne)8, 624462-624462. PubMed  Europe PubMed DOI
  163. Guo,Y., Wang,B., Gao,H., Gao,L., Hua,R. and Xu,J.D.
    ACE2 in the Gut: The Center of the 2019-nCoV Infected Pathology
    Front Mol Biosci8, 708336-708336. PubMed  Europe PubMed DOI  V
  164. Hamet,P., Pausova,Z., Attaoua,R., Hishmih,C., Haloui,M., Shin,J., Paus,T., Abrhamowicz,M., Gaudet,D., Santucci,L., Kotchen,T.A., Cowley,A.W., Hussin,J. and Tremblay,J.
    SARS-COV-2 RECEPTOR ACE2 GENE is associated with hypertension and SEVERity of COVID 19: interaction with sex, obesity and SMOKING
    Am J Hypertens PubMed  Europe PubMed DOI
  165. Han,P., Su,C., Zhang,Y., Bai,C., Zheng,A., Qiao,C., Wang,Q., Niu,S., Chen,Q., Zhang,Y., Li,W., Liao,H., Li,J., Zhang,Z., Cho,H., Yang,M., Rong,X., Hu,Y., Huang,N., Yan,J., Wang,Q., Zhao,X., Gao,G.F. and Qi,J.
    Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants
    Nat Commun12, 6103-6103. PubMed  Europe PubMed DOI
  166. Healy,E.F. and Lilic,M.
    A model for COVID-19-induced dysregulation of ACE2 shedding by ADAM17
    Biochem Biophys Res Commun573, 158-163. PubMed  Europe PubMed DOI
  167. Higuchi,Y., Suzuki,T., Arimori,T., Ikemura,N., Mihara,E., Kirita,Y., Ohgitani,E., Mazda,O., Motooka,D., Nakamura,S., Sakai,Y., Itoh,Y., Sugihara,F., Matsuura,Y., Matoba,S., Okamoto,T., Takagi,J. and Hoshino,A.
    Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2
    Nat Commun12, 3802-3802. PubMed  Europe PubMed DOI
  168. Hmazzou,R., Marc,Y., Flahault,A., Gerbier,R., de Mota,N. and Llorens-Cortes,C.
    Brain ACE2 activation following brain aminopeptidase A blockade by firibastat in salt-dependent hypertension
    Clin Sci (Lond)135, 775-791. PubMed  Europe PubMed DOI
  169. Huo,J., Bas,A.L., Ruza,R.R., Duyvesteyn,H.M.E., Mikolajek,H., Malinauskas,T., Tan,T.K., Rijal,P., Dumoux,M., Ward,P.N., Ren,J., Zhou,D., Harrison,P.J., Weckener,M., Clare,D.K., Vogirala,V.K., Radecke,J., Moynie,L., Zhao,Y., Gilbert-Jaramillo,J., Knight,M.L., Tree,J.A., Buttigieg,K.R., Coombes,N., Elmore,M.J., Carroll,M.W., Carrique,L., Shah,P.N.M., James,W., Townsend,A.R., Stuart,D.I., Owens,R.J. and Naismith,J.H.
    Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
    Nat Struct Mol Biol PubMed  Europe PubMed DOI
  170. Hussain,A., Tang,O., Sun,C., Jia,X., Selvin,E., Nambi,V., Folsom,A., Heiss,G., Zannad,F., Mosley,T., Virani,S.S., Coresh,J., Boerwinkle,E., Yu,B., Cunningham,J.W., Shah,A.M., Solomon,S.D., de Lemos,J.A., Hoogeveen,R.C. and Ballantyne,C.M.
    Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (From the Atherosclerosis Risk in Communities Study)
    Am J Cardiol PubMed  Europe PubMed DOI
  171. Jackson,C.B., Farzan,M., Chen,B. and Choe,H.
    Mechanisms of SARS-CoV-2 entry into cells
    Nat Rev Mol Cell Biol PubMed  Europe PubMed DOI  V
  172. Jia,G.H. and Sowers,J.R.
    Management of hypertension in patients with COVID-19: Implication of angiotensin-converting enzyme 2
    Cardiol Plus6, 210-217. PubMed  Europe PubMed DOI  V
  173. Karakas Celik,S., Cakmak Genc,G., Piskin,N., Acikgoz,B., Altinsoy,B., Kurucu Issiz,B. and Dursun,A.
    Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study
    J Med Virol PubMed  Europe PubMed DOI
  174. Kermani,N.Z., Song,W.J., Badi,Y., Versi,A., Guo,Y., Sun,K., Bhavsar,P., Howarth,P., Dahlen,S.E., Sterk,P.J., Djukanovic,R., Adcock,I.M. and Chung,K.F.
    Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma
    Respir Res22, 10-10. PubMed  Europe PubMed DOI
  175. Khoury,E.E., Knaney,Y., Fokra,A., Kinaneh,S., Azzam,Z., Heyman,S.N. and Abassi,Z.
    Pulmonary, cardiac and renal distribution of ACE2, furin, TMPRSS2 and ADAM17 in rats with heart failure: Potential implication for COVID-19 disease
    J Cell Mol Med PubMed  Europe PubMed DOI
  176. Kiseleva,A.A., Troisi,E.M., Hensley,S.E., Kohli,R.M. and Epstein,J.A.
    SARS-CoV-2 spike protein binding selectively accelerates substrate-specific catalytic activity of ACE2
    J Biochem PubMed  Europe PubMed DOI
  177. Koehler,M., Ray,A., Moreira,R.A., Juniku,B., Poma,A.B. and Alsteens,D.
    Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants
    Nat Commun12, 6977-6977. PubMed  Europe PubMed DOI
  178. Kragstrup,T.W., Singh,H.S., Grundberg,I., Nielsen,A.L., Rivellese,F., Mehta,A., Goldberg,M.B., Filbin,M.R., Qvist,P. and Bibby,B.M.
    Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients
    PLoS ONE16, e0252799-e0252799. PubMed  Europe PubMed DOI
  179. Kumar Verma,A., Kumar,V., Singh,S., Goswami,B.C., Camps,I., Sekar,A., Yoon,S. and Lee,K.W.
    Repurposing potential of Ayurvedic medicinal plants derived active principles against SARS-CoV-2 associated target proteins revealed by molecular docking, molecular dynamics and MM-PBSA studies
    Biomed Pharmacother137, 111356-111356. PubMed  Europe PubMed DOI  I
  180. Kuriakose,J., Montezano,A.C. and Touyz,R.M.
    ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease
    Clin Sci (Lond)135, 387-407. PubMed  Europe PubMed DOI  V
  181. Larue,R.C., Xing,E., Kenney,A.D., Zhang,Y., Tuazon,J.A., Li,J., Yount,J.S., Li,P.K. and Sharma,A.
    Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2
    Bioconjug Chem32, 215-223. PubMed  Europe PubMed DOI
  182. Lee,J.H., Choi,M., Jung,Y., Lee,S.K., Lee,C.S., Kim,J., Kim,J., Kim,N.H., Kim,B.T. and Kim,H.G.
    A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2)
    Biosens Bioelectron171, 112715-112715. PubMed  Europe PubMed DOI
  183. Letarov,A.V., Babenko,V.V. and Kulikov,E.E.
    Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection
    Biochemistry (Mosc)86, 257-261. PubMed  Europe PubMed DOI
  184. Li,S., Cai,B., Ma,W., Yang,F., Xu,Y. and Xu,B.
    ACE2 as a key target for treatment of COVID-19 related cardiovascular diseases: current progress and prospect
    Curr Drug Targets PubMed  Europe PubMed DOI  V
  185. Liu,K., Tan,S., Niu,S., Wang,J., Wu,L., Sun,H., Zhang,Y., Pan,X., Qu,X., Du,P., Meng,Y., Jia,Y., Chen,Q., Deng,C., Yan,J., Wang,H.W., Wang,Q., Qi,J. and Gao,G.F.
    Cross-species recognition of SARS-CoV-2 to bat ACE2
    Proc Natl Acad Sci U S A118, PubMed  Europe PubMed DOI
  186. Liu,K., Pan,X., Li,L., Yu,F., Zheng,A., Du,P., Han,P., Meng,Y., Zhang,Y., Wu,L., Chen,Q., Song,C., Jia,Y., Niu,S., Lu,D., Qiao,C., Chen,Z., Ma,D., Ma,X., Tan,S., Zhao,X., Qi,J., Gao,G.F. and Wang,Q.
    Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species
    Cell184, 3438-3451. PubMed  Europe PubMed DOI
  187. Liu,P., Xie,X., Gao,L. and Jin,J.
    His345 mutant of angiotensin-converting enzyme 2 (ACE2) remains enzymatically active against angiotensin II
    Proc Natl Acad Sci U S A118, PubMed  Europe PubMed DOI
  188. Liu,X., Wang,Y.L., Wu,J., Qi,J., Zeng,Z., Wan,Q., Chen,Z., Manandhar,P., Cavener,V.S., Boyle,N.R., Fu,X., Salazar,E., Kuchipudi,S.V., Kapur,V., Zhang,X., Umetani,M., Sen,M., Willson,R.C., Chen,S.H. and Zu,Y.
    Neutralizing Aptamers Block S/RBD-ACE2 Interactions and Prevent Host Cell Infection
    Angew Chem Int Ed Engl PubMed  Europe PubMed DOI
  189. Liu,Y., Hu,G., Wang,Y., Ren,W., Zhao,X., Ji,F., Zhu,Y., Feng,F., Gong,M., Ju,X., Zhu,Y., Cai,X., Lan,J., Guo,J., Xie,M., Dong,L., Zhu,Z., Na,J., Wu,J., Lan,X., Xie,Y., Wang,X., Yuan,Z., Zhang,R. and Ding,Q.
    Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2
    Proc Natl Acad Sci U S A118, PubMed  Europe PubMed DOI
  190. Low-Gan,J., Huang,R., Kelley,A., Jenkins,G.W., McGregor,D. and Smider,V.V.
    Diversity of ACE2 and its interaction with SARS-CoV-2 receptor binding domain
    Biochem J478, 3671-3684. PubMed  Europe PubMed DOI
  191. Luan,B., Wang,H. and Huynh,T.
    Enhanced binding of the N501Y-mutated SARS-CoV-2 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations
    FEBS Lett PubMed  Europe PubMed DOI
  192. Ma,S., Li,H., Yang,J. and Yu,K.
    Molecular simulation studies of the interactions between the human/pangolin/cat/bat ACE2 and the receptor binding domain of the SARS-CoV-2 spike protein
    Biochimie187, 1-13. PubMed  Europe PubMed DOI
  193. Mao,Q., Chu,S., Shapiro,S., Bliss,J.M. and De Paepe,M.E.
    Increased placental expression of angiotensin-converting enzyme 2, the receptor of SARS-CoV-2, associated with hypoxia in twin anemia-polycythemia sequence (TAPS)
    Placenta105, 7-13. PubMed  Europe PubMed DOI
  194. Mehdipour,A.R. and Hummer,G.
    Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
    Proc Natl Acad Sci U S A118, PubMed  Europe PubMed DOI
  195. Muus,C., Luecken,M.D., Eraslan,G., Sikkema,L., Waghray,A., Heimberg,G., Kobayashi,Y., Vaishnav,E.D., Subramanian,A., Smillie,C., Jagadeesh,K.A., Duong,E.T., Fiskin,E., Triglia,E.T., Ansari,M., Cai,P., Lin,B., Buchanan,J., Chen,S., Shu,J., Haber,A.L., Chung,H., Montoro,D.T., Adams,T., Aliee,H., Allon,S.J., Andrusivova,Z., Angelidis,I., Ashenberg,O., Bassler,K., Becavin,C., Benhar,I., Bergenstrahle,J., Bergenstrahle,L., Bolt,L., Braun,E., Bui,L.T., Callori,S., Chaffin,M., Chichelnitskiy,E., Chiou,J., Conlon,T.M., Cuoco,M.S., Cuomo,A.S.E., Deprez,M., Duclos,G., Fine,D., Fischer,D.S., Ghazanfar,S., Gillich,A., Giotti,B., Gould,J., Guo,M., Gutierrez,A.J., Habermann,A.C., Harvey,T., He,P., Hou,X., Hu,L., Hu,Y., Jaiswal,A., Ji,L., Jiang,P., Kapellos,T.S., Kuo,C.S., Larsson,L., Leney-Greene,M.A., Lim,K., Litvinukova,M., Ludwig,L.S., Lukassen,S., Luo,W., Maatz,H., Madissoon,E., Mamanova,L., Manakongtreecheep,K., Leroy,S., Mayr,C.H., Mbano,I.M., McAdams,A.M., Nabhan,A.N., Nyquist,S.K., Penland,L., Poirion,O.B., Poli,S., Qi,C., Queen,R., Reichart,D., Rosas,I., Schupp,J.C., Shea,C.V., Shi,X., Sinha,R., Sit,R.V., Slowikowski,K., Slyper,M., Smith,N.P., Sountoulidis,A., Strunz,M., Sullivan,T.B., Sun,D., Talavera-Lopez,C., Tan,P., Tantivit,J., Travaglini,K.J., Tucker,N.R., Vernon,K.A., Wadsworth,M.H., Waldman,J., Wang,X., Xu,K., Yan,W., Zhao,W. and Ziegler,C.G.K.
    Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics
    Nat Med27, 546-559. PubMed  Europe PubMed DOI
  196. Nath,K.A., Singh,R.D., Grande,J.P., Garovic,V.D., Croatt,A.J., Ackerman,A.W., Barry,M.A. and Agarwal,A.
    Expression of ACE2 in the Intact and Acutely Injured Kidney
    Kidney3602, 1095-1106. PubMed  Europe PubMed DOI
  197. Nomura,H., Kuruppu,S. and Rajapakse,N.W.
    Stimulation of Angiotensin Converting Enzyme 2: A Novel Treatment Strategy for Diabetic Nephropathy
    Front Physiol12, 813012-813012. PubMed  Europe PubMed DOI  V
  198. Ozono,S., Zhang,Y., Ode,H., Sano,K., Tan,T.S., Imai,K., Miyoshi,K., Kishigami,S., Ueno,T., Iwatani,Y., Suzuki,T. and Tokunaga,K.
    SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity
    Nat Commun12, 848-848. PubMed  Europe PubMed DOI
  199. Pagliaro,P., Thairi,C., Alloatti,G. and Penna,C.
    Angiotensin-converting enzyme 2: a key enzyme in key organs
    J Cardiovasc Med (Hagerstown) PubMed  Europe PubMed DOI  V
  200. Paniri,A., Hosseini,M.M., Moballegh-Eslam,M. and Akhavan-Niaki,H.
    Comprehensive in silico identification of impacts of ACE2 SNPs on COVID-19 susceptibility in different populations
    Gene Rep22, 100979-100979. PubMed  Europe PubMed DOI
  201. Perico,L., Benigni,A. and Remuzzi,G.
    Angiotensin-converting enzyme 2: from a vasoactive peptide to the gatekeeper of a global pandemic
    Curr Opin Nephrol Hypertens30, 252-263. PubMed  Europe PubMed DOI  V
  202. Polak,Y. and Speth,R.C.
    Metabolism of angiotensin peptides by angiotensin converting enzyme 2 (ACE2) and analysis of the effect of excess zinc on ACE2 enzymatic activity
    Peptides137, 170477-170477. PubMed  Europe PubMed DOI
  203. Prevost,J., Richard,J., Gasser,R., Ding,S., Fage,C., Anand,S.P., Adam,D., Vergara,N.G., Tauzin,A., Benlarbi,M., Gong,S.Y., Goyette,G., Prive,A., Moreira,S., Charest,H., Roger,M., Mothes,W., Pazgier,M., Brochiero,E., Boivin,G., Abrams,C.F., Schon,A. and Finzi,A.
    Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2
    J Biol Chem101151-101151. PubMed  Europe PubMed DOI
  204. Qi,J., Zhou,Y., Hua,J., Zhang,L., Bian,J., Liu,B., Zhao,Z. and Jin,S.
    The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection
    Int J Environ Res Public Health18, PubMed  Europe PubMed DOI
  205. Raghuvamsi,P.V., Tulsian,N.K., Samsudin,F., Qian,X., Purushotorman,K., Yue,G., Kozma,M.M., Hwa,W.Y., Lescar,J., Bond,P.J., MacAry,P.A. and Anand,G.S.
    SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets
    elife10, PubMed  Europe PubMed DOI
  206. Rahman,M.M., Hasan,M. and Ahmed,A.
    Potential detrimental role of soluble ACE2 in severe COVID-19 comorbid patients
    Rev Med Virol31, 1-12. PubMed  Europe PubMed DOI  V
  207. Rathi,H., Burman,V., Datta,S.K., Rana,S.V., Mirza,A.A., Saha,S., Kumar,R. and Naithani,M.
    Review on COVID-19 Etiopathogenesis, Clinical Presentation and Treatment Available with Emphasis on ACE2
    Indian J Clin Biochem1-20. PubMed  Europe PubMed DOI  V
  208. Refaey,R.H., El-Ashrey,M.K. and Nissan,Y.M.
    Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study
    Virology554, 48-54. PubMed  Europe PubMed DOI  I
  209. Sahu,T., Mehta,A., Ratre,Y.K., Jaiswal,A., Vishvakarma,N.K., Bhaskar,L.V.K.S. and Verma,H.K.
    Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings
    World J Gastroenterol27, 449-469. PubMed  Europe PubMed DOI  V
  210. Samtani,R. and Krishna,K.
    ACE2 and COVID-19: An anthropological perspective
    Anthropol Anz PubMed  Europe PubMed DOI  V
  211. Sarver,D.C. and Wong,G.W.
    Obesity alters Ace2 and Tmprss2 expression in lung, trachea, and esophagus in a sex-dependent manner: Implications for COVID-19
    Biochem Biophys Res Commun538, 92-96-96. PubMed  Europe PubMed DOI
  212. Sato,T., Ueha,R., Goto,T., Yamauchi,A., Kondo,K. and Yamasoba,T.
    Expression of ACE2 and TMPRSS2 Proteins in the Upper and Lower Aerodigestive Tracts of Rats: Implications on COVID 19 Infections
    Laryngoscope131, E932-E939. PubMed  Europe PubMed DOI
  213. Sawa,Y., Ibaragi,S., Okui,T., Yamashita,J., Ikebe,T. and Harada,H.
    Expression of SARS-CoV-2 entry factors in human oral tissue
    J Anat PubMed  Europe PubMed DOI
  214. Scagnolari,C., Bitossi,C., Viscido,A., Frasca,F., Oliveto,G., Scordio,M., Petrarca,L., Mancino,E., Nenna,R., Riva,E., De Vito,C., Midulla,F., Antonelli,G. and Pierangeli,A.
    ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry?
    Cytokine140, 155430-155430. PubMed  Europe PubMed DOI
  215. Schnichels,S., Rohrbach,J.M., Bayyoud,T., Thaler,S., Ziemssen,F. and Hurst,J.
    Can SARS-CoV-2 infect the eye? An overview of the receptor status in ocular tissue
    Ophthalmologe118, 81-84. PubMed  Europe PubMed DOI  V
  216. Seyedpour,S., Khodaei,B., Loghman,A.H., Seyedpour,N., Kisomi,M.F., Balibegloo,M., Nezamabadi,S.S., Gholami,B., Saghazadeh,A. and Rezaei,N.
    Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies
    J Cell Physiol236, 2364-2392. PubMed  Europe PubMed DOI
  217. Seyran,M., Takayama,K., Uversky,V.N., Lundstrom,K., Palu,G., Sherchan,S.P., Attrish,D., Rezaei,N., Aljabali,A.A.A., Ghosh,S., Pizzol,D., Chauhan,G., Adadi,P., Mohamed Abd El-Aziz,T., Soares,A.G., Kandimalla,R., Tambuwala,M., Hassan,S.S., Azad,G.K., Pal Choudhury,P., Baetas-da-Cruz,W., Serrano-Aroca,A., Brufsky,A.M. and Uhal,B.D.
    The structural basis of accelerated host cell entry by SARS-CoV-2dagger
    FEBS J288, 5010-5020. PubMed  Europe PubMed DOI
  218. Shah,A., Patel,V. and Parmar,B.
    Discovery of Some Antiviral Natural products to fight against Novel Corona Virus (SARS-CoV-2) using Insilico approach
    Comb Chem High Throughput Screen24, 1271-1280. PubMed  Europe PubMed DOI  I
  219. Shajahan,A., Archer-Hartmann,S., Supekar,N.T., Gleinich,A.S., Heiss,C. and Azadi,P.
    Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2
    Glycobiology31, 410-424. PubMed  Europe PubMed DOI
  220. Sharma,R.K., Li,J., Krishnan,S., Richards,E.M., Raizada,M.K. and Mohandas,R.
    Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases
    Clin Sci (Lond)135, 1-17. PubMed  Europe PubMed DOI  V
  221. Soni,S., Jiang,Y., Tesfaigzi,Y., Hornick,J.L. and Cataltepe,S.
    Comparative analysis of ACE2 protein expression in rodent, non-human primate, and human respiratory tract at baseline and after injury: A conundrum for COVID-19 pathogenesis
    PLoS ONE16, e0247510-e0247510. PubMed  Europe PubMed DOI
  222. Sriram,K. and Insel,P.A.
    Inflammation and thrombosis in COVID-19 pathophysiology: Proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets
    Physiol Rev101, 545-567. PubMed  Europe PubMed DOI
  223. Stone,L.
    An ACE2 in the kidney
    Nat Rev Urol18, 132-132. PubMed  Europe PubMed DOI
  224. Suh,S.H., Ma,S.K., Kim,S.W. and Bae,E.H.
    Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019
    Korean J Intern Med36, 247-262. PubMed  Europe PubMed DOI  V
  225. Sun,K., Gu,L., Ma,L. and Duan,Y.
    Atlas of ACE2 gene expression reveals novel insights into transmission of SARS-CoV-2
    Heliyon7, e05850-e05850. PubMed  Europe PubMed DOI
  226. Sun,Z., Ren,K., Zhang,X., Chen,J., Jiang,Z., Jiang,J., Ji,F., Ouyang,X. and Li,L.
    Mass Spectrometry Analysis of Newly Emerging Coronavirus HCoV-19 Spike Protein and Human ACE2 Reveals Camouflaging Glycans and Unique Post-Translational Modifications
    Engineering (Beijing)7, 1441-1451. PubMed  Europe PubMed DOI
  227. Taha,M.M., Shahy,E.M., Mahdy-Abdallah,H., Ibrahim,K.S. and El Tahlawy,E.M.
    Evaluation of the effect of serum cystatin-C and ACE I/D and ACE G2350A polymorphisms on kidney function among hypertensive sewage workers
    Environ Sci Pollut Res Int28, 1619-1626. PubMed  Europe PubMed DOI
  228. Tamanna,S., Lumbers,E.R., Morosin,S.K., Delforce,S.J. and Pringle,K.G.
    ACE2: A key modulator of RAS and pregnancy
    Am J Physiol Regul Integr Comp Physiol PubMed  Europe PubMed DOI  V
  229. Tembhre,M.K., Parihar,A.S., Sharma,V.K., Imran,S., Bhari,N., Lakshmy,R. and Bhalla,A.
    Enhanced expression of ACE2 in psoriatic skin and its upregulation in keratinocytes by interferon-gamma: Implication of inflammatory milieu in skin tropism of SARS-CoV-2
    Br J Dermatol184, 577-579. PubMed  Europe PubMed DOI
  230. Torre-Fuentes,L., Matias-Guiu,J., Hernandez-Lorenzo,L., Montero-Escribano,P., Pytel,V., Porta-Etessam,J., Gomez-Pinedo,U. and Matias-Guiu,J.A.
    ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain
    J Med Virol93, 863-869. PubMed  Europe PubMed DOI
  231. Triposkiadis,F., Starling,R.C., Xanthopoulos,A., Butler,J. and Boudoulas,H.
    Renin-angiotensin-system inhibition in the context of corona virus disease-19: experimental evidence, observational studies, and clinical implications
    Heart Fail Rev26, 381-389. PubMed  Europe PubMed DOI
  232. Tuli,H.S., Sood,S., Kaur,J., Kumar,P., Seth,P., Punia,S., Yadav,P., Sharma,A.K., Aggarwal,D. and Sak,K.
    Mechanistic insight into anti-COVID-19 drugs: recent trends and advancements
    3 Biotech11, 110-110. PubMed  Europe PubMed DOI  V  I
  233. Upreti,S., Prusty,J.S., Pandey,S.C., Kumar,A. and Samant,M.
    Identification of novel inhibitors of angiotensin-converting enzyme 2 (ACE-2) receptor from Urtica dioica to combat coronavirus disease 2019 (COVID-19)
    Mol Divers PubMed  Europe PubMed DOI
  234. Uranaka,T., Kashio,A., Ueha,R., Sato,T., Bing,H., Ying,G., Kinoshita,M., Kondo,K. and Yamasoba,T.
    Expression of ACE2, TMPRSS2, and Furin in Mouse Ear Tissue, and the Implications for SARS-CoV-2 Infection
    Laryngoscope131, E2013-E2017. PubMed  Europe PubMed DOI
  235. Virant-Klun,I. and Strle,F.
    Human Oocytes Express Both ACE2 and BSG Genes and Corresponding Proteins: Is SARS-CoV-2 Infection Possible?
    Stem Cell Rev Rep PubMed  Europe PubMed DOI
  236. Viveiros,A., Rasmuson,J., Vu,J., Mulvagh,S.L., Yip,C.Y.Y., Norris,C.M. and Oudit,G.Y.
    Sex Differences in COVID-19: Candidate Pathways, Genetics of ACE2, and Sex Hormones
    Am J Physiol Heart Circ Physiol320, H296-H304. PubMed  Europe PubMed DOI
  237. Wang,G., Yang,M.L., Duan,Z.L., Liu,F.L., Jin,L., Long,C.B., Zhang,M., Tang,X.P., Xu,L., Li,Y.C., Kamau,P.M., Yang,L., Liu,H.Q., Xu,J.W., Chen,J.K., Zheng,Y.T., Peng,X.Z. and Lai,R.
    Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models
    Cell Res31, 17-24. PubMed  Europe PubMed DOI
  238. Wang,H., Song,J., Yao,Y., Deng,Y.K., Wang,Z.C., Liao,B., Ma,J., He,C., Pan,L., Liu,Y., Xie,J.G., Zeng,M. and Liu,Z.
    Angiotensin-converting enzyme II expression and its implication in the association between COVID-19 and allergic rhinitis
    Allergy76, 906-910. PubMed  Europe PubMed DOI
  239. Wang,L.F., Sun,Y.Y., Pan,Q., Yin,Y.Q., Tian,X.M., Liu,Y., Bu,T., Zhang,Q., Wang,Y.A., Zhao,J. and Luo,Y.
    Diminazen Aceturate Protects Pulmonary Ischemia-Reperfusion Injury via Inhibition of ADAM17-Mediated Angiotensin-Converting Enzyme 2 Shedding
    Front Pharmacol12, 713632-713632. PubMed  Europe PubMed DOI
  240. Wang,M., Bu,X., Fang,G., Luan,G., Huang,Y., Akdis,C.A., Wang,C. and Zhang,L.
    Distinct expression of SARS-CoV-2 receptor ACE2 correlates with endotypes of chronic rhinosinusitis with nasal polyps
    Allergy76, 789-803. PubMed  Europe PubMed DOI
  241. Wang,Q., Qiu,Y., Li,J.Y., Liao,C.H., Zhou,Z.J. and Ge,X.Y.
    Receptor utilization of angiotensin-converting enzyme 2 (ACE2) indicates a narrower host range of SARS-CoV-2 than that of SARS-CoV
    Transbound Emerg Dis68, 1046-1053. PubMed  Europe PubMed DOI
  242. Wang,X.S.
    Angiotensin-converting enzyme 2 connects COVID-19 with cancer and cancer immunotherapy
    World J Gastrointest Oncol13, 157-160. PubMed  Europe PubMed DOI
  243. Wiese,O., Zemlin,A.E. and Pillay,T.S.
    Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2)
    J Clin Pathol74, 285-290. PubMed  Europe PubMed DOI  T
  244. Wong,L.M. and Jiang,G.
    A Plausible Link of TMPRSS2/ACE2/AR Signaling to Male Mortality during the COVID-19 Pandemic in the United States
    Pathogens10, PubMed  Europe PubMed DOI
  245. Xiao,K., Song,L., Bai,Y., Liu,P., Liu,Y., Xie,F. and Xie,L.
    Decipering the Molecular Mechanism of ACE2 Regulating A549 Cells
    Front Genet12, 653725-653725. PubMed  Europe PubMed DOI
  246. Xiao,T., Lu,J., Zhang,J., Johnson,R.I., McKay,L.G.A., Storm,N., Lavine,C.L., Peng,H., Cai,Y., Rits-Volloch,S., Lu,S., Quinlan,B.D., Farzan,M., Seaman,M.S., Griffiths,A. and Chen,B.
    A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent
    Nat Struct Mol Biol28, 202-209. PubMed  Europe PubMed DOI
  247. Xu,F., Gao,J., Orgil,B.O., Bajpai,A.K., Gu,Q., Purevjav,E., Davenport,A.S., Li,K., Towbin,J.A., Black,D.D., Pierre,J.F. and Lu,L.
    Ace2 and Tmprss2 Expressions Are Regulated by Dhx32 and Influence the Gastrointestinal Symptoms Caused by SARS-CoV-2
    J Pers Med11, PubMed  Europe PubMed DOI
  248. Yadav,D.K., Singh,D.D., Han,I., Kumar,Y. and Choi,E.H.
    Current Potential Therapeutic Approaches against SARS-CoV-2: A Review
    Biomedicines9, PubMed  Europe PubMed DOI  I
  249. Yalcin,H.C., Sukumaran,V., Al-Ruweidi,M.K.A.A. and Shurbaji,S.
    Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms
    Int J Mol Sci22, PubMed  Europe PubMed DOI  V
  250. Yan,H., Jiao,H., Liu,Q., Zhang,Z., Xiong,Q., Wang,B.J., Wang,X., Guo,M., Wang,L.F., Lan,K., Chen,Y. and Zhao,H.
    ACE2 receptor usage reveals variation in susceptibility to SARS-CoV and SARS-CoV-2 infection among bat species
    Nat Ecol Evol5, 600-608. PubMed  Europe PubMed DOI
  251. Yang,J., Chen,T. and Zhou,Y.
    Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes
    Hereditas158, 4-4. PubMed  Europe PubMed DOI
  252. Yang,J., Petitjean,S.J.L., Koehler,M., Zhang,Q., Dumitru,A.C., Chen,W., Derclaye,S., Vincent,S.P., Soumillion,P. and Alsteens,D.
    Author Correction: Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
    Nat Commun12, 2996-2996. PubMed  Europe PubMed DOI
  253. Yang,W., Li,L., Zhang,K., Ma,K., Xie,H., Gong,Y., Zhou,J. and Gong,K.
    ACE2 Correlated With Immune Infiltration Serves As A Novel Prognostic Biomarker In Clear Cell Renal Cell Carcinoma: Implication For COVID-19
    Int J Biol Sci17, 20-31. PubMed  Europe PubMed DOI
  254. Yao,Y., Ma,D., Xu,Y., Yuan,X.L., Liang,J.J., Chen,S.L., Jhanji,V. and Ng,T.K.
    Hydroxychloroquine treatment on SARS-CoV-2 receptor ACE2, TMPRSS2 and NRP1 expression in human primary pterygium and conjunctival cells
    Exp Eye Res214, 108864-108864. PubMed  Europe PubMed DOI
  255. Ye,S., Zhang,G. and Jiang,J.
    AI-based spectroscopic monitoring of real-time interactions between SARS-CoV-2 and human ACE2
    Proc Natl Acad Sci U S A118, PubMed  Europe PubMed DOI
  256. Yeung,M.L., Teng,J.L.L., Jia,L., Zhang,C., Huang,C., Cai,J.P., Zhou,R., Chan,K.H., Zhao,H., Zhu,L., Siu,K.L., Fung,S.Y., Yung,S., Chan,T.M., To,K.K., Chan,J.F., Cai,Z., Lau,S.K.P., Chen,Z., Jin,D.Y., Woo,P.C.Y. and Yuen,K.Y.
    Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system
    Cell184, 2212-2228. PubMed  Europe PubMed DOI
  257. Zanganeh,S., Goodarzi,N., Doroudian,M. and Movahed,E.
    Potential COVID-19 therapeutic approaches targeting angiotensin-converting enzyme 2; An updated review
    Rev Med Virole2321-e2321. PubMed  Europe PubMed DOI
  258. Zhang,F., Li,W., Feng,J., Ramos da Silva,S., Ju,E., Zhang,H., Chang,Y., Moore,P.S., Guo,H. and Gao,S.J.
    SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems
    J Med Virol PubMed  Europe PubMed DOI
  259. Zhang,H.L., Li,Y.M., Sun,J., Zhang,Y.Y., Wang,T.Y., Sun,M.X., Wang,M.H., Yang,Y.L., Hu,X.L., Tang,Y.D., Zhao,J. and Cai,X.
    Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species
    J Biol Chem100435-100435. PubMed  Europe PubMed DOI
  260. Zhang,Q., Jeppesen,D.K., Higginbotham,J.N., Franklin,J.L., Crowe,J.E., Jr. and Coffey,R.J.
    ACE2-containing extracellular vesicles and exomeres bind the SARS-CoV-2 spike protein
    Gastroenterology160, 958-961. PubMed  Europe PubMed DOI
  261. Zhang,Y., Niu,G., Flisikowska,T., Schnieke,A. and Flisikowski,K.
    A tissue- and gender-specific regulation of the SARS-CoV-2 receptor ACE2 by p53 in pigs
    Biochem Biophys Res Commun553, 25-29. PubMed  Europe PubMed DOI
  262. Zhang,Y., Hu,S., Wang,J., Xue,Z., Wang,C. and Wang,N.
    Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2
    Virology554, 83-88. PubMed  Europe PubMed DOI
  263. Zhang,Z., Guo,L., Huang,L., Zhang,C., Luo,R., Zeng,L., Liang,H., Li,Q., Lu,X., Wang,X., Yan Ma,C., Shao,J., Luo,W., Li,L., Liu,L., Li,Z., Zhou,X., Zhang,X., Liu,J., Yang,J., Kwan,K.Y., Liu,W., Xu,Y., Jiang,H., Liu,H., Du,H., Wu,Y., Yu,G., Chen,J., Wu,J., Zhang,J., Liao,C., Chen,H.J., Chen,Z., Tse,H.F., Xia,H. and Lian,Q.
    Distinct disease severity between children and older adults with COVID-19: Impacts of ACE2 expression, distribution, and lung progenitor cells
    Clin Infect Dis73, e4154-e4165. PubMed  Europe PubMed DOI
  264. Zhao,D., Chen,X., Han,D., Zhong,J., Zhang,S.E. and Yang,C.
    Pulmonary ACE2 expression in neonatal and adult rats
    FEBS Open Bio11, 2266-2272. PubMed  Europe PubMed DOI
  265. Zhou,P., Wang,H., Chen,Z. and Liu,Q.
    Context contribution to the intermolecular recognition of human ACE2-derived peptides by SARS-CoV-2 spike protein: implications for improving the peptide affinity but not altering the peptide specificity by optimizing indirect readout
    Mol Omics17, 86-94. PubMed  Europe PubMed DOI
  266. Zhou,Y., Huang,Y., Song,X., Guo,X., Pang,J., Wang,J., Zhang,S. and Wang,C.
    Single-cell transcriptional profile of ACE2 in healthy and failing human hearts
    Sci China Life Sci64, 652-655. PubMed  Europe PubMed DOI
  267. Zhou,Z., Yang,Z., Ou,J., Zhang,H., Zhang,Q., Dong,M. and Zhang,G.
    Temperature dependence of the SARS-CoV-2 affinity to human ACE2 determines COVID-19 progression and clinical outcome
    Comput Struct Biotechnol J19, 161-167. PubMed  Europe PubMed DOI
  268. Zhu,F., Zhong,Y., Ji,H., Ge,R., Guo,L., Song,H., Wu,H., Jiao,P., Li,S., Wang,C. and Du,H.
    ACE2 and TMPRSS2 in human saliva can adsorb to the oral mucosal epithelium
    J Anat240, 398-409. PubMed  Europe PubMed DOI
  269. Zhu,H., Zhang,L., Ma,Y., Zhai,M., Xia,L., Liu,J., Yu,S. and Duan,W.
    The role of SARS-CoV-2 target ACE2 in cardiovascular diseases
    J Cell Mol Med25, 1342-1349. PubMed  Europe PubMed DOI  V
  270. 2020

  271. ACE2 enzymatic activity
    PubMed  Europe PubMed

  272. ACE2 binding
    PubMed  Europe PubMed

  273. Spike-ACE2 protein-protein interaction (QD)
    PubMed  Europe PubMed
  274. Abassi,Z., Higazi,A.A.R., Kinaneh,S., Armaly,Z., Skorecki,K. and Heyman,S.N.
    ACE2, COVID-19 Infection, Inflammation, and Coagulopathy: Missing Pieces in the Puzzle
    Front Physiol11, 574753-574753. PubMed  Europe PubMed DOI
  275. Abd El-Aziz,T.M., Al-Sabi,A. and Stockand,J.D.
    Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID-19
    Signal Transduct Target Ther5, 258-258. PubMed  Europe PubMed DOI
  276. Abhinand,C.S., Nair,A.S., Krishnamurthy,A., Oommen,O.V. and Sudhakaran,P.R.
    Potential protease inhibitors and their combinations to block SARS-CoV-2
    J Biomol Struct Dyn1-15. PubMed  Europe PubMed DOI  I
  277. Adhikari,P., Li,N., Shin,M., Steinmetz,N.F., Twarock,R., Podgornik,R. and Ching,W.Y.
    Intra- and intermolecular atomic-scale interactions in the receptor binding domain of SARS-CoV-2 spike protein: implication for ACE2 receptor binding
    Phys Chem Chem Phys22, 18272-18283. PubMed  Europe PubMed DOI
  278. Akhtar,S., Benter,I.F., Danjuma,M.I., Doi,S.A.R., Hasan,S.S. and Habib,A.M.
    Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety
    J Drug Target1-17. PubMed  Europe PubMed DOI
  279. Al-Benna,S.
    Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients
    Obes Med19, 100283-100283. PubMed  Europe PubMed DOI
  280. Al-Horani,R.A., Kar,S. and Aliter,K.F.
    Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials
    Int J Mol Sci21, PubMed  Europe PubMed DOI  V
  281. Alazmi,M. and Motwalli,O.
    Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates
    J Mol Model26, 338-338. PubMed  Europe PubMed DOI
  282. Alexander,M.R., Schoeder,C.T., Brown,J.A., Smart,C.D., Moth,C., Wikswo,J.P., Capra,J.A., Meiler,J., Chen,W. and Madhur,M.S.
    Predicting susceptibility to SARS-CoV-2 infection based on structural differences in ACE2 across species
    FASEB J34, 15946-15960. PubMed  Europe PubMed DOI
  283. Alexpandi,R., De Mesquita,J.F., Pandian,S.K. and Ravi,A.V.
    Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis
    Front Microbiol11, 1796-1796. PubMed  Europe PubMed DOI  I
  284. AlGhamdi,N.A., Alsuwat,H.S., Borgio,J.F. and AbdulAzeez,S.
    Emerging of composition variations of SARS-CoV-2 spike protein and human ACE2 contribute to the level of infection: in silico approaches
    J Biomol Struct Dyn1-12. PubMed  Europe PubMed DOI
  285. Ali,A. and Vijayan,R.
    Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms
    Sci Rep10, 14214-14214. PubMed  Europe PubMed DOI
  286. Ali,F., Elserafy,M., Alkordi,M.H. and Amin,M.
    ACE2 coding variants in different populations and their potential impact on SARS-CoV-2 binding affinity
    Biochem Biophys Rep24, 100798-100798. PubMed  Europe PubMed DOI
  287. Allen,J.D., Watanabe,Y., Chawla,H., Newby,M.L. and Crispin,M.
    Subtle Influence of ACE2 Glycan Processing on SARS-CoV-2 Recognition
    J Mol Biol433, 166762-166762. PubMed  Europe PubMed DOI
  288. Alsufyani,H.A. and Alrefaie,Z.
    Renin-Angiotensin System Implications to COVID-19 Comorbidities
    J Microsc Ultrastruct8, 148-151. PubMed  Europe PubMed DOI  V
  289. Amano,T.
    Angiotensin-Converting Enzyme 2 as a Versatile Player in the Management of Coronavirus Disease 2019
    J Diabetes Investig11, 1120-1122. PubMed  Europe PubMed DOI
  290. Amraei,R. and Rahimi,N.
    COVID-19, Renin-Angiotensin System and Endothelial Dysfunction
    Cells9, PubMed  Europe PubMed DOI
  291. Armijos-Jaramillo,V., Yeager,J., Muslin,C. and Perez-Castillo,Y.
    SARS-CoV-2, an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability
    Evol Appl PubMed  Europe PubMed DOI
  292. Ashraf,U.M., Abokor,A.A., Edwards,J.M., Waigi,E.W., Royfman,R.S., Hasan,S.A., Smedlund,K.B., Hardy,A.M.G., Chakravarti,R. and Koch,L.G.
    SARS-CoV-2, ACE2 expression, and systemic organ invasion
    Physiol Genomics PubMed  Europe PubMed DOI  V
  293. Avanzini,M.A., Mura,M., Percivalle,E., Bastaroli,F., Croce,S., Valsecchi,C., Lenta,E., Nykjaer,G., Cassaniti,I., Bagnarino,J., Baldanti,F., Zecca,M., Comoli,P. and Gnecchi,M.
    Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection
    Stem Cells Transl Med PubMed  Europe PubMed DOI
  294. Azizan,E. and Brown,M.
    ACE2 role in SARS-CoV-2 infectivity and Covid-19 severity
    Malays J Pathol42, 363-367. PubMed  Europe PubMed  V
  295. Azouz,N.P., Klingler,A.M., Callahan,V., Akhrymuk,I.V., Elez,K., Raich,L., Henry,B.M., Benoit,J.L., Benoit,S.W., Noe,F., Kehn-Hall,K. and Rothenberg,M.E.
    Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2
    bioRxiv PubMed  Europe PubMed DOI
  296. Bader,M.
    [ACE2 - the hijacked all-rounder]
    Nephrologe1-4. PubMed  Europe PubMed DOI
  297. Bader,M., Turner,A.J. and Alenina,N.
    ACE2, a multifunctional protein - from cardiovascular regulation to COVID-19
    Clin Sci (Lond)134, 3229-3232. PubMed  Europe PubMed DOI
  298. Bala,A., Sengupta,A., Matsabisa,M.G. and Chabalala,H.P.
    COVID-19: Pathophysiology; Mechanism of Transmission and Possible Molecular Drug Target for Management
    Curr Mol Pharmacol PubMed  Europe PubMed DOI  V
  299. Balkrishna,A., Pokhrel,S. and Varshney,A.
    Tinocordiside from Tinospora cordifolia (Giloy) May Curb SARS-CoV-2 Contagion by Disrupting the Electrostatic Interactions between Host ACE2 and Viral S-Protein Receptor Binding Domain
    Comb Chem High Throughput Screen PubMed  Europe PubMed DOI
  300. Bao,R., Hernandez,K., Huang,L. and Luke,J.J.
    ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19
    J Immunother Cancer8, PubMed  Europe PubMed DOI
  301. Baral,R., White,M. and Vassiliou,V.S.
    Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients
    Curr Atheroscler Rep22, 61-61. PubMed  Europe PubMed DOI  V
  302. Barash,A., Machluf,Y., Ariel,I. and Dekel,Y.
    The Pursuit of COVID-19 Biomarkers: Putting the Spotlight on ACE2 and TMPRSS2 Regulatory Sequences
    Front Med (Lausanne)7, 582793-582793. PubMed  Europe PubMed DOI
  303. Barilla,F., Bassareo,P.P., Calcaterra,G., Romeo,F. and Mehta,J.L.
    Focus on clinical practice: angiotensin-converting enzyme 2 and corona virus disease 2019: pathophysiology and clinical implications
    J Cardiovasc Med (Hagerstown)21, 630-633. PubMed  Europe PubMed DOI
  304. Barker,H. and Parkkila,S.
    Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2
    PLoS ONE15, e0240647-e0240647. PubMed  Europe PubMed DOI
  305. Barnett,B.P., Wahlin,K., Krawczyk,M., Spencer,D., Welsbie,D., Afshari,N. and Chao,D.
    Potential of Ocular Transmission of SARS-CoV-2: A Review
    Vision (Basel)4, PubMed  Europe PubMed DOI  V
  306. Barochiner,J. and Martinez,R.
    Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis
    J Clin Pharm Ther PubMed  Europe PubMed DOI
  307. Barros,E.P., Casalino,L., Gaieb,Z., Dommer,A.C., Wang,Y., Fallon,L., Raguette,L., Belfon,K., Simmerling,C. and Amaro,R.E.
    The Flexibility of ACE2 in the Context of SARS-CoV-2 Infection
    Biophys J PubMed  Europe PubMed DOI
  308. Barros,R.O., Junior,F.L.C.C., Pereira,W.S., Oliveira,N.M.N. and Ramos,R.M.
    Interaction of Drug Candidates with Various SARS-CoV-2 Receptors: An in Silico Study to Combat COVID-19
    J Proteome Res PubMed  Europe PubMed DOI  I
  309. Bartolome,A., Liang,J., Wang,P., Ho,D.D. and Pajvani,U.B.
    Angiotensin converting enzyme 2 is a novel target of the gamma-secretase complex
    bioRxiv PubMed  Europe PubMed DOI
  310. Bartova,E., Legartova,S., Krejci,J. and Arcidiacono,O.A.
    Cell differentiation and aging accompanied by depletion of the ACE2 protein
    Aging (Albany NY)12, 22495-22508. PubMed  Europe PubMed DOI
  311. Batchu,S.N., Kaur,H., Yerra,V.G., Advani,S.L., Kabir,M.G., Liu,Y., Klein,T. and Advani,A.
    Lung and Kidney ACE2 and TMPRSS2 in Renin Angiotensin System Blocker Treated Comorbid Diabetic Mice Mimicking Host Factors That Have Been Linked to Severe COVID-19
    Diabetes PubMed  Europe PubMed DOI  I
  312. Batlle,D., Wysocki,J. and Satchell,K.
    Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
    Clin Sci (Lond)134, 543-545. PubMed  Europe PubMed DOI  U
  313. Baughn,L.B., Sharma,N., Elhaik,E., Sekulic,A., Bryce,A.H. and Fonseca,R.
    Targeting TMPRSS2 in SARS-CoV-2 Infection
    Mayo Clin Proc95, 1989-1999. PubMed  Europe PubMed DOI
  314. Beeraka,N.M., Sadhu,S.P., Madhunapantula,S.V., Rao Pragada,R., Svistunov,A.A., Nikolenko,V.N., Mikhaleva,L.M. and Aliev,G.
    Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors-The Current Status
    Front Immunol11, 552925-552925. PubMed  Europe PubMed DOI  V
  315. Behl,T., Kaur,I., Bungau,S., Kumar,A., Uddin,M.S., Kumar,C., Pal,G., Sahil, Shrivastava,K., Zengin,G. and Arora,S.
    The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions
    Life Sci257, 118075-118075. PubMed  Europe PubMed DOI  V
  316. Bellis,A., Mauro,C., Barbato,E., Trimarco,B. and Morisco,C.
    The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19
    Int J Mol Sci21, PubMed  Europe PubMed DOI  V  I
  317. Benetti,E., Tita,R., Spiga,O., Ciolfi,A., Birolo,G., Bruselles,A., Doddato,G., Giliberti,A., Marconi,C., Musacchia,F., Pippucci,T., Torella,A., Trezza,A., Valentino,F., Baldassarri,M., Brusco,A., Asselta,R., Bruttini,M., Furini,S., Seri,M., Nigro,V., Matullo,G., Tartaglia,M., Mari,F., Renieri,A. and Pinto,A.M.
    ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population
    Eur J Hum Genet PubMed  Europe PubMed DOI
  318. Bernardi,A., Huang,Y., Harris,B., Xiong,Y., Nandi,S., McDonald,K.A. and Faller,R.
    Development and simulation of fully glycosylated molecular models of ACE2-Fc fusion proteins and their interaction with the SARS-CoV-2 spike protein binding domain
    PLoS ONE15, e0237295-e0237295. PubMed  Europe PubMed DOI
  319. Bhari,V.K., Kumar,D., Kumar,S. and Mishra,R.
    SARS-CoV-2 cell receptor gene ACE2 -mediated immunomodulation in breast cancer subtypes
    Biochem Biophys Rep24, 100844-100844. PubMed  Europe PubMed DOI
  320. Bhattarai,A., Pawnikar,S. and Miao,Y.
    Mechanism of ligand recognition by human ACE2 receptor
    bioRxiv PubMed  Europe PubMed DOI  I
  321. Bloise,E., Zhang,J., Nakpu,J., Hamada,H., Dunk,C.E., Li,S., Imperio,G.E., Nadeem,L., Kibschull,M., Lye,P., Matthews,S.G. and Lye,S.J.
    Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia
    Am J Obstet Gynecol PubMed  Europe PubMed DOI
  322. Borro,M., Di Girolamo,P., Gentile,G., De Luca,O., Preissner,R., Marcolongo,A., Ferracuti,S. and Simmaco,M.
    Evidence-Based Considerations Exploring Relations between SARS-CoV-2 Pandemic and Air Pollution: Involvement of PM2.5-Mediated Up-Regulation of the Viral Receptor ACE-2
    Int J Environ Res Public Health17, PubMed  Europe PubMed DOI
  323. Bosso,M., Thanaraj,T.A., Abu-Farha,M., Alanbaei,M., Abubaker,J. and Al-Mulla,F.
    The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19
    Mol Ther Methods Clin Dev18, 321-327. PubMed  Europe PubMed DOI
  324. Bouricha,E.M., Hakmi,M., Akachar,J., Belyamani,L. and Ibrahimi,A.
    In silico analysis of ACE2 orthologues to predict animal host range with high susceptibility to SARS-CoV-2
    3 Biotech10, 483-483. PubMed  Europe PubMed DOI
  325. Br,B., Damle,H., Ganju,S. and Damle,L.
    In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19
    F1000Res9, 663-663. PubMed  Europe PubMed DOI
  326. Branco,A.C.C.C., Sato,M.N. and Alberca,R.W.
    The Possible Dual Role of the ACE2 Receptor in Asthma and Coronavirus (SARS-CoV2) Infection
    Front Cell Infect Microbiol10, 550571-550571. PubMed  Europe PubMed DOI
  327. Braun,M., Sharon,E., Unterman,I., Miller,M., Shtern,A.M., Benenson,S., Vainstein,A. and Tabach,Y.
    ACE2 Co-evolutionary Pattern Suggests Targets for Pharmaceutical Intervention in the COVID-19 Pandemic
    iScience23, 101384-101384. PubMed  Europe PubMed DOI
  328. Braz,H.L.B., Silveira,J.A.M., Marinho,A.D., de Moraes,M.E.A., Moraes Filho,M.O., Monteiro,H.S.A. and Jorge,R.J.B.
    In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection
    Int J Antimicrob Agents106119-106119. PubMed  Europe PubMed DOI
  329. Brenner,S.R.
    Erythropoietin-induced hemoglobin subunit beta may stimulate innate immune RNA virus pattern recognition, suppress reactive oxygen species, reduce ACE2 viral doorway opening, and neutrophil extracellular traps against COVID-19
    J Med Virol PubMed  Europe PubMed DOI
  330. Brooke,G.N. and Prischi,F.
    Structural and functional modelling of SARS-CoV-2 entry in animal models
    Sci Rep10, 15917-15917. PubMed  Europe PubMed DOI
  331. Buchrieser,J., Dufloo,J., Hubert,M., Monel,B., Planas,D., Michael Rajah,M., Planchais,C., Porrot,F., Guivel-Benhassine,F., van der Werf,S., Casartelli,N., Mouquet,H., Bruel,T. and Schwartz,O.
    Syncytia formation by SARS-CoV-2 infected cells
    EMBO Je106267-e106267. PubMed  Europe PubMed DOI
  332. Busnadiego,I., Fernbach,S., Pohl,M.O., Karakus,U., Huber,M., Trkola,A., Stertz,S. and Hale,B.G.
    Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2
    MBio11, PubMed  Europe PubMed DOI
  333. Cadegiani,F.A., Goren,A. and Wambier,C.G.
    Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS)
    Med Hypotheses143, 110112-110112. PubMed  Europe PubMed DOI
  334. Calcagnile,M., Forgez,P., Iannelli,A., Bucci,C., Alifano,M. and Alifano,P.
    Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein
    Biochimie180, 143-148. PubMed  Europe PubMed DOI
  335. Calo,L.A. and Davis,P.A.
    Are the Clinical Presentations (Phenotypes) of Gitelman's and Bartter's Syndromes Gene Mutations Driven by Their Effects on Intracellular pH, Their "pH" Enotype?
    Int J Mol Sci21, PubMed  Europe PubMed DOI
  336. Camargo,S.M.R., Vuille-Dit-Bille,R.N., Meier,C.F. and Verrey,F.
    ACE2 and gut amino acid transport
    Clin Sci (Lond)134, 2823-2833. PubMed  Europe PubMed DOI
  337. Cameron,A., Porterfield,C.A., Byron,L.D., Wang,J., Pearson,Z., Bohrhunter,J.L., Cardillo,A.B., Ryan-Muntz,L., Sorensen,R.A., Caserta,M.T., Angeloni,S., Hardy,D.J., Zand,M.S. and Pecora,N.D.
    A multiplex microsphere IgG assay for SARS-CoV-2 using ACE2-mediated inhibition as a surrogate for neutralization
    J Clin Microbiol PubMed  Europe PubMed DOI  V
  338. Campbell,R.A., Boilard,E. and Rondina,M.T.
    Is there a role for the ACE2 receptor in SARS-CoV-2 interactions with platelets?
    J Thromb Haemost PubMed  Europe PubMed DOI
  339. Cao,W., Dong,C., Kim,S., Hou,D., Tai,W., Du,L., Im,W. and Zhang,X.F.
    Biomechanical Characterization of SARS-CoV-2 Spike RBD and Human ACE2 Protein-Protein Interaction
    bioRxiv PubMed  Europe PubMed DOI
  340. Cao,Y., Sun,Y., Tian,X., Bai,Z., Gong,Y., Qi,J., Liu,D., Liu,W. and Li,J.
    Analysis of ACE2 Gene-Encoded Proteins Across Mammalian Species
    Front Vet Sci7, 457-457. PubMed  Europe PubMed DOI
  341. Carino,A., Moraca,F., Fiorillo,B., Marchiano,S., Sepe,V., Biagioli,M., Finamore,C., Bozza,S., Francisci,D., Distrutti,E., Catalanotti,B., Zampella,A. and Fiorucci,S.
    Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain
    Front Chem8, 572885-572885. PubMed  Europe PubMed DOI
  342. Carvalho,T.
    ACE2, the viral gateway
    Nat Med26, 1807-1807. PubMed  Europe PubMed DOI
  343. Cava,C., Bertoli,G. and Castiglioni,I.
    A protein interaction map identifies existing drugs targeting SARS-CoV-2
    BMC Pharmacol Toxicol21, 65-65. PubMed  Europe PubMed DOI
  344. Cavasotto,C. and Di Filippo,J.
    In silico Drug Repurposing for COVID-19: Targeting SARS-CoV-2 Proteins through Docking and Consensus Ranking
    Mol Inform PubMed  Europe PubMed DOI
  345. Chadchan,S.B., Maurya,V.K., Popli,P. and Kommagani,R.
    The SARS-CoV-2 receptor, Angiotensin converting enzyme 2 (ACE2) is required for human endometrial stromal cell decidualization
    bioRxiv PubMed  Europe PubMed DOI  K
  346. Chadchan,S.B., Popli,P., Maurya,V.K. and Kommagani,R.
    The SARS-CoV-2 receptor, Angiotensin converting enzyme 2 (ACE2) is required for human endometrial stromal cell decidualization
    Biol Reprod PubMed  Europe PubMed DOI  K
  347. Chakraborty,K. and Francis,P.
    Callypyrones from marine Callyspongiidae sponge Callyspongia diffusa: antihypertensive bis-gamma-pyrone polypropionates attenuate angiotensin-converting enzyme
    Nat Prod Res1-12. PubMed  Europe PubMed DOI  I
  348. Chakraborty,S.
    Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity
    Biochem Biophys Res Commun PubMed  Europe PubMed DOI
  349. Chambers,J.P., Yu,J., Valdes,J.J. and Arulanandam,B.P.
    SARS-CoV-2, Early Entry Events
    J Pathog2020, 9238696-9238696. PubMed  Europe PubMed DOI
  350. Chan,K.K., Dorosky,D., Sharma,P., Abbasi,S.A., Dye,J.M., Kranz,D.M., Herbert,A.S. and Procko,E.
    Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
    Science PubMed  Europe PubMed DOI
  351. Chang,E.H., Willis,A.L., Romanoski,C.E., Cusanovich,D.A., Pouladi,N., Li,J., Lussier,Y.A. and Martinez,F.D.
    RV Infections in Asthmatics Increase ACE2 Expression and Cytokine Pathways Implicated in COVID-19
    Am J Respir Crit Care Med PubMed  Europe PubMed DOI
  352. Chatterjee,P., Gheblawi,M., Wang,K., Vu,J., Kondaiah,P. and Oudit,G.Y.
    Interaction between the apelinergic system and ACE2 in the cardiovascular system: therapeutic implications
    Clin Sci (Lond)134, 2319-2336. PubMed  Europe PubMed DOI  V
  353. Chen,J., Jiang,Q., Xia,X., Liu,K., Yu,Z., Tao,W., Gong,W. and Han,J.J.
    Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation
    Aging Cell19, PubMed  Europe PubMed DOI
  354. Chen,Y., Gong,W., Wei,H., Dai,W. and Xu,S.
    2019-nCoV may create complications in colon cancer patients with ACE2 expression
    Int J Clin Exp Pathol13, 2305-2311. PubMed  Europe PubMed
  355. Chenna,A., Konala,V.M., Bose,S., Roy,S., Madhira,B.R., Gayam,V., Naramala,S. and Adapa,S.
    Acute Kidney Injury in a Case Series of Patients with Confirmed COVID-19 (Coronavirus Disease 2019): Role of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Blockade
    Case Rep Nephrol2020, 8811931-8811931. PubMed  Europe PubMed DOI
  356. Chiappelli,F.
    Towards Neuro-CoViD-19
    Bioinformation16, 288-292. PubMed  Europe PubMed DOI
  357. Chiocchetti,R., Galiazzo,G., Fracassi,F., Giancola,F. and Pietra,M.
    ACE2 Expression in the Cat and the Tiger Gastrointestinal Tracts
    Front Vet Sci7, 514-514. PubMed  Europe PubMed DOI
  358. Chuang,H.C., Chen,Y.Y., Hsiao,T.C., Chou,H.C., Kuo,H.P., Feng,P.H., Ho,S.C., Chen,J.K., Chuang,K.J. and Lee,K.Y.
    Alteration in angiotensin-converting enzyme 2 by PM1 during the development of emphysema in rats
    ERJ Open Res6, PubMed  Europe PubMed DOI
  359. Chung,M.K., Karnik,S., Saef,J., Bergmann,C., Barnard,J., Lederman,M.M., Tilton,J., Cheng,F., Harding,C.V., Young,J.B., Mehta,N., Cameron,S.J., McCrae,K.R., Schmaier,A.H., Smith,J.D., Kalra,A., Gebreselassie,S.K., Thomas,G., Hawkins,E.S. and Svensson,L.G.
    SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy
    EBioMedicine58, 102907-102907. PubMed  Europe PubMed DOI
  360. Clausen,T.M., Sandoval,D.R., Spliid,C.B., Pihl,J., Painter,C.D., Thacker,B.E., Glass,C.A., Narayanan,A., Majowicz,S.A., Zhang,Y., Torres,J.L., Golden,G.J., Porell,R., Garretson,A.F., Laubach,L., Feldman,J., Yin,X., Pu,Y., Hauser,B., Caradonna,T.M., Kellman,B.P., Martino,C., Gordts,P.L.S.M., Leibel,S.L., Chanda,S.K., Schmidt,A.G., Godula,K., Jose,J., Corbett,K.D., Ward,A.B., Carlin,A.F. and Esko,J.D.
    SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
    bioRxiv PubMed  Europe PubMed DOI
  361. Coate,K.C., Cha,J., Shrestha,S., Wang,W., Goncalves,L.M., Almaca,J., Kapp,M.E., Fasolino,M., Morgan,A., Dai,C., Saunders,D.C., Bottino,R., Aramandla,R., Jenkins,R., Stein,R., Kaestner,K.H., Vahedi,G., Consortium,H., Brissova,M. and Powers,A.C.
    SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 are Expressed in the Pancreas but are Not Enriched in Islet Endocrine Cells
    bioRxiv PubMed  Europe PubMed DOI
  362. Coate,K.C., Cha,J., Shrestha,S., Wang,W., Goncalves,L.M., Almaca,J., Kapp,M.E., Fasolino,M., Morgan,A., Dai,C., Saunders,D.C., Bottino,R., Aramandla,R., Jenkins,R., Stein,R., Kaestner,K.H., Vahedi,G., Brissova,M. and Powers,A.C.
    SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in beta Cells
    Cell Metab32, 1028-1040. PubMed  Europe PubMed DOI
  363. Cohen,J.B., Hanff,T.C., Bress,A.P. and South,A.M.
    Relationship Between ACE2 and Other Components of the Renin-Angiotensin System
    Curr Hypertens Rep22, 44-44. PubMed  Europe PubMed DOI  V
  364. Conceicao,C., Thakur,N., Human,S., Kelly,J.T., Logan,L., Bialy,D., Bhat,S., Stevenson-Leggett,P., Zagrajek,A.K., Hollinghurst,P., Varga,M., Tsirigoti,C., Tully,M., Chiu,C., Moffat,K., Silesian,A.P., Hammond,J.A., Maier,H.J., Bickerton,E., Shelton,H., Dietrich,I., Graham,S.C. and Bailey,D.
    The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins
    PLoS Biol18, e3001016-e3001016. PubMed  Europe PubMed DOI
  365. Couselo-Seijas,M., Almenglo,C., Agra-Bermejo,M., Luis Fernandez,A., Alvarez,E., Gonzalez-Juanatey,R. and Eiras,S.
    Higher ACE2 expression levels in epicardial cells than subcutaneous stromal cells from patients with cardiovascular disease: Diabetes and obesity as possible enhancer
    Eur J Clin Investe13463-e13463. PubMed  Europe PubMed DOI
  366. Cui,D., Liu,Y., Jiang,X., Ding,C., Poon,L.C., Wang,H. and Yang,H.
    Single-cell RNA expression profiling of ACE2 and TMPRSS2 in the human trophectoderm and placenta
    Ultrasound Obstet Gynecol PubMed  Europe PubMed DOI
  367. Damas,J., Hughes,G.M., Keough,K.C., Painter,C.A., Persky,N.S., Corbo,M., Hiller,M., Koepfli,K.P., Pfenning,A.R., Zhao,H., Genereux,D.P., Swofford,R., Pollard,K.S., Ryder,O.A., Nweeia,M.T., Lindblad-Toh,K., Teeling,E.C., Karlsson,E.K. and Lewin,H.A.
    Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates
    Proc Natl Acad Sci U S A117, 22311-22322. PubMed  Europe PubMed DOI
  368. Dambha-Miller,H., Albasri,A., Hodgson,S., Wilcox,C., Islam,N., Khan,S., Little,P. and Griffin,S.
    Drug treatments affecting ACE2 in COVID-19 infection: a systematic review protocol
    BJGP Open PubMed  Europe PubMed DOI  V
  369. Darriverre,L., Fieux,F. and de la Jonquiere,C.
    [Acute renal failure during COVID-19 epidemic]
    Prat Anesth Reanim24, 207-211. PubMed  Europe PubMed DOI
  370. Dastan,F., Abedini,A., Shahabi,S., Kiani,A., Saffaei,A. and Zare,A.
    Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung
    Iran J Allergy Asthma Immunol19, 10-12. PubMed  Europe PubMed DOI  I
  371. Datta,P.K., Liu,F., Fischer,T., Rappaport,J. and Qin,X.
    SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
    Theranostics10, 7448-7464. PubMed  Europe PubMed DOI
  372. de la Cruz,A., Ashraf,S., Vittorio,T.J. and Bella,J.N.
    COVID-19 and renin-angiotensin system modulators: what do we know so far?
    Expert Rev Cardiovasc Ther1-6. PubMed  Europe PubMed DOI
  373. de Oliveira,A.P., Lopes,A.L.F., Pacheco,G., de Sa Guimaraes Noleto,I.R., Nicolau,L.A.D. and Medeiros,J.V.R.
    Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route
    Med Hypotheses144, 110243-110243. PubMed  Europe PubMed DOI
  374. de Vries,M., Mohamed,A.S., Prescott,R.A., Valero-Jimenez,A.M., Desvignes,L., O'Connor,R., Steppan,C., Anderson,A.S., Binder,J. and Dittmann,M.
    Comparative study of a 3CL (pro) inhibitor and remdesivir against both major SARS-CoV-2 clades in human airway models
    bioRxiv PubMed  Europe PubMed DOI  I
  375. Dehury,B., Raina,V., Misra,N. and Suar,M.
    Effect of mutation on structure, function and dynamics of receptor binding domain of human SARS-CoV-2 with host cell receptor ACE2: a molecular dynamics simulations study
    J Biomol Struct Dyn1-15. PubMed  Europe PubMed DOI
  376. DeKosky,B.J.
    A molecular trap against COVID-19
    Science369, 1167-1168. PubMed  Europe PubMed DOI
  377. Delgado Blanco,J., Hernandez-Alias,X., Cianferoni,D. and Serrano,L.
    In silico mutagenesis of human ACE2 with S protein and translational efficiency explain SARS-CoV-2 infectivity in different species
    PLoS Comput Biol16, e1008450-e1008450. PubMed  Europe PubMed DOI
  378. Descamps,G., Verset,L., Trelcat,A., Hopkins,C., Lechien,J.R., Journe,F. and Saussez,S.
    ACE2 Protein Landscape in the Head and Neck Region: The Conundrum of SARS-CoV-2 Infection
    Biology (Basel)9, PubMed  Europe PubMed DOI
  379. Devarakonda,C.K.V., Meredith,E., Ghosh,M. and Shapiro,L.H.
    Coronavirus Receptors as Immune Modulators
    J Immunol PubMed  Europe PubMed DOI  V
  380. Ding,Q., Shults,N.V., Harris,B.T. and Suzuki,Y.J.
    Angiotensin-converting enzyme 2 (ACE2) is upregulated in Alzheimer's disease brain
    bioRxiv PubMed  Europe PubMed DOI
  381. Divani,A.A., Andalib,S., Di Napoli,M., Lattanzi,S., Hussain,M.S., Biller,J., McCullough,L.D., Azarpazhooh,M.R., Seletska,A., Mayer,S.A. and Torbey,M.
    Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights
    J Stroke Cerebrovasc Dis29, 104941-104941. PubMed  Europe PubMed DOI  V
  382. Djomkam,A.L.Z., Olwal,C.O., Sala,T.B. and Paemka,L.
    Commentary: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
    Front Oncol10, 1448-1448. PubMed  Europe PubMed DOI
  383. Do-Umehara,H.C., Chen,C., Zhang,Q., Misharin,A.V., Abdala-Valencia,H., Casalino-Matsuda,S.M., Reyfman,P.A., Anekalla,K.R., Gonzalez-Gonzalez,F.J., Sala,M.A., Peng,C., Wu,P., Wong,C.C.L., Kalhan,R., Bharat,A., Perlman,H., Ridge,K.M., Sznajder,J.I., Sporn,P.H.S., Chandel,N.S., Yu,J., Fu,X., Petrache,I., Tuder,R., Budinger,G.R.S. and Liu,J.
    Epithelial cell-specific loss of function of Miz1 causes a spontaneous COPD-like phenotype and up-regulates Ace2 expression in mice
    Sci Adv6, eabb7238-eabb7238. PubMed  Europe PubMed DOI
  384. Dominska,K.
    Involvement of ACE2/Ang-(1-7)/MAS1 Axis in the Regulation of Ovarian Function in Mammals
    Int J Mol Sci21, PubMed  Europe PubMed DOI  V
  385. Drew,E.D. and Janes,R.W.
    Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity
    BMC Mol Cell Biol21, 49-49. PubMed  Europe PubMed DOI
  386. Du,F., Liu,B. and Zhang,S.
    COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness
    J Thromb Thrombolysis PubMed  Europe PubMed DOI  V
  387. Du,H., Wang,D.W. and Chen,C.
    The potential effects of DPP-4 inhibitors on cardiovascular system in COVID-19 patients
    J Cell Mol Med PubMed  Europe PubMed DOI
  388. Du,X., Zeng,X., Zhang,J., Pan,K., Song,L., Zhou,J., Zhou,L., Xie,Y., Sun,Q., Ge,W., Chen,R., Zhao,J. and Kan,H.
    Ambient fine particulate matter induced the elevation of blood pressure through ACE2/Ang(1-7) pathway: The evidence from urine metabolites
    Ecotoxicol Environ Saf203, 111044-111044. PubMed  Europe PubMed DOI
  389. Duan,F., Guo,L., Yang,L., Han,Y., Thakur,A., Nilsson-Payant,B.E., Wang,P., Zhang,Z., Ma,C.Y., Zhou,X., Han,T., Zhang,T., Wang,X., Xu,D., Duan,X., Xiang,J., Tse,H.F., Liao,C., Luo,W., Huang,F.P., Chen,Y.W., Evans,T., Schwartz,R.E., tenOever,B., Ho,D.D., Chen,S., Lian,Q. and Chen,H.J.
    Modeling COVID-19 with Human Pluripotent Stem Cell-Derived Cells Reveals Synergistic Effects of Anti-inflammatory Macrophages with ACE2 Inhibition Against SARS-CoV-2
    Res Sq PubMed  Europe PubMed DOI
  390. Duan,R., Xue,X., Zhang,Q.Q., Wang,S.Y., Gong,P.Y., E,Y., Jiang,T. and Zhang,Y.D.
    ACE2 activator diminazene aceturate ameliorates Alzheimer's disease-like neuropathology and rescues cognitive impairment in SAMP8 mice
    Aging (Albany NY)12, 14819-14829. PubMed  Europe PubMed DOI  I
  391. Eapen,M.S., Lu,W., Hackett,T.L., Singhera,G.K., Thompson,I.E., McAlinden,K.D., Hardikar,A., Weber,H.C., Haug,G., Wark,P.A.B., Chia,C. and Sohal,S.S.
    Dysregulation of endocytic machinery and ACE2 in small airways of smokers and COPD patients can augment their susceptibility to SARS-CoV-2 (COVID-19) infections
    Am J Physiol Lung Cell Mol Physiol PubMed  Europe PubMed DOI
  392. Eberli,F.R. and Kurz,D.
    Cardiovascular aspects of COVID-19
    Swiss Med Wkly150, w20417-w20417. PubMed  Europe PubMed DOI  V
  393. Edmonston,D.L., South,A.M., Sparks,M.A. and Cohen,J.B.
    Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System
    Adv Chronic Kidney Dis27, 404-411. PubMed  Europe PubMed DOI  V
  394. Elmorsi,R.
    The therapeutic potential of targeting ACE2 in COVID-19
    Eur Rev Med Pharmacol Sci24, 9744-9747. PubMed  Europe PubMed DOI
  395. Esparza,T.J., Martin,N.P., Anderson,G.P., Goldman,E.R. and Brody,D.L.
    High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme
    Sci Rep10, 22370-22370. PubMed  Europe PubMed DOI
  396. Fang,S., Zheng,R., Lei,C., Wang,J., Zheng,R. and Li,M.
    Key residues influencing binding affinities of 2019-nCoV with ACE2 in different species
    Brief Bioinform PubMed  Europe PubMed DOI
  397. Feng,Q., Li,L. and Wang,X.
    Identifying Pathways and Networks Associated With the SARS-CoV-2 Cell Receptor ACE2 Based on Gene Expression Profiles in Normal and SARS-CoV-2-Infected Human Tissues
    Front Mol Biosci7, 568954-568954. PubMed  Europe PubMed DOI
  398. Ferrandi,P.J., Alway,S.E. and Mohamed,J.S.
    The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies
    J Appl Physiol (1985) PubMed  Europe PubMed DOI
  399. Ferrandi,P.J., Alway,S.E. and Mohamed,J.S.
    Last Word on Viewpoint: The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies
    J Appl Physiol (1985)129, 872-872. PubMed  Europe PubMed DOI
  400. Ferrario,C.M., Ahmad,S. and Groban,L.
    Twenty years of progress in angiotensin converting enzyme 2 and its link to SARS-CoV-2 disease
    Clin Sci (Lond)134, 2645-2664. PubMed  Europe PubMed DOI  V
  401. Fignani,D., Licata,G., Brusco,N., Nigi,L., Grieco,G.E., Marselli,L., Overbergh,L., Gysemans,C., Colli,M.L., Marchetti,P., Mathieu,C., Eizirik,D.L., Sebastiani,G. and Dotta,F.
    SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic beta-Cells and in the Human Pancreas Microvasculature
    Front Endocrinol (Lausanne)11, 596898-596898. PubMed  Europe PubMed DOI
  402. Foroozanfar,E., Forouzanfar,M., Farkhondeh,T., Samarghandian,S. and Forouzanfar,F.
    ACE2 as a potential target for management of novel coronavirus (nCoV- 2019)
    Curr Drug Discov Technol PubMed  Europe PubMed DOI  V
  403. Forouzesh,N. and Onufriev,A.V.
    MMGB/SA Consensus Estimate of the Binding Free Energy Between the Novel Coronavirus Spike Protein to the Human ACE2 Receptor
    bioRxiv PubMed  Europe PubMed DOI
  404. Forssen,P., Samuelsson,J., Lacki,K. and Fornstedt,T.
    Advanced Analysis of Biosensor Data for SARS-CoV-2 RBD and ACE2 Interactions
    Anal Chem92, 11520-11524. PubMed  Europe PubMed DOI
  405. Franco,R., Rivas-Santisteban,R., Serrano-Marin,J., Rodriguez-Perez,A.I., Labandeira-Garcia,J.L. and Navarro,G.
    SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production
    J Immunol PubMed  Europe PubMed DOI
  406. Franco,R., Lillo,A., Rivas-Santisteban,R., Rodriguez-Perez,A.I., Reyes-Resina,I., Labandeira-Garcia,J.L. and Navarro,G.
    Functional Complexes of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Receptors: Expression in Adult but Not Fetal Lung Tissue
    Int J Mol Sci21, PubMed  Europe PubMed DOI
  407. Fu,J., Jia,Q., Zhou,H., Zhang,L., Wang,S., Liang,P., Lv,Y. and Han,S.
    Cell membrane chromatography for the analysis of the interaction between chloroquine and hydroxychloroquine with ACE2 receptors
    J Chromatogr B Analyt Technol Biomed Life Sci1162, 122469-122469. PubMed  Europe PubMed DOI
  408. Fuentes-Prior,P.
    Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection
    J Biol Chem PubMed  Europe PubMed DOI  V
  409. Galan,M. and Jimenez-Altayo,F.
    Small Resistance Artery Disease and ACE2 in Hypertension: A New Paradigm in the Context of COVID-19
    Front Cardiovasc Med7, 588692-588692. PubMed  Europe PubMed DOI  V
  410. Galanopoulos,M., Doukatas,A. and Gazouli,M.
    Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract
    World J Gastroenterol26, 6335-6345. PubMed  Europe PubMed DOI  V
  411. Gan,R., Rosoman,N.P., Henshaw,D.J.E., Noble,E.P., Georgius,P. and Sommerfeld,N.
    COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease
    Med Hypotheses144, 110024-110024. PubMed  Europe PubMed DOI  V
  412. Gao,F., Zheng,K.I., Fan,Y.C., Targher,G., Byrne,C.D. and Zheng,M.H.
    ACE2: A Linkage for the Interplay Between COVID-19 and Decompensated Cirrhosis
    Am J Gastroenterol PubMed  Europe PubMed DOI
  413. Gao,L.Q., Xu,J. and Chen,S.D.
    In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking
    Chin J Integr Med26, 527-532. PubMed  Europe PubMed DOI
  414. Gao,S. and Zhang,L.
    ACE2 partially dictates the host range and tropism of SARS-CoV-2
    Comput Struct Biotechnol J18, 4040-4047. PubMed  Europe PubMed DOI  V
  415. Gao,S., Luan,J., Cui,H. and Zhang,L.
    ACE2 isoform diversity predicts the host susceptibility of SARS-CoV-2
    Transbound Emerg Dis PubMed  Europe PubMed DOI
  416. Gaunkar,R.B., Nagarsekar,A., Carvalho,K.M., Jodalli,P.S. and Mascarenhas,K.
    COVID-19 in Smokeless Tobacco Habitues: Increased Susceptibility and Transmission
    Cureus12, e8824-e8824. PubMed  Europe PubMed DOI
  417. Ge,J., Zhang,S., Zhang,L. and Wang,X.
    Structural basis of severe acute respiratory syndrome coronavirus 2 infection
    Curr Opin HIV AIDS PubMed  Europe PubMed DOI  V
  418. Ghahestani,S.M., Mahmoudi,J., Hajebrahimi,S., Sioofy-Khojine,A.B., Salehi-Pourmehr,H., Sadeghi-Ghyassi,F. and Mostafaei,H.
    Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of Our Sight?
    Iran J Allergy Asthma Immunol19, 13-17. PubMed  Europe PubMed DOI
  419. Gheblawi,M., Wang,K., Viveiros,A., Nguyen,Q., Zhong,J.C., Turner,A.J., Raizada,M.K., Grant,M.B. and Oudit,G.Y.
    Response by Gheblawi et al to Letter Regarding Article, "Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2"
    Circ Res127, e46-e46. PubMed  Europe PubMed DOI
  420. Ghorbani,M., Brooks,B.R. and Klauda,J.B.
    Critical Sequence Hot-spots for Binding of nCOV-2019 to ACE2 as Evaluated by Molecular Simulations
    bioRxiv PubMed  Europe PubMed DOI
  421. Gil-Moles,M., Basu,U., Bussing,R., Hoffmeister,H., Turck,S., Varchmin,A. and Ott,I.
    Gold Metallodrugs to Target Coronavirus Proteins: Inhibitory Effects on the Spike-ACE2 Interaction and on PLpro Protease Activity by Auranofin and Gold Organometallics
    Chemistry PubMed  Europe PubMed DOI  I
  422. Gilbert,R.E., Caldwell,L., Misra,P.S., Chan,K., Burns,K.D., Wrana,J.L. and Yuen,D.A.
    Overexpression of the Severe Acute Respiratory Syndrome Coronavirus-2 Receptor, Angiotensin-Converting Enzyme 2, in Diabetic Kidney Disease: Implications for Kidney Injury in Novel Coronavirus Disease 2019
    Can J Diabetes PubMed  Europe PubMed DOI
  423. Gilzad-Kohan,H. and Jamali,F.
    Anti-Inflammatory Properties of Drugs Used to Control COVID-19 and their Effects on the Renin-Angiotensin System and Angiotensin-Converting Enzyme-2
    J Pharm Pharm Sci23, 259-277. PubMed  Europe PubMed DOI  V  I
  424. Glasgow,A., Glasgow,J., Limonta,D., Solomon,P., Lui,I., Zhang,Y., Nix,M.A., Rettko,N.J., Lim,S.A., Zha,S., Yamin,R., Kao,K., Rosenberg,O.S., Ravetch,J.V., Wiita,A.P., Leung,K.K., Zhou,X.X., Hobman,T.C., Kortemme,T. and Wells,J.A.
    Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
    bioRxiv PubMed  Europe PubMed DOI
  425. Golden,J.W., Cline,C.R., Zeng,X., Garrison,A.R., Carey,B.D., Mucker,E.M., White,L.E., Shamblin,J.D., Brocato,R.L., Liu,J., Babka,A.M., Rauch,H.B., Smith,J.M., Hollidge,B.S., Fitzpatrick,C., Badger,C.V. and Hooper,J.W.
    Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease
    JCI Insight PubMed  Europe PubMed DOI
  426. Gollapalli,P., B S,S., Rimac,H., Patil,P., Nalilu,S.K., Kandagalla,S. and Shetty,P.
    Pathway enrichment analysis of virus-host interactome and prioritization of novel compounds targeting the spike glycoprotein receptor binding domain-human angiotensin-converting enzyme 2 interface to combat SARS-CoV-2
    J Biomol Struct Dyn1-14. PubMed  Europe PubMed DOI
  427. Gomez,J., Albaiceta,G.M., Garcia-Clemente,M., Lopez-Larrea,C., Amado-Rodriguez,L., Lopez-Alonso,I., Hermida,T., Enriquez,A.I., Herrero,P., Melon,S., Alvarez-Arguelles,M.E., Boga,J.A., Rojo-Alba,S., Cuesta-Llavona,E., Alvarez,V., Lorca,R. and Coto,E.
    Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome
    Gene762, 145102-145102. PubMed  Europe PubMed DOI
  428. Gopinath,K., Jokinen,E.M., Kurkinen,S.T. and Pentikainen,O.T.
    Screening of Natural Products Targeting SARS-CoV-2-ACE2 Receptor Interface - A MixMD Based HTVS Pipeline
    Front Chem8, 589769-589769. PubMed  Europe PubMed DOI
  429. Gorshkov,K., Susumu,K., Chen,J., Xu,M., Pradhan,M., Zhu,W., Hu,X., Breger,J.C., Wolak,M. and Oh,E.
    Quantum Dot-Conjugated SARS-CoV-2 Spike Pseudo-Virions Enable Tracking of Angiotensin Converting Enzyme 2 Binding and Endocytosis
    ACS Nano14, 12234-12247. PubMed  Europe PubMed DOI
  430. Grajewski,R.S., Rokohl,A.C., Becker,M., Paulsen,F. and Heindl,L.M.
    Malignancy going viral: ACE2 and TMPRSS2 expression in conjunctival neoplastic diseases
    Ann Anat234, 151661-151661. PubMed  Europe PubMed DOI
  431. Gregoriou,G.C., Patel,S.D., Winters,B.L. and Bagley,E.E.
    Neprilysin controls the synaptic activity of neuropeptides in the intercalated cells of the amygdala
    Mol Pharmacol PubMed  Europe PubMed DOI  I
  432. Groban,L., Wang,H., Sun,X., Ahmad,S. and Ferrario,C.M.
    Is Sex a Determinant of COVID-19 Infection? Truth or Myth?
    Curr Hypertens Rep22, 62-62. PubMed  Europe PubMed DOI  V
  433. Gross,L.Z.F., Sacerdoti,M., Piiper,A., Zeuzem,S., Leroux,A.E. and Biondi,R.M.
    ACE2, the Receptor that Enables Infection by SARS-CoV-2: Biochemistry, Structure, Allostery and Evaluation of the Potential Development of ACE2 Modulators
    ChemMedChem PubMed  Europe PubMed DOI  V
  434. Grover,A. and Oberoi,M.
    A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers
    Eur Heart J Cardiovasc Pharmacother PubMed  Europe PubMed DOI
  435. Gue,Y.X., Kanji,R., Markides,V. and Gorog,D.A.
    Angiotensin Converting Enzyme 2 May Mediate Disease Severity In COVID-19
    Am J Cardiol130, 161-162. PubMed  Europe PubMed DOI
  436. Gue,Y.X. and Gorog,D.A.
    Reduction in ACE2 may mediate the prothrombotic phenotype in COVID-19
    Eur Heart J PubMed  Europe PubMed DOI
  437. Gue,Y.X., Kanji,R., Markides,V. and Gorog,D.A.
    Angiotensin Converting Enzyme 2 May Mediate Disease Severity In COVID-19
    Am J Cardiol130, 161-162. PubMed  Europe PubMed DOI
  438. Gul,R., Uh-Hyun,K. and Alfadda,A.A.
    Renin angiotensin system at the interface of COVID-19 infection
    Eur J Pharmacol173656-173656. PubMed  Europe PubMed DOI
  439. Guler,N., Siddiqui,F. and Fareed,J.
    Is the Reason of Increased D-Dimer Levels in COVID-19 Because of ACE-2-Induced Apoptosis in Endothelium?
    Clin Appl Thromb Hemost26, 1076029620935526-1076029620935526. PubMed  Europe PubMed DOI
  440. Gumashta,J. and Gumashta,R.
    Role of the Backbenchers of the Renin-Angiotensin System ACE2 and AT2 Receptors in COVID-19: Lessons From SARS
    Cureus12, e8411-e8411. PubMed  Europe PubMed DOI  V
  441. Guo,L., Bi,W., Wang,X., Xu,W., Yan,R., Zhang,Y., Zhao,K., Li,Y., Zhang,M., Cai,X., Jiang,S., Xie,Y., Zhou,Q., Lu,L. and Dang,B.
    Engineered trimeric ACE2 binds viral spike protein and locks it in "Three-up" conformation to potently inhibit SARS-CoV-2 infection
    Cell Res PubMed  Europe PubMed DOI
  442. Guo,X., Chen,Z., Xia,Y., Lin,W. and Li,H.
    Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2)
    J Transl Med18, 321-321. PubMed  Europe PubMed DOI
  443. Gupta,R., Meena,K., Patnaik,I. and Kumar,A.
    ACE2 Expression in the Pancreas and Association With COVID-19 Infection
    Pancreas PubMed  Europe PubMed DOI
  444. Hadi-Alijanvand,H. and Rouhani,M.
    Studying the Effects of ACE2 Mutations on the Stability, Dynamics, and Dissociation Process of SARS-CoV-2 S1/hACE2 Complexes
    J Proteome Res PubMed  Europe PubMed DOI
  445. Haghighi,M.M., Kakhki,E.G., Sato,C., Ghani,M. and Rogaeva,E.
    The Intersection between COVID-19, the Gene Family of ACE2 and Alzheimer's Disease
    Neurosci Insights15, 2633105520975743-2633105520975743. PubMed  Europe PubMed DOI
  446. Hakmi,M., Bouricha,E.L.M., Akachar,J., Lmimouni,B., El Harti,J., Belyamani,L. and Ibrahimi,A.
    In silico exploration of small-molecule alpha-helix mimetics as inhibitors of SARS-COV-2 attachment to ACE2
    J Biomol Struct Dyn1-12. PubMed  Europe PubMed DOI
  447. Hallaj,S., Ghorbani,A., Mousavi-Aghdas,S.A., Mirza-Aghazadeh-Attari,M., Sevbitov,A., Hashemi,V., Hallaj,T. and Jadidi-Niaragh,F.
    Angiotensin-Converting Enzyme as a new immunologic target for the new SARS-CoV-2
    Immunol Cell Biol PubMed  Europe PubMed DOI
  448. Han,T., Kang,J., Li,G., Ge,J. and Gu,J.
    Analysis of 2019-nCoV receptor ACE2 expression in different tissues and its significance study
    Ann Transl Med8, 1077-1077. PubMed  Europe PubMed DOI
  449. Hanrahan,T.P., Lubel,J.S. and Garg,M.
    Letter to the Editor: Lessons from COVID-19, ACE2 and intestinal inflammation - could a virus trigger chronic intestinal inflammation?
    Clin Gastroenterol Hepatol PubMed  Europe PubMed DOI
  450. Hanson,Q.M., Wilson,K.M., Shen,M., Itkin,Z., Eastman,R.T., Shinn,P. and Hall,M.D.
    Targeting ACE2-RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity Assay
    ACS Pharmacol Transl Sci3, 1352-1360. PubMed  Europe PubMed DOI
  451. Hardenberg,J.B. and Luft,F.C.
    Covid-19, ACE2 and the kidney
    Acta Physiol (Oxf)230, e13539-e13539. PubMed  Europe PubMed DOI
  452. Hassan,S.S., Ghosh,S., Attrish,D., Choudhury,P.P., Aljabali,A.A.A., Uhal,B.D., Lundstrom,K., Rezaei,N., Uversky,V.N., Seyran,M., Pizzol,D., Adadi,P., Soares,A., El-Aziz,T.M.A., Kandimalla,R., Tambuwala,M.M., Azad,G.K., Sherchan,S.P., Baetas-da-Cruz,W., Takayama,K., Serrano-Aroca,A., Chauhan,G., Palu,G. and Brufsky,A.M.
    Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features
    Molecules25, PubMed  Europe PubMed DOI
  453. Hassert,M., Geerling,E., Stone,E.T., Steffen,T.L., Dickson,A., Feldman,M.S., Class,J., Richner,J.M., Brien,J.D. and Pinto,A.K.
    mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2
    bioRxiv PubMed  Europe PubMed DOI  M
  454. Hassert,M., Geerling,E., Stone,E.T., Steffen,T.L., Feldman,M.S., Dickson,A.L., Class,J., Richner,J.M., Brien,J.D. and Pinto,A.K.
    mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2
    PLoS Pathog16, e1009163-e1009163. PubMed  Europe PubMed DOI
  455. Hati,S. and Bhattacharyya,S.
    Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor
    ACS Omega5, 16292-16298. PubMed  Europe PubMed DOI
  456. Hatmal,M.M., Alshaer,W., Al-Hatamleh,M.A.I., Hatmal,M., Smadi,O., Taha,M.O., Oweida,A.J., Boer,J.C., Mohamud,R. and Plebanski,M.
    Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
    Cells9, PubMed  Europe PubMed DOI  V
  457. Hattori,T., Koide,A., Panchenko,T., Romero,L.A., Teng,K.W., Tada,T., Landau,N.R. and Koide,S.
    The ACE2-binding interface of SARS-CoV-2 Spike inherently deflects immune recognition
    bioRxiv PubMed  Europe PubMed DOI
  458. Hattori,T., Koide,A., Noval,M.G., Panchenko,T., Romero,L.A., Teng,K.W., Tada,T., Landau,N.R., Stapleford,K.A. and Koide,S.
    The ACE2-binding Interface of SARS-CoV-2 Spike Inherently Deflects Immune Recognition
    J Mol Biol433, 166748-166748. PubMed  Europe PubMed DOI
  459. He,Q., Mok,T.N., Yun,L., He,C., Li,J. and Pan,J.
    Single-cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: A potential pathway of COVID-19 infection
    Mol Genet Genomic Mede1442-e1442. PubMed  Europe PubMed DOI
  460. Heegaard,P.M.H., Sturek,M., Alloosh,M. and Belsham,G.J.
    Animal Models for COVID-19: More to the Picture Than ACE2, Rodents, Ferrets, and Non-human Primates. A Case for Porcine Respiratory Coronavirus and the Obese Ossabaw Pig
    Front Microbiol11, 573756-573756. PubMed  Europe PubMed DOI
  461. Hennighausen,L. and Lee,H.K.
    Activation of the SARS-CoV-2 Receptor Ace2 by Cytokines Through Pan JAK-STAT Enhancers
    SSRN3601827-3601827. PubMed  Europe PubMed DOI
  462. Hikmet,F., Mear,L., Edvinsson,A., Micke,P., Uhlen,M. and Lindskog,C.
    The protein expression profile of ACE2 in human tissues
    Mol Syst Biol16, e9610-e9610. PubMed  Europe PubMed DOI
  463. Hoevenaar,M., Goossens,D. and Roorda,J.
    Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads
    J Renin Angiotensin Aldosterone Syst21, 1470320320979097-1470320320979097. PubMed  Europe PubMed DOI  V
  464. Huang,H., Wang,J., Liu,Z. and Gao,F.
    The angiotensin-converting enzyme 2/angiotensin (1-7)/mas axis protects against pyroptosis in LPS-induced lung injury by inhibiting NLRP3 activation
    Arch Biochem Biophys693, 108562-108562. PubMed  Europe PubMed DOI  I
  465. Huang,H.H., Wang,P.H., Yang,Y.P., Chou,S.J., Chu,P.W., Wu,G.J. and Chang,C.C.
    A review of severe acute respiratory syndrome coronavirus 2 infection in the reproductive system
    J Chin Med Assoc83, 895-897. PubMed  Europe PubMed DOI
  466. Huang,K.Y., Lin,M.S., Kuo,T.C., Chen,C.L., Lin,C.C., Chou,Y.C., Chao,T.L., Pang,Y.H., Kao,H.C., Huang,R.S., Lin,S., Chang,S.Y. and Yang,P.C.
    Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infection
    EMBO Mol Mede12828-e12828. PubMed  Europe PubMed DOI
  467. Huang,S.W., Miller,S.O., Yen,C.H. and Wang,S.F.
    Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation
    Genes (Basel)12, PubMed  Europe PubMed DOI
  468. Huang,X., Zhang,C., Pearce,R., Omenn,G.S. and Zhang,Y.
    Identifying the Zoonotic Origin of SARS-CoV-2 by Modeling the Binding Affinity between the Spike Receptor-Binding Domain and Host ACE2
    J Proteome Res PubMed  Europe PubMed DOI
  469. Huang,X., Pearce,R. and Zhang,Y.
    De novo design of protein peptides to block association of the SARS-CoV-2 spike protein with human ACE2
    Aging (Albany NY)12, 11263-11276. PubMed  Europe PubMed DOI
  470. Huh,T., Larouche-Lebel,E., Loughran,K.A. and Oyama,M.A.
    Effect of angiotensin receptor blockers and angiotensin-converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in cats with heart disease
    J Vet Intern Med PubMed  Europe PubMed DOI
  471. Huo,J., Le Bas,A., Ruza,R.R., Duyvesteyn,H.M.E., Mikolajek,H., Malinauskas,T., Tan,T.K., Rijal,P., Dumoux,M., Ward,P.N., Ren,J., Zhou,D., Harrison,P.J., Weckener,M., Clare,D.K., Vogirala,V.K., Radecke,J., Moynie,L., Zhao,Y., Gilbert-Jaramillo,J., Knight,M.L., Tree,J.A., Buttigieg,K.R., Coombes,N., Elmore,M.J., Carroll,M.W., Carrique,L., Shah,P.N.M., James,W., Townsend,A.R., Stuart,D.I., Owens,R.J. and Naismith,J.H.
    Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
    Nat Struct Mol Biol PubMed  Europe PubMed DOI
  472. Hussien,M.A. and Abdelaziz,A.E.M.
    Molecular docking suggests repurposing of brincidofovir as a potential drug targeting SARS-CoV-2 ACE2 receptor and main protease
    Netw Model Anal Health Inform Bioinform9, 56-56. PubMed  Europe PubMed DOI
  473. Inal,J.M.
    Decoy ACE2-expressing extracellular vesicles that competitively bind SARS-CoV-2 as a possible COVID-19 therapy
    Clin Sci (Lond)134, 1301-1304. PubMed  Europe PubMed DOI
  474. Ionescu,M.I.
    An Overview of the Crystallized Structures of the SARS-CoV-2
    Protein J PubMed  Europe PubMed DOI
  475. Iwasaki,M., Saito,J., Zhao,H., Sakamoto,A., Hirota,K. and Ma,D.
    Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications
    Inflammation PubMed  Europe PubMed DOI  V
  476. Jacobs,M., Van Eeckhoutte,H.P., Wijnant,S.R.A., Janssens,W., Joos,G.F., Brusselle,G.G. and Bracke,K.R.
    Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects
    Eur Respir J PubMed  Europe PubMed DOI
  477. Ji,X., Tan,W., Zhang,C., Zhai,Y., Hsueh,Y., Zhang,Z., Zhang,C., Lu,Y., Duan,B., Tan,G., Na,R., Deng,G. and Niu,G.
    TWIRLS, a knowledge-mining technology, suggests a possible mechanism for the pathological changes in the human host after coronavirus infection via ACE2
    Drug Dev Res PubMed  Europe PubMed DOI
  478. Jia,H., Neptune,E. and Cui,H.
    Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges
    Am J Respir Cell Mol Biol PubMed  Europe PubMed DOI  V
  479. Jiang,Y.P., Zhao,X.X., Lv,H.Q. and Wen,C.P.
    Drug screening and development from the affinity of S protein of new coronavirus with ACE2
    Eur J Clin Microbiol Infect Dis PubMed  Europe PubMed DOI
  480. Jing,H., Ackerman,W.E., Zhao,G., El Helou,Y., Buhimschi,C.S. and Buhimschi,I.A.
    Connecting the dots on vertical transmission of SARS-CoV-2 using protein-protein interaction network analysis - Potential roles of placental ACE2 and ENDOU
    Placenta104, 16-19. PubMed  Europe PubMed DOI
  481. Kalhor,H., Sadeghi,S., Abolhasani,H., Kalhor,R. and Rahimi,H.
    Repurposing of the approved small molecule drugs in order to inhibit SARS-CoV-2 S protein and human ACE2 interaction through virtual screening approaches
    J Biomol Struct Dyn1-16. PubMed  Europe PubMed DOI
  482. Kalra,R.S., Tomar,D., Meena,A.S. and Kandimalla,R.
    SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings
    Pathogens9, PubMed  Europe PubMed DOI  V
  483. Kashour,T., Bin Abdulhak,A.A., Tlayjeh,H., Hassett,L.C., Noman,A., Mohsen,A., Al-Mallah,M.H. and Tleyjeh,I.M.
    Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Mortality Among COVID-19 Patients: A Systematic Review and Meta-Analysis
    Am J Ther PubMed  Europe PubMed DOI
  484. Kenarkoohi,A., Maleki,M., Safari,T., Kafashian,M., Saljoughi,F. and Sohrabipour,S.
    Angiotensin-converting Enzyme 2 roles in the Pathogenesis of COVID-19
    Curr Hypertens Rev PubMed  Europe PubMed DOI
  485. Kerslake,R., Hall,M., Randeva,H.S., Spandidos,D.A., Chatha,K., Kyrou,I. and Karteris,E.
    Coexpression of peripheral olfactory receptors with SARSCoV2 infection mediators: Potential implications beyond loss of smell as a COVID19 symptom
    Int J Mol Med46, 949-956. PubMed  Europe PubMed DOI
  486. Khanna,K., Raymond,W., Charbit,A.R., Jin,J., Gitlin,I., Tang,M., Sperber,H.S., Franz,S., Pillai,S., Simmons,G. and Fahy,J.V.
    Binding of SARS-CoV-2 spike protein to ACE2 is disabled by thiol-based drugs; evidence from in vitro SARS-CoV-2 infection studies
    bioRxiv PubMed  Europe PubMed DOI
  487. Khayat,A.S., de Assumpcao,P.P., Meireles Khayat,B.C., Thomaz Araujo,T.M., Batista-Gomes,J.A., Imbiriba,L.C., Ishak,G., de Assumpcao,P.B., Moreira,F.C., Burbano,R.R., Ribeiro-Dos-Santos,A., Ribeiro-Dos-Santos,A.K., Dos Santos,N.P.C. and Dos Santos,S.E.B.
    ACE2 polymorphisms as potential players in COVID-19 outcome
    PLoS ONE15, e0243887-e0243887. PubMed  Europe PubMed DOI
  488. Khelfaoui,H., Harkati,D. and Saleh,B.A.
    Molecular docking, molecular dynamics simulations and reactivity, studies on approved drugs library targeting ACE2 and SARS-CoV-2 binding with ACE2
    J Biomol Struct Dyn1-17. PubMed  Europe PubMed DOI
  489. Kim,J., Mukherjee,A., Nelson,D., Jozic,A. and Sahay,G.
    Rapid generation of circulating and mucosal decoy ACE2 using mRNA nanotherapeutics for the potential treatment of SARS-CoV-2
    bioRxiv PubMed  Europe PubMed DOI
  490. Kim,K., Ko,Y., Ko,D.S. and Kim,Y.H.
    Prognostic Significance of COVID-19 Receptor ACE2 and Recommendation for Antihypertensive Drug in Renal Cell Carcinoma
    Biomed Res Int2020, 2054376-2054376. PubMed  Europe PubMed DOI
  491. Kintscher,U., Slagman,A., Domenig,O., Rohle,R., Konietschke,F., Poglitsch,M. and Mockel,M.
    Plasma Angiotensin Peptide Profiling and ACE2-Activity in COVID-19 Patients treated with Pharmacological Blockers of the Renin Angiotensin System
    Hypertension PubMed  Europe PubMed DOI
  492. Kipshidze,N., Dangas,G., White,C.J., Kipshidze,N., Siddiqui,F., Lattimer,C.R., Carter,C.A. and Fareed,J.
    Viral Coagulopathy in Patients With COVID-19: Treatment and Care
    Clin Appl Thromb Hemost26, 1076029620936776-1076029620936776. PubMed  Europe PubMed DOI
  493. Kishk,S.M., Kishk,R.M., Yassen,A.S.A., Nafie,M.S., Nemr,N.A., ElMasry,G., Al-Rejaie,S. and Simons,C.
    Molecular Insights into Human Transmembrane Protease Serine-2 (TMPS2) Inhibitors against SARS-CoV2: Homology Modelling, Molecular Dynamics, and Docking Studies
    Molecules25, PubMed  Europe PubMed DOI  I
  494. Klhufek,J.
    The role of angiotensin-converting enzyme 2 in the pathogenesis of COVID-19: the villain or the hero?
    Acta Clin Belg1-8. PubMed  Europe PubMed DOI
  495. Kornilov,S.A., Lucas,I., Jade,K., Dai,C.L., Lovejoy,J.C. and Magis,A.T.
    Plasma levels of soluble ACE2are associated with sex, Metabolic Syndrome, and its biomarkers in a large cohort, pointing to a possible mechanism for increased severity in COVID-19
    Crit Care24, 452-452. PubMed  Europe PubMed DOI
  496. Kumar,A., Panwar,A., Batra,K., Dey,S. and Maan,S.
    In-silico analysis of angiotensin converting enzyme 2 (ACE2) of livestock, pet and poultry animals to determine its susceptibility to SARS-CoV- 2 infection
    Comb Chem High Throughput Screen PubMed  Europe PubMed DOI
  497. Kumar,A., Pandey,S.N., Pareek,V., Narayan,R.K., Faiq,M.A. and Kumari,C.
    Predicting susceptibility for SARS-CoV-2 infection in domestic and wildlife animals using ACE2 protein sequence homology
    Zoo Biol PubMed  Europe PubMed DOI
  498. Kumar,A., Faiq,M.A., Pareek,V., Raza,K., Narayan,R.K., Prasoon,P., Kumar,P., Kulandhasamy,M., Kumari,C., Kant,K., Singh,H.N., Qadri,R., Pandey,S.N. and Kumar,S.
    Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients
    Med Hypotheses144, 110271-110271. PubMed  Europe PubMed DOI
  499. Kumar,A., Narayan,R.K., Kumari,C., Faiq,M.A., Kulandhasamy,M., Kant,K. and Pareek,V.
    SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients
    Med Hypotheses145, 110320-110320. PubMed  Europe PubMed DOI
  500. Kumar,P., Sah,A.K., Tripathi,G., Kashyap,A., Tripathi,A., Rao,R., Mishra,P.C., Mallick,K., Husain,A. and Kashyap,M.K.
    Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19
    Mol Cell Biochem PubMed  Europe PubMed DOI  V  I
  501. Kurbel,S.
    The renin-angiotensin system in COVID-19: Why ACE2 targeting by coronaviruses produces higher mortality in elderly hypertensive patients?
    Bioessayse2000112-e2000112. PubMed  Europe PubMed DOI
  502. Lai,Y.J., Chang,C.M., Lin,C.K., Yang,Y.P., Chien,C.S., Wang,P.H. and Chang,C.C.
    Severe acute respiratory syndrome coronavirus-2 and the deduction effect of angiotensin-converting enzyme 2 in pregnancy
    J Chin Med Assoc83, 812-816. PubMed  Europe PubMed DOI
  503. Lam,S.D., Bordin,N., Waman,V.P., Scholes,H.M., Ashford,P., Sen,N., van Dorp,L., Rauer,C., Dawson,N.L., Pang,C.S.M., Abbasian,M., Sillitoe,I., Edwards,S.J.L., Fraternali,F., Lees,J.G., Santini,J.M. and Orengo,C.A.
    SARS-CoV-2 spike protein predicted to form complexes with host receptor protein orthologues from a broad range of mammals
    Sci Rep10, 16471-16471. PubMed  Europe PubMed DOI
  504. Laurini,E., Marson,D., Aulic,S., Fermeglia,M. and Pricl,S.
    Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex
    ACS Nano14, 11821-11830. PubMed  Europe PubMed DOI
  505. Lazartigues,E., Qadir,M.M.F. and Mauvais-Jarvis,F.
    Endocrine significance of SARS-CoV-2's reliance on ACE2
    Endocrinology PubMed  Europe PubMed DOI
  506. Lee,A.C., Chakladar,J., Li,W.T., Chen,C., Chang,E.Y., Wang-Rodriguez,J. and Ongkeko,W.M.
    Tobacco, but Not Nicotine and Flavor-Less Electronic Cigarettes, Induces ACE2 and Immune Dysregulation
    Int J Mol Sci21, PubMed  Europe PubMed DOI
  507. Lee,H.K., Jung,O. and Hennighausen,L.
    Activation of Interferon-Stimulated Transcriptomes and ACE2 Isoforms in Human Airway Epithelium Is Curbed by Janus Kinase Inhibitors
    Res Sq PubMed  Europe PubMed DOI
  508. Lee,I.H., Lee,J.W. and Kong,S.W.
    A survey of genetic variants in SARS-CoV-2 interacting domains of ACE2, TMPRSS2 and TLR3/7/8 across populations
    Infect Genet Evol85, 104507-104507. PubMed  Europe PubMed DOI
  509. Lee,I.T., Nakayama,T., Wu,C.T., Goltsev,Y., Jiang,S., Gall,P.A., Liao,C.K., Shih,L.C., Schurch,C.M., McIlwain,D.R., Chu,P., Borchard,N.A., Zarabanda,D., Dholakia,S.S., Yang,A., Kim,D., Chen,H., Kanie,T., Lin,C.D., Tsai,M.H., Phillips,K.M., Kim,R., Overdevest,J.B., Tyler,M.A., Yan,C.H., Lin,C.F., Lin,Y.T., Bau,D.T., Tsay,G.J., Patel,Z.M., Tsou,Y.A., Tzankov,A., Matter,M.S., Tai,C.J., Yeh,T.H., Hwang,P.H., Nolan,G.P., Nayak,J.V. and Jackson,P.K.
    ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs
    Nat Commun11, 5453-5453. PubMed  Europe PubMed DOI
  510. Lee,J.J., Kopetz,S., Vilar,E., Shen,J.P., Chen,K. and Maitra,A.
    Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract
    Genes (Basel)11, PubMed  Europe PubMed DOI
  511. Lee,S.H., Jee,S.W., Hwang,D.Y. and Kang,J.K.
    Characterization of changes in global gene expression in the hearts and kidneys of transgenic mice overexpressing human angiotensin-converting enzyme 2
    Lab Anim Res36, 23-23. PubMed  Europe PubMed DOI  I
  512. Lehrer,S. and Rheinstein,P.H.
    Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2
    In Vivo34, 3023-3026. PubMed  Europe PubMed DOI
  513. Lei,Y., Zhang,J., Schiavon,C.R., He,M., Chen,L., Shen,H., Zhang,Y., Yin,Q., Cho,Y., Andrade,L., Shadel,G.S., Hepokoski,M., Lei,T., Wang,H., Zhang,J., Yuan,J.X., Malhotra,A., Manor,U., Wang,S., Yuan,Z.Y. and Shyy,J.Y.
    SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE2
    bioRxiv PubMed  Europe PubMed DOI
  514. Leow,M.K.S.
    Clarifying the controversial risk-benefit profile of soluble ACE2 in COVID-19
    Crit Care24, 396-396. PubMed  Europe PubMed DOI
  515. Leung,C. and Wong,A.P.
    The role of angiotensin-converting enzyme 2 (ACE2) receptor in the intestine in COVID-19: more research needed
    Gastroenterol Hepatol Bed Bench13, 280-281. PubMed  Europe PubMed
  516. Li,F.F., Zhang,Q., Wang,G.Y. and Liu,S.L.
    Comparative analysis of SARS-CoV-2 and its receptor ACE2 with evolutionarily related coronaviruses
    Aging (Albany NY)12, 20938-20945. PubMed  Europe PubMed DOI
  517. Li,H., Xie,L., Chen,L., Zhang,L., Han,Y., Yan,Z. and Guo,X.
    Genomic, epigenomic, and immune subtype analysis of CTSL/B and SARS-CoV-2 receptor ACE2 in pan-cancer
    Aging (Albany NY)12, 22370-22389. PubMed  Europe PubMed DOI
  518. Li,J., Stevens,B.R., Richards,E.M. and Raizada,M.K.
    SARS-CoV-2 Receptor ACE2 (Angiotensin-Converting Enzyme 2) Is Upregulated in Colonic Organoids From Hypertensive Rats
    Hypertension76, e26-e26. PubMed  Europe PubMed DOI
  519. Li,J., Ma,X., Guo,S., Hou,C., Shi,L., Zhang,H., Zheng,B., Liao,C., Yang,L., Ye,L. and He,X.
    A Hydrophobic-Interaction-Based Mechanism Triggers Docking between the SARS-CoV-2 Spike and Angiotensin-Converting Enzyme 2
    Glob Chall2000067-2000067. PubMed  Europe PubMed DOI
  520. Li,Y., Wang,H., Tang,X., Fang,S., Ma,D., Du,C., Wang,Y., Pan,H., Yao,W., Zhang,R., Zou,X., Zheng,J., Xu,L., Farzan,M. and Zhong,G.
    SARS-CoV-2 and three related coronaviruses utilize multiple ACE2 orthologs and are potently blocked by an improved ACE2-Ig
    J Virol PubMed  Europe PubMed DOI
  521. Li,Y., Xu,Q., Ma,L., Wu,D., Gao,J., Chen,G. and Li,H.
    Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2
    J Cell Mol Med PubMed  Europe PubMed DOI
  522. Li,Y., Xu,Q., Ma,L., Wu,D., Gao,J., Chen,G. and Li,H.
    Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2
    J Cell Mol Med PubMed  Europe PubMed DOI
  523. Li,Z., Li,X., Shen,J., Tan,H., Rong,T., Lin,Y., Feng,E., Chen,Z., Jiao,Y., Liu,G., Zhang,L., Vai Chan,M.T. and Kei Wu,W.K.
    Bioinformatic analysis of SMN1-ACE/ACE2 interactions hinted at a potential protective effect of spinal muscular atrophy against COVID-19-induced lung injury
    Brief Bioinform PubMed  Europe PubMed DOI
  524. Li,Z., Xu,X., Yang,M., Feng,J., Liu,C. and Yang,C.
    Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic
    Aging (Albany NY)12, PubMed  Europe PubMed DOI  V
  525. Liao,W. and Wu,J.
    The ACE2/Ang (1-7)/MasR axis as an emerging target for antihypertensive peptides
    Crit Rev Food Sci Nutr1-15. PubMed  Europe PubMed DOI
  526. Lim,H., Baek,A., Kim,J., Kim,M.S., Liu,J., Nam,K.Y., Yoon,J. and No,K.T.
    Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method
    Sci Rep10, 16862-16862. PubMed  Europe PubMed DOI
  527. Lim,K.H., Yang,S., Kim,S.H. and Joo,J.Y.
    Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease
    J Infect81, e33-e33. PubMed  Europe PubMed DOI
  528. Lin,H.B. and Liu,P.P.
    COVID-19 and the Heart: ACE2 Level is Not Destiny, But the Company It Keeps May Hold the Fate
    JACC Basic Transl Sci PubMed  Europe PubMed DOI
  529. Linsky,T.W., Vergara,R., Codina,N., Nelson,J.W., Walker,M.J., Su,W., Hsiang,T.Y., Esser-Nobis,K., Yu,K., Hou,Y.J., Priya,T., Mitsumoto,M., Pong,A., Lau,U.Y., Mason,M.L., Chen,J., Chen,A., Berrocal,T., Peng,H., Clairmont,N.S., Castellanos,J., Lin,Y.R., Josephson-Day,A., Baric,R., Walkey,C.D., Swanson,R., Gale,M., Blancas-Mejia,L.M., Yen,H.L. and Silva,D.A.
    De novo design of ACE2 protein decoys to neutralize SARS-CoV-2
    bioRxiv PubMed  Europe PubMed DOI
  530. Lippi,G., Lavie,C.J., Henry,B.M. and Sanchis-Gomar,F.
    Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?
    Clin Chem Lab Med PubMed  Europe PubMed DOI
  531. Liu,H., Gai,S., Wang,X., Zeng,J., Sun,C., Zhao,Y. and Zheng,Z.
    Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart
    Cardiovasc Res116, 1733-1741. PubMed  Europe PubMed DOI
  532. Liu,J., Chen,G.Q., Wei,L. and Jiao,F.Y.
    [A review on the role of angiotensin-converting enzyme 2 in children with coronavirus disease 2019]
    Zhongguo Dang Dai Er Ke Za Zhi22, 1344-1348. PubMed  Europe PubMed
  533. Liu,X., Raghuvanshi,R., Ceylan,F.D. and Bolling,B.W.
    Quercetin and Its Metabolites Inhibit Recombinant Human Angiotensin-Converting Enzyme 2 (ACE2) Activity
    J Agric Food Chem PubMed  Europe PubMed DOI  I
  534. Liu,Y., Qu,H.Q., Qu,J., Tian,L. and Hakonarson,H.
    Expression Pattern of the SARS-CoV-2 Entry Genes ACE2 and TMPRSS2 in the Respiratory Tract
    Viruses12, PubMed  Europe PubMed DOI
  535. Lopes,L.R., de Mattos Cardillo,G. and Paiva,P.B.
    Molecular evolution and phylogenetic analysis of SARS-CoV-2 and hosts ACE2 protein suggest Malayan pangolin as intermediary host
    Braz J Microbiol PubMed  Europe PubMed DOI
  536. Lores,E., Wysocki,J. and Batlle,D.
    ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery
    Clin Sci (Lond)134, 2791-2805. PubMed  Europe PubMed DOI  V
  537. Lou,L.L., Xie,L., Hu,Y., Chen,L.N., Liang,P., Shi,F., Liu,C.J. and Liu,H.M.
    [Association of age distribution with the expression of angiotensin-converting enzyme 2 in lung tissues in severe acute respiratory syndrome coronavirus 2 infection: reflections from the study of RAS pathway expression in mice]
    Zhongguo Dang Dai Er Ke Za Zhi22, 1119-1124. PubMed  Europe PubMed
  538. Low-Gan,J., Huang,R., Warner,G., Kelley,A., McGregor,D. and Smider,V.
    Diversity of ACE2 and its interaction with SARS-CoV-2 receptor binding domain
    bioRxiv PubMed  Europe PubMed DOI
  539. Lozano-Gonzalez,K., Padilla-Rodriguez,E., Texis,T., Gutierrez,M.N., Rodriguez-Dorantes,M., Cuevas-Cordoba,B., Ramirez-Garcia,E., Mino-Leon,D., Sanchez-Garcia,S. and Gonzalez-Covarrubias,V.
    Allele Frequency of ACE2 Intron Variants and Its Association with Blood Pressure
    DNA Cell Biol PubMed  Europe PubMed DOI
  540. Lu,D., Chatterjee,S., Xiao,K., Riedel,I., Wang,Y., Foo,R., Bar,C. and Thum,T.
    MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes
    J Mol Cell Cardiol148, 46-49. PubMed  Europe PubMed DOI
  541. Lu,J. and Sun,P.D.
    High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity
    bioRxiv PubMed  Europe PubMed DOI
  542. Lu,J. and Sun,P.D.
    High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity
    J Biol Chem PubMed  Europe PubMed DOI
  543. Lu,J., Hou,Y., Ge,S., Wang,X., Wang,J., Hu,T., Lv,Y., He,H. and Wang,C.
    Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro
    Life Sci266, 118889-118889. PubMed  Europe PubMed DOI
  544. Lu,L., Liu,X., Jin,R., Guan,R., Lin,R. and Qu,Z.
    Potential Roles of the Renin-Angiotensin System in the Pathogenesis and Treatment of COVID-19
    Biomed Res Int2020, 7520746-7520746. PubMed  Europe PubMed DOI  V
  545. Lu,M., Qiu,L., Jia,G., Guo,R. and Leng,Q.
    Single-cell expression profiles of ACE2 and TMPRSS2 reveals potential vertical transmission and fetus infection of SARS-CoV-2
    Aging (Albany NY)12, 19880-19897. PubMed  Europe PubMed DOI
  546. Luo,J., Lu,S., Yu,M., Zhu,L., Zhu,C., Li,C., Fang,J., Zhu,X. and Wang,X.
    The potential involvement of JAK-STAT signaling pathway in the COVID-19 infection assisted by ACE2
    Gene145325-145325. PubMed  Europe PubMed DOI
  547. Lupi,L., Adamo,M., Inciardi,R.M. and Metra,M.
    ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19
    Eur Heart J PubMed  Europe PubMed DOI
  548. Ma,A., Gao,L., Wafi,A.M., Yu,L., Rudebush,T., Zhou,W. and Zucker,I.H.
    Overexpression of Central ACE2 (Angiotensin-Converting Enzyme 2) Attenuates the Pressor Response to Chronic Central Infusion of Ang II (Angiotensin II): A Potential Role for Nrf2 (Nuclear Factor [Erythroid-Derived 2]-Like 2)
    Hypertension76, 1514-1525. PubMed  Europe PubMed DOI  K
  549. Ma,X., Gao,F., Chen,Q., Xuan,X., Wang,Y., Deng,H., Yang,F. and Yuan,L.
    ACE2 modulates glucose homeostasis through GABA signaling during metabolic stress
    J Endocrinol246, 223-236. PubMed  Europe PubMed DOI
  550. Mahdian,S., Ebrahim-Habibi,A. and Zarrabi,M.
    Drug repurposing using computational methods to identify therapeutic options for COVID-19
    J Diabetes Metab Disord1-9. PubMed  Europe PubMed DOI  I
  551. Majeed,J., Ajmera,P. and Goyal,R.K.
    Delineating clinical characteristics and comorbidities among 206 COVID-19deceasedpatients in India: Emerging significance of renin angiotensin system derangement
    Diabetes Res Clin Pract108349-108349. PubMed  Europe PubMed DOI
  552. Maksimowski,N., Williams,V.R. and Scholey,J.W.
    Kidney ACE2 expression: Implications for chronic kidney disease
    PLoS ONE15, e0241534-e0241534. PubMed  Europe PubMed DOI
  553. Maleki Dana,P., Sadoughi,F., Hallajzadeh,J., Asemi,Z., Mansournia,M.A., Yousefi,B. and Momen-Heravi,M.
    An Insight into the Sex Differences in COVID-19 Patients: What are the Possible Causes?
    Prehosp Disaster Med35, 438-441. PubMed  Europe PubMed DOI
  554. Manolis,A.S., Manolis,T.A., Manolis,A.A. and Melita,H.
    The Controversy of Renin-Angiotensin-System Blocker Facilitation Versus Countering COVID-19 Infection
    J Cardiovasc Pharmacol PubMed  Europe PubMed DOI
  555. Maremanda,K.P., Sundar,I.K., Li,D. and Rahman,I.
    Age-dependent assessment of genes involved in cellular senescence, telomere and mitochondrial pathways in human lung tissue of smokers, COPD and IPF: Associations with SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 axis
    Res Sq PubMed  Europe PubMed DOI
  556. Martelli-Junior,H., Machado,R.A., Martelli,D.R.B., Andrade,M.C. and Coletta,R.D.
    Oral cancer and ACE2 receptor of SARS-CoV-2
    Oral Oncol104920-104920. PubMed  Europe PubMed DOI
  557. Masre,S.F., Jufri,N.F., Ibrahim,F.W. and Abdul Raub,S.H.
    Classical and alternative receptors for SARS-CoV-2 therapeutic strategy
    Rev Med Virole2207-e2207. PubMed  Europe PubMed DOI  V
  558. Matarese,A., Gambardella,J., Sardu,C. and Santulli,G.
    miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19
    Biomedicines8, PubMed  Europe PubMed DOI
  559. McLachlan,C.S.
    The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms
    Clin Hypertens26, 14-14. PubMed  Europe PubMed DOI
  560. McNaughton,B. and Rosario,P.A.
    Computational Hot-Spot Analysis of the SARS-CoV-2 Receptor Binding Domain / ACE2 Complex
    Chembiochem PubMed  Europe PubMed DOI
  561. Medina-Enriquez,M.M., Lopez-Leon,S., Carlos-Escalante,J.A., Aponte-Torres,Z., Cuapio,A. and Wegman-Ostrosky,T.
    ACE2: the molecular doorway to SARS-CoV-2
    Cell Biosci10, 148-148. PubMed  Europe PubMed DOI  V
  562. Meini,S., Zanichelli,A., Sbrojavacca,R., Iuri,F., Roberts,A.T., Suffritti,C. and Tascini,C.
    Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
    Front Immunol11, 2014-2014. PubMed  Europe PubMed DOI
  563. Melin,A.D., Janiak,M.C., Marrone,F., III, Arora,P.S. and Higham,J.P.
    Comparative ACE2 variation and primate COVID-19 risk
    Commun Biol3, 641-641. PubMed  Europe PubMed DOI
  564. Mellott,D., Tseng,C.T., Drelich,A., Fajtova,P., Chenna,B.C., Kostomiris,D., Hsu,J.C., Zhu,J., Taylor,Z., Tat,V., Katzfuss,A., Li,L., Giardini,M.A., Skinner,D., Hirata,K., Beck,S., Carlin,A.F., Clark,A.E., Berreta,L., Maneval,D., Frueh,F., Hurst,B.L., Wang,H., Kocurek,K.I., Raushel,F.M., O'Donoghue,A., Siqueira-Neto,J.L., Meek,T.D. and McKerrow,J.H.
    A cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cells
    bioRxiv PubMed  Europe PubMed DOI  I
  565. Melo Junior,A.F., Dalpiaz,P.L.M., Escouto,L.D.S., Sousa,G.J., Aires,R., Oliveira,N.D., Carmona,A.K., Gava,A.L. and Bissoli,N.S.
    Involvement of sex hormones, oxidative stress, ACE and ACE2 activity in the impairment of renal function and remodelling in SHR
    Life Sci257, 118138-118138. PubMed  Europe PubMed DOI
  566. Mercurio,I., Tragni,V., Busto,F., De Grassi,A. and Pierri,C.L.
    Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies
    Cell Mol Life Sci PubMed  Europe PubMed DOI
  567. Michaud,V., Deodhar,M., Arwood,M., Al Rihani,S.B., Dow,P. and Turgeon,J.
    ACE2 as a Therapeutic Target for COVID-19; its Role in Infectious Processes and Regulation by Modulators of the RAAS System
    J Clin Med9, PubMed  Europe PubMed DOI  V
  568. Ming,Y. and Qiang,L.
    Involvement of Spike Protein, Furin, and ACE2 in SARS-CoV-2-Related Cardiovascular Complications
    SN Compr Clin Med1-6. PubMed  Europe PubMed DOI
  569. Mjaess,G., Karam,A., Aoun,F., Albisinni,S. and Roumeguere,T.
    COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor
    Prog Urol PubMed  Europe PubMed DOI
  570. Mohammad,A., Marafie,S.K., Alshawaf,E., Abu-Farha,M., Abubaker,J. and Al-Mulla,F.
    Structural analysis of ACE2 variant N720D demonstrates a higher binding affinity to TMPRSS2
    Life Sci259, 118219-118219. PubMed  Europe PubMed DOI
  571. Moin,A.S.M., Sathyapalan,T., Atkin,S.L. and Butler,A.E.
    Renin-Angiotensin System overactivation in polycystic ovary syndrome, a risk for SARS-CoV-2 infection?
    Metabol Open7, 100052-100052. PubMed  Europe PubMed DOI
  572. Mokuda,S., Tokunaga,T., Masumoto,J. and Sugiyama,E.
    Angiotensin-converting Enzyme 2, a SARS-CoV-2 receptor, Is Upregulated by Interleukin 6 through STAT3 Signaling in Synovial Tissues
    J Rheumatol PubMed  Europe PubMed DOI
  573. Momtazi-Borojeni,A.A., Banach,M., Reiner,Z., Pirro,M., Bianconi,V., Al-Rasadi,K. and Sahebkar,A.
    Interaction Between Coronavirus S-Protein and Human ACE2: Hints for Exploring Efficient Therapeutic Targets to Treat COVID-19
    Angiology3319720952284-3319720952284. PubMed  Europe PubMed DOI  V
  574. Monda,V.M., Porcellati,F., Strollo,F. and Gentile,S.
    ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
    Diabetes Ther11, 1909-1914. PubMed  Europe PubMed DOI
  575. Monteil,V., Dyczynski,M., Lauschke,V.M., Kwon,H., Wirnsberger,G., Youhanna,S., Zhang,H., Slutsky,S., Hurtado Del Pozo,C., Horn,M., Montserrat,N., Penninger,J.M. and Mirazimi,A.
    Human soluble ACE2 improves the effect of remdesivir in SARS-CoV-2 infection
    EMBO Mol Mede13426-e13426. PubMed  Europe PubMed DOI
  576. Mou,H., Quinlan,B.D., Peng,H., Guo,Y., Peng,S., Zhang,L., Davis-Gardner,M.E., Gardner,M.R., Crynen,G., Voo,Z.X., Bailey,C.C., Alpert,M.D., Rader,C., Choe,H. and Farzan,M.
    Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2
    bioRxiv PubMed  Europe PubMed DOI
  577. Mouffouk,C., Mouffouk,S., Mouffouk,S., Hambaba,L. and Haba,H.
    Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CL(pro) and PL(pro)), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)
    Eur J Pharmacol891, 173759-173759. PubMed  Europe PubMed DOI
  578. Mu,C., Sheng,Y., Wang,Q., Amin,A., Li,X. and Xie,Y.
    Potential compound from herbal food of rhizoma polygonati for treatment of COVID-19 analyzed by network pharmacology and molecular docking technology
    J Funct Foods104149-104149. PubMed  Europe PubMed DOI
  579. Muchtaridi,M., Fauzi,M., Khairul Ikram,N.K., Mohd Gazzali,A. and Wahab,H.A.
    Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2
    Molecules25, PubMed  Europe PubMed DOI
  580. Mugnai,M.L., Templeton,C., Elber,R. and Thirumalai,D.
    Role of Long-range Allosteric Communication in Determining the Stability and Disassembly of SARS-COV-2 in Complex with ACE2
    bioRxiv PubMed  Europe PubMed DOI
  581. Muhanna,D., Arnipalli,S.R., Kumar,S.B. and Ziouzenkova,O.
    Osmotic Adaptation by Na(+)-Dependent Transporters and ACE2: Correlation with Hemostatic Crisis in COVID-19
    Biomedicines8, PubMed  Europe PubMed DOI  V
  582. Muller,W.E.G., Neufurth,M., Schepler,H., Wang,S., Tolba,E., Schroder,H.C. and Wang,X.
    The biomaterial polyphosphate blocks stoichiometric binding of the SARS-CoV-2 S-protein to the cellular ACE2 receptor
    Biomater Sci8, 6603-6610. PubMed  Europe PubMed DOI
  583. Nagy,B., Fejes,Z., Szentkereszty,Z., Suto,R., Varkonyi,I., Ajzner,E., Kappelmayer,J., Papp,Z., Toth,A. and Fagyas,M.
    A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient
    Int J Infect Dis PubMed  Europe PubMed DOI
  584. Nascimento Conde,J., Schutt,W.R., Gorbunova,E.E. and Mackow,E.R.
    Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses
    MBio11, PubMed  Europe PubMed DOI
  585. Navarra,A., Albani,E., Castellano,S., Arruzzolo,L. and Levi-Setti,P.E.
    Coronavirus Disease-19 Infection: Implications on Male Fertility and Reproduction
    Front Physiol11, 574761-574761. PubMed  Europe PubMed DOI  V
  586. Nawijn,M.C. and Timens,W.
    Can ACE2 expression explain SARS-CoV-2 infection of the respiratory epithelia in COVID-19?
    Mol Syst Biol16, e9841-e9841. PubMed  Europe PubMed DOI
  587. Nersisyan,S., Shkurnikov,M., Turchinovich,A., Knyazev,E. and Tonevitsky,A.
    Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2
    PLoS ONE15, e0235987-e0235987. PubMed  Europe PubMed DOI
  588. Neufurth,M., Wang,X., Tolba,E., Lieberwirth,I., Wang,S., Schroder,H.C. and Muller,W.E.G.
    The inorganic polymer, polyphosphate, blocks binding of SARS-CoV-2 spike protein to ACE2 receptor at physiological concentrations
    Biochem Pharmacol182, 114215-114215. PubMed  Europe PubMed DOI
  589. Nguyen,H.L., Lan,P.D., Thai,N.Q., Nissley,D.A., O'Brien,E.P. and Li,M.S.
    Does SARS-CoV-2 Bind to Human ACE2 More Strongly Than Does SARS-CoV?
    J Phys Chem B124, 7336-7347. PubMed  Europe PubMed DOI
  590. Nguyen,H.T., Zhang,S., Wang,Q., Anang,S., Wang,J., Ding,H., Kappes,J.C. and Sodroski,J.
    Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects
    J Virol PubMed  Europe PubMed DOI
  591. Ni,J., Yang,F., Huang,X.R., Meng,J., Chen,J., Bader,M., Penninger,J.M., Fung,E., Yu,X.Q. and Lan,H.Y.
    Dual deficiency of angiotensin-converting enzyme-2 and Mas receptor enhances angiotensin II-induced hypertension and hypertensive nephropathy
    J Cell Mol Med PubMed  Europe PubMed DOI
  592. Ni,W., Yang,X., Yang,D., Bao,J., Li,R., Xiao,Y., Hou,C., Wang,H., Liu,J., Yang,D., Xu,Y., Cao,Z. and Gao,Z.
    Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
    Crit Care24, 422-422. PubMed  Europe PubMed DOI
  593. Ni,X., Sun,C., Tian,Y., Huang,Y., Gong,T., Song,L., Yang,X., Li,K., Zheng,N., Wang,J., Wu,H., Zhang,R., Wang,Y., Wang,G. and Qin,J.
    Could urinary ACE2 protein level help identify individuals susceptible to SARS-CoV-2 infection and complication?
    Sci China Life Sci PubMed  Europe PubMed DOI
  594. Nicolau,L.A.D., Noleto,I.R.S.G. and Medeiros,J.V.R.
    Could a specific ACE2 activator drug improve the clinical outcome of SARS-CoV-2? A potential pharmacological insight
    Expert Rev Clin Pharmacol1-5. PubMed  Europe PubMed DOI
  595. Noy-Porat,T., Makdasi,E., Alcalay,R., Mechaly,A., Levy,Y., Bercovich-Kinori,A., Zauberman,A., Tamir,H., Yahalom-Ronen,Y., Israeli,M., Epstein,E., Achdout,H., Melamed,S., Chitlaru,T., Weiss,S., Peretz,E., Rosen,O., Paran,N., Yitzhaki,S., Shapira,S.C., Israely,T., Mazor,O. and Rosenfeld,R.
    A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes
    Nat Commun11, 4303-4303. PubMed  Europe PubMed DOI
  596. Nunes,J.P.L.
    Mortality and use of angiotensin-converting enzyme inhibitors in COVID 19 disease: a systematic review
    Porto Biomed J5, e085-e085. PubMed  Europe PubMed DOI  V
  597. O'Sullivan,M.J., Mitchel,J.A., Mwase,C., McGill,M., Kanki,P. and Park,J.A.
    In well-differentiated primary human bronchial epithelial cells, TGF-beta1 and TGF-beta2 induce expression of furin
    Am J Physiol Lung Cell Mol Physiol PubMed  Europe PubMed DOI
  598. Oaklander,A.L.
    Discovery of ACE2 receptors for SARS-CoV-2 (COVID-19) on peripheral small-fiber sensory neurons of uncertain clinical significance
    Pain PubMed  Europe PubMed DOI
  599. Obukhov,A.G., Stevens,B.R., Prasad,R., Li Calzi,S., Boulton,M.E., Raizada,M.K., Oudit,G.Y. and Grant,M.B.
    SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes
    Diabetes PubMed  Europe PubMed DOI
  600. Ogawa,J., Zhu,W., Tonnu,N., Singer,O., Hunter,T., Ryan,A.L. and Pao,G.M.
    The D614G mutation in the SARS-CoV2 Spike protein increases infectivity in an ACE2 receptor dependent manner
    bioRxiv PubMed  Europe PubMed DOI
  601. Ogunlade,B., Guidry,J.J., Mukerjee,S., Sriramula,S., Lazartigues,E. and Filipeanu,C.M.
    The Actin Bundling Protein Fascin-1 as an ACE2-Accessory Protein
    Cell Mol Neurobiol PubMed  Europe PubMed DOI
  602. Oladunni,F.S., Park,J.G., Pino,P.A., Gonzalez,O., Akhter,A., Allue-Guardia,A., Olmo-Fontanez,A., Gautam,S., Garcia-Vilanova,A., Ye,C., Chiem,K., Headley,C., Dwivedi,V., Parodi,L.M., Alfson,K.J., Staples,H.M., Schami,A., Garcia,J.I., Whigham,A., Platt,R.N., Gazi,M., Martinez,J., Chuba,C., Earley,S., Rodriguez,O.H., Mdaki,S.D., Kavelish,K.N., Escalona,R., Hallam,C.R.A., Christie,C., Patterson,J.L., Anderson,T.J.C., Carrion,R., Jr., Dick,E.J., Jr., Hall-Ursone,S., Schlesinger,L.S., Alvarez,X., Kaushal,D., Giavedoni,L.D., Turner,J., Martinez-Sobrido,L. and Torrelles,J.B.
    Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice
    Nat Commun11, 6122-6122. PubMed  Europe PubMed DOI
  603. Onabajo,O.O., Banday,A.R., Yan,W., Obajemu,A., Stanifer,M.L., Santer,D.M., Florez-Vargas,O., Piontkivska,H., Vargas,J., Kee,C., Tyrrell,D.L.J., Mendoza,J.L., Boulant,S. and Prokunina-Olsson,L.
    Interferons and viruses induce a novel primate-specific isoform dACE2 and not the SARS-CoV-2 receptor ACE2
    bioRxiv PubMed  Europe PubMed DOI
  604. Onweni,C.L., Zhang,Y.S., Caulfield,T., Hopkins,C.E., Fairweather,L. and Freeman,W.D.
    ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking
    Crit Care24, 475-475. PubMed  Europe PubMed DOI
  605. Ortiz-Fernandez,L. and Sawalha,A.H.
    Genetic variability in the expression of the SARS-CoV-2 host cell entry factors across populations
    Genes Immun PubMed  Europe PubMed DOI
  606. Oz,M., Lorke,D.E. and Kabbani,N.
    A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor
    Pharmacol Ther107750-107750. PubMed  Europe PubMed DOI  V
  607. Pabalan,N., Tharabenjasin,P., Suntornsaratoon,P., Jarjanazi,H. and Muanprasat,C.
    Ethnic and age-specific acute lung injury/acute respiratory distress syndrome risk associated with angiotensin-converting enzyme insertion/deletion polymorphisms, implications for COVID-19: A meta-analysis
    Infect Genet Evol104682-104682. PubMed  Europe PubMed DOI
  608. Pagliaro,P. and Penna,C.
    ACE/ACE2 Ratio: A Key Also in 2019 Coronavirus Disease (Covid-19)?
    Front Med (Lausanne)7, 335-335. PubMed  Europe PubMed DOI
  609. Pan,B., Fang,S., Zhang,J., Pan,Y., Liu,H., Wang,Y., Li,M. and Liu,L.
    Chinese herbal compounds against SARS-CoV-2: Puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor
    Comput Struct Biotechnol J18, 3518-3527. PubMed  Europe PubMed DOI  I
  610. Pang,X.C., Zhang,H.X., Zhang,Z., Rinkiko,S., Cui,Y.M. and Zhu,Y.Z.
    The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities
    Molecules26, PubMed  Europe PubMed DOI  V
  611. Papageorgiou,A.C. and Mohsin,I.
    The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies
    Cells9, PubMed  Europe PubMed DOI  V
  612. Parekh,R.U. and Sriramula,S.
    Activation of Kinin B1R Upregulates ADAM17 and Results in ACE2 Shedding in Neurons
    Int J Mol Sci22, PubMed  Europe PubMed DOI
  613. Pathak,G.A., Wendt,F.R., Goswami,A., De Angelis,F. and Polimanti,R.
    ACE2 Netlas: In-silico functional characterization and drug-gene interactions of ACE2 gene network to understand its potential involvement in COVID-19 susceptibility
    medRxiv PubMed  Europe PubMed DOI
  614. Payandeh,Z., Rahbar,M.R., Jahangiri,A., Hashemi,Z.S., Zakeri,A., Jafarisani,M., Rasaee,M.J. and Khalili,S.
    Design of an engineered ACE2 as a novel therapeutics against COVID-19
    J Theor Biol505, 110425-110425. PubMed  Europe PubMed DOI
  615. Penninger,J.M., Grant,M.B. and Sung,J.J.Y.
    The Role of Angiotensin Converting Enzyme 2 in Modulating Gut Microbiota, Intestinal Inflammation, and Coronavirus Infection
    Gastroenterology PubMed  Europe PubMed DOI
  616. Pereira,V.M., Reis,F.M., Casalechi,M. and Reis,A.M.
    Angiotensin-(1-7), angiotensin-converting enzyme 2 and Mas receptor in rat polycystic ovaries
    Protein Pept Lett PubMed  Europe PubMed DOI
  617. Perez-Vizcaino,F.
    Lung ACE2 and ADAM17 in pulmonary arterial hypertension: Implications for COVID-19?
    J Heart Lung Transplant PubMed  Europe PubMed DOI
  618. Pierce,J.B., Simion,V., Icli,B., Perez-Cremades,D., Cheng,H.S. and Feinberg,M.W.
    Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs
    Genes (Basel)11, PubMed  Europe PubMed DOI
  619. Pique-Regi,R., Romero,R., Tarca,A.L., Luca,F., Xu,Y., Alazizi,A., Leng,Y., Hsu,C.D. and Gomez-Lopez,N.
    Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?
    elife9, PubMed  Europe PubMed DOI
  620. Ponga,M.
    Quantifying the adhesive strength between the SARS-CoV-2 S-proteins and human receptor and its effect in therapeutics
    Sci Rep10, 17538-17538. PubMed  Europe PubMed DOI
  621. Poochi,S.P., Easwaran,M., Balasubramanian,B., Anbuselvam,M., Meyyazhagan,A., Park,S., Bhotla,H.K., Anbuselvam,J., Arumugam,V.A., Keshavarao,S., Kanniyappan,G.V., Pappusamy,M. and Kaul,T.
    Employing bioactive compounds derived from Ipomoea obscura (L.) to evaluate potential inhibitor for SARS-CoV-2 main protease and ACE2 protein
    Food Front PubMed  Europe PubMed DOI
  622. Prajapat,M., Shekhar,N., Sarma,P., Avti,P., Singh,S., Kaur,H., Bhattacharyya,A., Kumar,S., Sharma,S., Prakash,A. and Medhi,B.
    Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2
    J Mol Graph Model101, 107716-107716. PubMed  Europe PubMed DOI  I
  623. Prashantha,C.N., Gouthami,K., Lavanya,L., Bhavanam,S., Jakhar,A., Shakthiraju,R.G., Suraj,V., Sahana,K.V., Sujana,H.S., Guruprasad,N.M. and Ramachandra,R.
    Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus
    J Mol Graph Model102, 107769-107769. PubMed  Europe PubMed DOI  I
  624. Preziuso,S.
    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Exhibits High Predicted Binding Affinity to ACE2 from Lagomorphs (Rabbits and Pikas)
    Animals (Basel)10, PubMed  Europe PubMed DOI
  625. Qian,K. and Hu,S.
    Ig-like ACE2 protein therapeutics: A revival in development during the COVID-19 pandemic
    MAbs12, e1782600-e1782600. PubMed  Europe PubMed DOI
  626. Qiao,J., Li,W., Bao,J., Peng,Q., Wen,D., Wang,J. and Sun,B.
    The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues
    Biochem Biophys Res Commun PubMed  Europe PubMed DOI
  627. Qiao,Y., Wang,X.M., Mannan,R., Pitchiaya,S., Zhang,Y., Wotring,J.W., Xiao,L., Robinson,D.R., Wu,Y.M., Tien,J.C., Cao,X., Simko,S.A., Apel,I.J., Bawa,P., Kregel,S., Narayanan,S.P., Raskind,G., Ellison,S.J., Parolia,A., Zelenka-Wang,S., McMurry,L., Su,F., Wang,R., Cheng,Y., Delekta,A.D., Mei,Z., Pretto,C.D., Wang,S., Mehra,R., Sexton,J.Z. and Chinnaiyan,A.M.
    Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2
    Proc Natl Acad Sci U S A PubMed  Europe PubMed DOI
  628. Ragia,G. and Manolopoulos,V.G.
    Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2 mediated SARS-CoV-2 entry
    Pharmacogenomics PubMed  Europe PubMed DOI
  629. Ragia,G. and Manolopoulos,V.G.
    Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
    Eur J Clin Pharmacol PubMed  Europe PubMed DOI  V  I
  630. Rangel,H.R., Ortega,J.T., Maksoud,S., Pujol,F.H. and Serrano,M.L.
    SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors
    Virus Res289, 198154-198154. PubMed  Europe PubMed DOI
  631. Ratajczak,M.Z., Bujko,K., Ciechanowicz,A., Sielatycka,K., Cymer,M., Marlicz,W. and Kucia,M.
    SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45(-) Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome
    Stem Cell Rev Rep PubMed  Europe PubMed DOI
  632. Rathod,S.B., Prajapati,P.B., Punjabi,L.B., Prajapati,K.N., Chauhan,N. and Mansuri,M.F.
    Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2
    In Silico Pharmacol8, 3-3. PubMed  Europe PubMed DOI
  633. Ravaioli,S., Tebaldi,M., Fonzi,E., Angeli,D., Mazza,M., Nicolini,F., Lucchesi,A., Fanini,F., Pirini,F., Tumedei,M.M., Cerchione,C., Viale,P., Sambri,V., Martinelli,G. and Bravaccini,S.
    ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
    Cell Transplant29, 963689720968749-963689720968749. PubMed  Europe PubMed DOI
  634. Rawat,P., Jemimah,S., Ponnuswamy,P.K. and Gromiha,M.M.
    Why are ACE2 binding coronavirus strains SARS-CoV/SARS-CoV-2 wild and NL63 mild?
    Proteins PubMed  Europe PubMed DOI
  635. Razeghian-Jahromi,I., Zibaeenezhad,M.J., Lu,Z., Zahra,E., Mahboobeh,R. and Lionetti,V.
    Angiotensin-converting enzyme 2: a double-edged sword in COVID-19 patients with an increased risk of heart failure
    Heart Fail Rev PubMed  Europe PubMed DOI
  636. Reis,F.M. and Reis,A.M.
    Angiotensin-converting enzyme 2 (ACE2), angiotensin-(1-7) and Mas receptor in gonadal and reproductive functions
    Clin Sci (Lond)134, 2929-2941. PubMed  Europe PubMed DOI
  637. Ren,P., Gong,C. and Ma,S.
    Evaluation of COVID-19 based on ACE2 expression in normal and cancer patients
    Open Med (Wars)15, 613-622. PubMed  Europe PubMed DOI
  638. Ren,X., Wang,S., Chen,X., Wei,X., Li,G., Ren,S., Zhang,T., Zhang,X., Lu,Z., You,Z., Wang,Z., Song,N. and Qin,C.
    Multiple Expression Assessments of ACE2 and TMPRSS2 SARS-CoV-2 Entry Molecules in the Urinary Tract and Their Associations with Clinical Manifestations of COVID-19
    Infect Drug Resist13, 3977-3990. PubMed  Europe PubMed DOI
  639. Rezaei,M., Ziai,S.A., Fakhri,S. and Pouriran,R.
    ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID-19
    J Cell Physiol PubMed  Europe PubMed DOI
  640. Rhodes,J.M., Subramanian,S., Laird,E., Griffin,G. and Kenny,R.A.
    Perspective: Vitamin D deficiency and COVID-19 severity - plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis
    J Intern Med PubMed  Europe PubMed DOI
  641. Rizzo,A., Mollica,V. and Massari,F.
    Re: Hanbing Song, Bobak Seddighzadeh, Matthew R. Cooperberg, Franklin W. Huang. Expression of ACE2 and TMPRSS2, the SARS-CoV-2 Receptor and Co-Receptor, in Prostate Epithelial Cells. Eur Urol. In press DOI: 10.1016/j.eururo.2020.04.065
    Eur Urol PubMed  Europe PubMed DOI
  642. Roberts,J., Pritchard,A.L., Treweeke,A.T., Rossi,A.G., Brace,N., Cahill,P., MacRury,S.M., Wei,J. and Megson,I.L.
    Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System
    Front Cardiovasc Med7, 629933-629933. PubMed  Europe PubMed DOI  V
  643. Robinson,F.A., Mihealsick,R.P., Wagener,B.M., Hanna,P., Poston,M.D., Efimov,I.F., Shivkumar,K. and Hoover,D.B.
    Role of angiotensin converting enzyme 2 and pericytes in cardiac complications of COVID-19 infection
    Am J Physiol Heart Circ Physiol PubMed  Europe PubMed DOI  V
  644. Roehrich,H., Yuan,C. and Hou,J.H.
    Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface
    Cornea PubMed  Europe PubMed DOI
  645. Roganovic,J. and Radenkovic,M.
    Letter to the Editor: Diabetes, obesity and hypertension may promote oral SARS-CoV-2 infection- salivary soluble ACE2 perspective
    Oral Dis PubMed  Europe PubMed DOI
  646. Roncati,L., Gallo,G., Manenti,A. and Palmieri,B.
    Renin-angiotensin system: the unexpected flaw inside the human immune system revealed by SARS-CoV-2
    Med Hypotheses140, 109686-109686. PubMed  Europe PubMed DOI
  647. Roncati,L. and Lusenti,B.
    The <<moonlighting protein>> able to explain the Th1 immune lockdown in severe COVID-19
    Med Hypotheses143, 110087-110087. PubMed  Europe PubMed DOI
  648. Rosario,P.A. and McNaughton,B.R.
    Computational Hot-Spot Analysis of the SARS-CoV-2 Receptor Binding Domain / ACE2 Complex
    bioRxiv PubMed  Europe PubMed DOI
  649. Rui,L., Haonan,L. and Wanyi,C.
    Silico analysis of interaction between full-length SARS-CoV2 S protein with human Ace2 receptor: Modelling, docking, MD simulation
    Biophys Chem267, 106472-106472. PubMed  Europe PubMed DOI
  650. Ryan,P.M. and Caplice,N.
    COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response
    Open Heart7, PubMed  Europe PubMed DOI
  651. Saadah,L.M., Deiab,G.I.A., Al-Balas,Q. and Basheti,I.A.
    Carnosine to Combat Novel Coronavirus (nCoV): Molecular Docking and Modeling to Cocrystallized Host Angiotensin-Converting Enzyme 2 (ACE2) and Viral Spike Protein
    Molecules25, PubMed  Europe PubMed DOI  I
  652. Saba,L., Gerosa,C., Fanni,D., Marongiu,F., La Nasa,G., Caocci,G., Barcellona,D., Balestrieri,A., Coghe,F., Orru,G., Coni,P., Piras,M., Ledda,F., Suri,J.S., Ronchi,A., D'Andrea,F., Cau,R., Castagnola,M. and Faa,G.
    Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review
    Eur Rev Med Pharmacol Sci24, 12609-12622. PubMed  Europe PubMed DOI
  653. Saffern,M.
    ACE2 is not induced by interferon
    Nat Rev Immunol PubMed  Europe PubMed DOI
  654. Saggese,C.E., Del Bianco,C., Di Ruzza,M.R., Magarelli,M., Gandini,R. and Plocco,M.
    COVID-19 and Stroke: Casual or Causal Role?
    Cerebrovasc Dis49, 341-344. PubMed  Europe PubMed DOI
  655. Saha,S., Chakrabarti,S., Singh,P.K., Poddar,J., Satapathi,S., Saini,S., Kakar,S.S. and Roy,P.
    Physiological Relevance of Angiotensin Converting Enzyme 2 As a Metabolic Linker and Therapeutic Implication of Mesenchymal Stem Cells in COVID-19 and Hypertension
    Stem Cell Rev Rep PubMed  Europe PubMed DOI  V
  656. Saheb Sharif-Askari,N., Saheb Sharif-Askari,F., Alabed,M., Temsah,M.H., Al Heialy,S., Hamid,Q. and Halwani,R.
    Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD
    Mol Ther Methods Clin Dev18, 1-6. PubMed  Europe PubMed DOI
  657. Sainz-Cort,A. and Heeroma,J.H.
    The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection
    J Cannabis Res2, 23-23. PubMed  Europe PubMed DOI
  658. Sakaguchi,W., Kubota,N., Shimizu,T., Saruta,J., Fuchida,S., Kawata,A., Yamamoto,Y., Sugimoto,M., Yakeishi,M. and Tsukinoki,K.
    Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity
    Int J Mol Sci21, PubMed  Europe PubMed DOI
  659. Sakamoto,A., Kawakami,R., Kawai,K., Gianatti,A., Pellegrini,D., Kutys,R., Guo,L., Mori,M., Cornelissen,A., Sato,Y., Bellasi,A., Faggi,L., Hong,C., Romero,M., Guagliumi,G., Virmani,R. and Finn,A.V.
    ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Serine Protease 2) Expression and Localization of SARS-CoV-2 Infection in the Human Heart
    Arterioscler Thromb Vasc BiolATVBAHA120315229-ATVBAHA120315229. PubMed  Europe PubMed DOI
  660. Salah,H.M., Arthur,J.M. and Mehta,J.L.
    Implications of renal ACE2 expression in the age of COVID-19
    Eur Heart J PubMed  Europe PubMed DOI
  661. Salah,H.M., Calcaterra,G. and Mehta,J.L.
    Renin-Angiotensin System Blockade and Mortality in Patients With Hypertension and COVID-19 Infection
    J Cardiovasc Pharmacol Ther1074248420947628-1074248420947628. PubMed  Europe PubMed DOI
  662. Sama,I.E., Voors,A.A. and van Veldhuisen,D.J.
    New data on soluble ACE2 in patients with atrial fibrillation reveal potential value for treatment of patients with COVID-19 and cardiovascular disease
    Eur Heart J PubMed  Europe PubMed DOI
  663. Samad,A., Jafar,T. and Rafi,J.H.
    Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analysis
    Genomics PubMed  Europe PubMed DOI
  664. Sanchez-Aguilar,M., Ibarra-Lara,L., Del Valle-Mondragon,L., Soria-Castro,E., Torres-Narvaez,J.C., Carreon-Torres,E., Sanchez-Mendoza,A. and Rubio-Ruiz,M.E.
    Nonclassical Axis of the Renin-Angiotensin System and Neprilysin: Key Mediators That Underlie the Cardioprotective Effect of PPAR-Alpha Activation during Myocardial Ischemia in a Metabolic Syndrome Model
    PPAR Res2020, 8894525-8894525. PubMed  Europe PubMed DOI
  665. Sang,E.R., Tian,Y., Gong,Y., Miller,L.C. and Sang,Y.
    Integrate structural analysis, isoform diversity, and interferon-inductive propensity of ACE2 to predict SARS-CoV2 susceptibility in vertebrates
    Heliyon6, e04818-e04818. PubMed  Europe PubMed DOI
  666. Saponaro,F., Rutigliano,G., Sestito,S., Bandini,L., Storti,B., Bizzarri,R. and Zucchi,R.
    ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
    Front Mol Biosci7, 588618-588618. PubMed  Europe PubMed DOI  V
  667. Sarzani,R., Giulietti,F., Di Pentima,C., Giordano,P. and Spannella,F.
    Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury
    Am J Physiol Lung Cell Mol Physiol319, L325-L325. PubMed  Europe PubMed DOI  V
  668. Scialo,F., Daniele,A., Amato,F., Pastore,L., Matera,M.G., Cazzola,M., Castaldo,G. and Bianco,A.
    ACE2: The Major Cell Entry Receptor for SARS-CoV-2
    Lung198, 867-877. PubMed  Europe PubMed DOI
  669. Sedokani,A. and Feizollahzadeh,S.
    Plasmapheresis, Anti-ACE2 and Anti-FcgammaRII Monoclonal Antibodies: A Possible Treatment for Severe Cases of COVID-19
    Drug Des Devel Ther14, 2607-2611. PubMed  Europe PubMed DOI
  670. Senapati,S., Kumar,S., Singh,A.K., Banerjee,P. and Bhagavatula,S.
    Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human
    J Genet99, PubMed  Europe PubMed
  671. Senkal,N., Meral,R., Medetalibeyoglu,A., Konyaoglu,H., Kose,M. and Tukek,T.
    Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19
    Anatol J Cardiol24, 21-29. PubMed  Europe PubMed DOI
  672. Seo,S.H. and Jang,Y.
    Cold-Adapted Live Attenuated SARS-Cov-2 Vaccine Completely Protects Human ACE2 Transgenic Mice from SARS-Cov-2 Infection
    Vaccines (Basel)8, PubMed  Europe PubMed DOI
  673. Seth,S., Batra,J. and Srinivasan,S.
    COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response
    Front Mol Biosci7, 215-215. PubMed  Europe PubMed DOI  V
  674. Shahid,M. and Shahzad-Ul-Hussan,S.
    Structural insights of key enzymes into therapeutic intervention against SARS-CoV-2
    J Struct Biol213, 107690-107690. PubMed  Europe PubMed DOI  V
  675. Sharifkashani,S., Bafrani,M.A., Khaboushan,A.S., Pirzadeh,M., Kheirandish,A., Yavarpour Bali,H., Hessami,A., Saghazadeh,A. and Rezaei,N.
    Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting
    Eur J Pharmacol884, 173455-173455. PubMed  Europe PubMed DOI  V
  676. Sharma,P. and Shanavas,A.
    Natural derivatives with dual binding potential against SARS-CoV-2 main protease and human ACE2 possess low oral bioavailability: a brief computational analysis
    J Biomol Struct Dyn1-12. PubMed  Europe PubMed DOI
  677. Sharma,R.K., Oliveira,A.C., Yang,T., Karas,M.M., Li,J., Lobaton,G.O., Aquino,V.P., Robles-Vera,I., de Kloet,A.D., Krause,E.G., Bryant,A.J., Verma,A., Li,Q., Richards,E.M. and Raizada,M.K.
    Correction to: Gut Pathology and Its Rescue by ACE2 (Angiotensin Converting Enzyme 2) in Hypoxia-Induced Pulmonary Hypertension
    Hypertension76, e40-e40. PubMed  Europe PubMed DOI
  678. Sheikhi,A. and Hojjat-Farsangi,M.
    An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein
    Hum Vaccin Immunother1-6. PubMed  Europe PubMed DOI
  679. Shen,H., Zhang,J., Wang,C., Jain,P.P., Xiong,M., Shi,X., Lei,Y., Chen,S., Yin,Q., Thistlethwaite,P.A., Wang,J., Gong,K., Yuan,Z.Y., Yuan,J.X. and Shyy,J.Y.
    MDM2-Mediated Ubiquitination of ACE2 Contributes to the Development of Pulmonary Arterial Hypertension
    Circulation142, 1190-1204. PubMed  Europe PubMed DOI
  680. Shen,M., Liu,C., Xu,R., Ruan,Z., Zhao,S., Zhang,H., Wang,W., Huang,X., Yang,L., Tang,Y., Yang,T. and Jia,X.
    Predicting the Animal Susceptibility and Therapeutic Drugs to SARS-CoV-2 Based on Spike Glycoprotein Combined With ACE2
    Front Genet11, 575012-575012. PubMed  Europe PubMed DOI  I
  681. Shen,M., Zhang,B., Wang,M., Meng,L. and Lv,B.
    Mica Can Alleviate TNBS-Induced Colitis in Mice by Reducing Angiotensin II and IL-17A and Increasing Angiotensin-Converting Enzyme 2, Angiotensin 1-7, and IL-10
    Mediators Inflamm2020, 3070345-3070345. PubMed  Europe PubMed DOI
  682. Shen,Q., Xiao,X., Aierken,A., Yue,W., Wu,X., Liao,M. and Hua,J.
    The ACE2 expression in Sertoli cells and germ cells may cause male reproductive disorder after SARS-CoV-2 infection
    J Cell Mol Med24, 9472-9477. PubMed  Europe PubMed DOI
  683. Shi,C., Lu,K., Xia,H., Zhang,P. and Zhang,B.
    Alteration and association between serum ACE2/ angiotensin(1-7)/Mas axis and oxidative stress in chronic kidney disease: A pilot study
    Medicine (Baltimore)99, e21492-e21492. PubMed  Europe PubMed DOI
  684. Shiers,S., Ray,P.R., Wangzhou,A., Sankaranarayanan,I., Tatsui,C.E., Rhines,L.D., Li,Y., Uhelski,M.L., Dougherty,P.M. and Price,T.J.
    ACE2 and SCARF expression in human DRG nociceptors: implications for SARS-CoV-2 virus neurological effects
    Pain161, 2494-2501. PubMed  Europe PubMed DOI
  685. Shikov,A.E., Barbitoff,Y.A., Glotov,A.S., Danilova,M.M., Tonyan,Z.N., Nasykhova,Y.A., Mikhailova,A.A., Bespalova,O.N., Kalinin,R.S., Mirzorustamova,A.M., Kogan,I.Y., Baranov,V.S., Chernov,A.N., Pavlovich,D.M., Azarenko,S.V., Fedyakov,M.A., Tsay,V.V., Eismont,Y.A., Romanova,O.V., Hobotnikov,D.N., Vologzhanin,D.A., Mosenko,S.V., Ponomareva,T.A., Talts,Y.A., Anisenkova,A.U., Lisovets,D.G., Sarana,A.M., Urazov,S.P., Scherbak,S.G. and Glotov,O.S.
    Analysis of the Spectrum of ACE2 Variation Suggests a Possible Influence of Rare and Common Variants on Susceptibility to COVID-19 and Severity of Outcome
    Front Genet11, 551220-551220. PubMed  Europe PubMed DOI
  686. Shrimp,J.H., Kales,S.C., Sanderson,P.E., Simeonov,A., Shen,M. and Hall,M.D.
    An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19
    ACS Pharmacol Transl Sci3, 997-1007. PubMed  Europe PubMed DOI  I
  687. Siljee,S., Pilkington,T., Brasch,H.D., Bockett,N., Patel,J., Paterson,E., Davis,P.F. and Tan,S.T.
    Cancer Stem Cells in Head and Neck Metastatic Malignant Melanoma Express Components of the Renin-Angiotensin System
    Life (Basel)10, PubMed  Europe PubMed DOI
  688. Silva-Aguiar,R.P., Peruchetti,D.B., Rocco,P.R.M., Schmaier,A.H., Silva,P.M.R., Martins,M.A., Carvalho,V.F., Pinheiro,A.A.S. and Caruso-Neves,C.
    Role of the renin angiotensin system in the development of severe COVID-19 in hypertensive patients
    Am J Physiol Lung Cell Mol Physiol319, L596-L602. PubMed  Europe PubMed DOI
  689. Silva de Almeida,T.C., Lanza,K., da Silva Filha,R., Campos,C., Fonseca,E.G., Chagas,M.W., Rocha,N.P., de Sa,M.A., Vieira,M.A.R., Caliari,M.V., Kangussu,L.M., Ferreira,A.J. and Simoes e Silva
    ACE2 activator diminazene aceturate exerts renoprotective effects in gentamicin-induced acute renal injury in rats
    Clin Sci (Lond)134, 3093-3106. PubMed  Europe PubMed DOI  I
  690. Singh,H., Choudhari,R., Nema,V. and Khan,A.A.
    ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease
    Microb Pathog150, 104621-104621. PubMed  Europe PubMed DOI
  691. Sinha,S., Sehgal,A. and Sehgal,R.
    Association of ACE2 receptor and ACEIs/ARBs with disease severity in COVID-19
    Drug Discov Ther14, 161-170. PubMed  Europe PubMed DOI  V
  692. Sinha,S., Cheng,K., Schaffer,A.A., Aldape,K., Schiff,E. and Ruppin,E.
    In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression
    Mol Syst Biol16, e9628-e9628. PubMed  Europe PubMed DOI
  693. Siri-Angkul,N., Chattipakorn,S.C. and Chattipakorn,N.
    Angiotensin converting enzyme 2 at the interface between renin-angiotensin system inhibition and coronavirus disease 2019
    J Physiol598, 4181-4195. PubMed  Europe PubMed DOI
  694. Sokolowska,M.
    Outsmarting SARS-CoV-2 by empowering a decoy ACE2
    Signal Transduct Target Ther5, 260-260. PubMed  Europe PubMed DOI
  695. Soldo,J., Heni,M., Konigsrainer,A., Haring,H.U., Birkenfeld,A.L. and Peter,A.
    Increased Hepatic ACE2 Expression in NAFL and Diabetes-A Risk for COVID-19 Patients?
    Diabetes Care43, e134-e136. PubMed  Europe PubMed DOI
  696. Sollena,P., Cappilli,S., Piccerillo,A., Chiricozzi,A. and Peris,K.
    COVID-19 hygiene measures: hand eczema and insights into ACE2 and integrins as key molecules for SARS-CoV-2 cutaneous transmission
    Int J Dermatol59, 1409-1410. PubMed  Europe PubMed DOI
  697. Somekh,I., Yakub Hanna,H., Heller,E., Bibi,H. and Somekh,E.
    AGE-DEPENDENT SENSORY IMPAIRMENT IN COVID-19 INFECTION AND ITS CORRELATION WITH ACE2 EXPRESSION
    Pediatr Infect Dis J39, e270-e272. PubMed  Europe PubMed DOI
  698. Son,M., Seo,J. and Yang,S.
    Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea
    Hypertension76, 742-749. PubMed  Europe PubMed DOI
  699. Song,J., Zhu,J., Chen,W., Zhu,G., Wang,W., Chen,C., Jia,Z., Zha,Y., Xu,P., Wang,Z., Sun,F. and Zhang,X.
    Expression profiles revealed potential kidney injury caused by SARS-CoV-2: a systematic analysis of ACE2 and clinical lessons learned from this discovery
    Aging (Albany NY)12, PubMed  Europe PubMed DOI
  700. Song,J., Han,J., Liu,F., Chen,X., Qian,S., Wang,Y., Jia,Z., Duan,X., Zhang,X. and Zhu,J.
    Systematic Analysis of Coronavirus Disease 2019 (COVID-19) Receptor ACE2 in Malignant Tumors: Pan-Cancer Analysis
    Front Mol Biosci7, 569414-569414. PubMed  Europe PubMed DOI
  701. Song,J.J., Yang,M., Liu,Y., Song,J.W., Wang,J., Chi,H.J., Liu,X.Y., Zuo,K., Yang,X.C. and Zhong,J.C.
    MicroRNA-122 aggravates angiotensin II-mediated apoptosis and autophagy imbalance in rat aortic adventitial fibroblasts via the modulation of SIRT6-elabela-ACE2 signaling
    Eur J Pharmacol883, 173374-173374. PubMed  Europe PubMed DOI
  702. South,A.M., Diz,D.I. and Chappell,M.C.
    COVID-19, ACE2 and the cardiovascular consequences
    Am J Physiol Heart Circ Physiol318, H1084-H1084. PubMed  Europe PubMed DOI
  703. Souza,P.F.N., Lopes,F.E.S., Amaral,J.L., Freitas,C.D.T. and Oliveira,J.T.A.
    A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor
    Int J Biol Macromol164, 66-76. PubMed  Europe PubMed DOI
  704. Srivastava,A., Bandopadhyay,A., Das,D., Pandey,R.K., Singh,V., Khanam,N., Srivastava,N., Singh,P.P., Dubey,P.K., Pathak,A., Gupta,P., Rai,N., Sultana,G.N.N. and Chaubey,G.
    Genetic Association of ACE2 rs2285666 Polymorphism With COVID-19 Spatial Distribution in India
    Front Genet11, 564741-564741. PubMed  Europe PubMed DOI
  705. Stanton,B.A., Hampton,T.H. and Ashare,A.
    SARS-CoV-2 (COVID-19) and Cystic Fibrosis
    Am J Physiol Lung Cell Mol Physiol319, L408-L415. PubMed  Europe PubMed DOI
  706. Starr,T.N., Greaney,A.J., Hilton,S.K., Ellis,D., Crawford,K.H.D., Dingens,A.S., Navarro,M.J., Bowen,J.E., Tortorici,M.A., Walls,A.C., King,N.P., Veesler,D. and Bloom,J.D.
    Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
    Cell182, 1295-1310. PubMed  Europe PubMed DOI
  707. Stein,R.A. and Young,L.M.
    From ACE2 to COVID-19: A multiorgan endothelial disease
    Int J Infect Dis100, 425-430. PubMed  Europe PubMed DOI
  708. Stout,A.E., Andre,N.M., Jaimes,J.A., Millet,J.K. and Whittaker,G.R.
    Coronaviruses in cats and other companion animals: Where does SARS-CoV-2/COVID-19 fit?
    Vet Microbiol247, 108777-108777. PubMed  Europe PubMed DOI  V
  709. Strafella,C., Caputo,V., Termine,A., Barati,S., Gambardella,S., Borgiani,P., Caltagirone,C., Novelli,G., Giardina,E. and Cascella,R.
    Analysis of ACE2 Genetic Variability among Populations Highlights a Possible Link with COVID-19-Related Neurological Complications
    Genes (Basel)11, PubMed  Europe PubMed DOI
  710. Straughn,A.R. and Kakar,S.S.
    Withaferin A: a potential therapeutic agent against COVID-19 infection
    J Ovarian Res13, 79-79. PubMed  Europe PubMed DOI
  711. Sungnak,W., Huang,N., Becavin,C. and Berg,M.
    SARS-CoV-2 Entry Genes Are Most Highly Expressed in Nasal Goblet and Ciliated Cells within Human Airways
    ArXiv PubMed  Europe PubMed
  712. Tabary,M., Khanmohammadi,S., Araghi,F., Dadkhahfar,S. and Tavangar,S.M.
    Pathologic features of COVID-19: A concise review
    Pathol Res Pract216, 153097-153097. PubMed  Europe PubMed DOI
  713. Tada,T., Fan,C., Chen,J.S., Kaur,R., Stapleford,K.A., Gristick,H., Dcosta,B.M., Wilen,C.B., Nimigean,C.M. and Landau,N.R.
    An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2
    Cell Rep33, 108528-108528. PubMed  Europe PubMed DOI
  714. Taglauer,E., Benarroch,Y., Rop,K., Barnett,E., Sabharwal,V., Yarrington,C. and Wachman,E.M.
    Consistent localization of SARS-CoV-2 spike glycoprotein and ACE2 over TMPRSS2 predominance in placental villi of 15 COVID-19 positive maternal-fetal dyads
    Placenta100, 69-74. PubMed  Europe PubMed DOI
  715. Tamanna,S., Clifton,V.L., Rae,K., van Helden,D.F., Lumbers,E.R. and Pringle,K.G.
    Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age
    Front Physiol11, 590787-590787. PubMed  Europe PubMed DOI
  716. Tan,A.L., Farrow,M., Biglands,J., Fernandes,R.J., Abraldes,J.A., de Souza Castro,F.A., de Souza,H.L., Arriel,R.A., Meireles,A., Marocolo,M., Gonzalez-Rayas,J.M., Rayas-Gomez,A.L., Mobayed-Vega,F.N., Gonzalez-Yanez,J.M., Hirai,D.M., Belbis,M.D., Holmes,M.J., Calvo,N., Ferguson,S.K., Fernandes,T., Oliveira,E.M., Pun,M. and Bhandari,S.S.
    Commentaries on Viewpoint: The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies
    J Appl Physiol (1985)129, 868-871. PubMed  Europe PubMed DOI
  717. Tan,C.S., Yeoh,S.F. and Long,C.M.
    COVID-19: Critical Role of Angiotensin 1-7 in ACE2 Modulation
    Ann Acad Med Singap49, 398-400. PubMed  Europe PubMed
  718. Tan,C.W., Chia,W.N., Qin,X., Liu,P., Chen,M.I., Tiu,C., Hu,Z., Chen,V.C., Young,B.E., Sia,W.R., Tan,Y.J., Foo,R., Yi,Y., Lye,D.C., Anderson,D.E. and Wang,L.F.
    A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction
    Nat Biotechnol38, 1073-1078. PubMed  Europe PubMed DOI
  719. Tan,H.W., Xu,Y.M. and Lau,A.T.Y.
    Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection
    Rev Med Virole2122-e2122. PubMed  Europe PubMed DOI  V
  720. Taneera,J., El-Huneidi,W., Hamad,M., Mohammed,A.K., Elaraby,E. and Hachim,M.Y.
    Expression Profile of SARS-CoV-2 Host Receptors in Human Pancreatic Islets Revealed Upregulation of ACE2 in Diabetic Donors
    Biology (Basel)9, PubMed  Europe PubMed DOI
  721. Tao,H., Bai,J., Zhang,W., Zheng,K., Guan,P., Ge,G., Li,M. and Geng,D.
    Bone biology and COVID-19 infection: Is ACE2 a potential influence factor?
    Med Hypotheses144, 110178-110178. PubMed  Europe PubMed DOI
  722. Tao,Q., Du,J., Li,X., Zeng,J., Tan,B., Xu,J., Lin,W. and Chen,X.L.
    Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19
    Drug Dev Ind Pharm46, 1345-1353. PubMed  Europe PubMed DOI  I
  723. Tavares,C.A.M., Avelino-Silva,T.J., Benard,G., Cardozo,F.A.M., Fernandes,J.R., Girardi,A.C.C. and Jacob Filho,W.
    ACE2 Expression and Risk Factors for COVID-19 Severity in Patients with Advanced Age
    Arq Bras Cardiol115, 701-707. PubMed  Europe PubMed DOI
  724. Ten Hove,A.S., Brinkman,D.J., Li Yim,A.Y.F., Verseijden,C., Hakvoort,T.B.M., Admiraal,I., Welting,O., van Hamersveld,P.H.P., Sinniger,V., Bonaz,B., Luyer,M.D. and de Jonge,W.J.
    The role of nicotinic receptors in SARS-CoV-2 receptor ACE2 expression in intestinal epithelia
    Bioelectron Med6, 20-20. PubMed  Europe PubMed DOI
  725. Teng,S. and Tang,Q.
    ACE2 enhance viral infection or viral infection aggravate the underlying diseases
    Comput Struct Biotechnol J18, 2100-2106. PubMed  Europe PubMed DOI
  726. Terali,K., Baddal,B. and Gulcan,H.O.
    Prioritizing potential ACE2 inhibitors in the COVID-19 pandemic: Insights from a molecular mechanics-assisted structure-based virtual screening experiment
    J Mol Graph Model100, 107697-107697. PubMed  Europe PubMed DOI
  727. Thunders,M. and Delahunt,B.
    Gene of the month: TMPRSS2 (transmembrane serine protease 2)
    J Clin Pathol73, 773-776. PubMed  Europe PubMed DOI
  728. Tiwari,V.
    Denovo designing, retrosynthetic analysis, and combinatorial synthesis of a hybrid antiviral (VTAR-01) to inhibit the interaction of SARS-CoV2 spike glycoprotein with human angiotensin-converting enzyme 2
    Biol Open9, bio054056-bio054056. PubMed  Europe PubMed DOI  I
  729. Tomchaney,M., Contoli,M., Mayo,J., Baraldo,S., Shuaizhi,L., Cabel,C.R., Bull,D.A., Lick,S., Malo,J., Knoper,S., Kim,S.S., Tram,J., Rojas-Quintero,J., Kraft,M., Ledford,J., Tesfaigzi,Y., Martinez,F.D., Thorne,C.A., Kheradmand,F., Campos,S.K., Papi,A. and Polverino,F.
    Paradoxical effects of cigarette smoke and COPD on SARS-CoV2 infection and disease
    bioRxiv PubMed  Europe PubMed DOI
  730. Uversky,V.N., Elrashdy,F., Aljadawi,A. and Redwan,E.M.
    Household pets and SARS-CoV2 transmissibility in the light of the ACE2 intrinsic disorder status
    J Biomol Struct Dyn1-4. PubMed  Europe PubMed DOI
  731. Valencia,I., Peiro,C., Lorenzo,O., Sanchez-Ferrer,C.F., Eckel,J. and Romacho,T.
    DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
    Front Pharmacol11, 1161-1161. PubMed  Europe PubMed DOI
  732. Vardhan,S. and Sahoo,S.K.
    In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19
    Comput Biol Med124, 103936-103936. PubMed  Europe PubMed DOI
  733. Vargas-Alarcon,G., Posadas-Sanchez,R. and Ramirez-Bello,J.
    Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies
    Life Sci260, 118313-118313. PubMed  Europe PubMed DOI
  734. Vargas-Ferrer,J. and Zamora-Mostacero,V.
    Re-detectable positive RT-PCR test results in recovered COVID-19 patients: The potential role of ACE2
    Disaster Med Public Health Prep1-4. PubMed  Europe PubMed DOI
  735. Varma,P., Lybrand,Z.R., Antopia,M.C. and Hsieh,J.
    Novel Targets of SARS-CoV-2 Spike Protein in Human Fetal Brain Development Suggest Early Pregnancy Vulnerability
    Front Neurosci14, 614680-614680. PubMed  Europe PubMed DOI
  736. Vazquez-Cornejo,E.
    Considerations on the use of antihypertensive blockers of the renin-angiotensin system in adults and children in the face of the COVID-19 pandemic
    Bol Med Hosp Infant Mex77, 274-281. PubMed  Europe PubMed DOI
  737. Verano-Braga,T., Martins,A.L.V., Motta-Santos,D., Campagnole-Santos,M.J. and Santos,R.A.S.
    ACE2 in the renin-angiotensin system
    Clin Sci (Lond)134, 3063-3078. PubMed  Europe PubMed DOI  V
  738. Verkhivker,G.
    Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2
    Int J Mol Sci21, PubMed  Europe PubMed DOI
  739. Verma,N.K., Fazil,M.H.U.T., Duggan,S.P. and Kelleher,D.
    Combination Therapy Using Inhalable GapmeR and Recombinant ACE2 for COVID-19
    Front Mol Biosci7, 197-197. PubMed  Europe PubMed DOI  K
  740. Viana,S.D., Nunes,S. and Reis,F.
    ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis
    Ageing Res Rev62, 101123-101123. PubMed  Europe PubMed DOI  V
  741. Vikse,J., Lippi,G. and Henry,B.M.
    Do sex-specific immunobiological factors and differences in angiotensin converting enzyme 2 (ACE2) expression explain increased severity and mortality of COVID-19 in males?
    Diagnosis (Berl)7, 385-386. PubMed  Europe PubMed DOI
  742. Voinsky,I. and Gurwitz,D.
    Smoking and COVID-19: Similar bronchial ACE2 and TMPRSS2 expression and higher TMPRSS4 expression in current versus never smokers
    Drug Dev Res81, 1073-1080. PubMed  Europe PubMed DOI
  743. Walker,S.N., Chokkalingam,N., Reuschel,E.L., Purwar,M., Xu,Z., Gary,E.N., Kim,K.Y., Helble,M., Schultheis,K., Walters,J., Ramos,S., Muthumani,K., Smith,T.R.F., Broderick,K.E., Tebas,P., Patel,A., Weiner,D.B. and Kulp,D.W.
    SARS-CoV-2 assays to detect functional antibody responses that block ACE2 recognition in vaccinated animals and infected patients
    J Clin Microbiol58, e01533-20-e01533-20. PubMed  Europe PubMed DOI
  744. Wang,B., Kovalchuk,A., Li,D., Rodriguez-Juarez,R., Ilnytskyy,Y., Kovalchuk,I. and Kovalchuk,O.
    In search of preventive strategies: novel high-CBD Cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissues
    Aging (Albany NY)12, 22425-22444. PubMed  Europe PubMed DOI
  745. Wang,J., Xu,X., Zhou,X., Chen,P., Liang,H., Li,X., Zhong,W. and Hao,P.
    Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection
    J Gen Virol101, 921-924. PubMed  Europe PubMed DOI
  746. Wang,J., Li,J., Cheng,C. and Liu,S.
    Angiotensin-converting enzyme 2 augments the effects of endothelial progenitor cells-exosomes on vascular smooth muscle cell phenotype transition
    Cell Tissue Res382, 509-518. PubMed  Europe PubMed DOI
  747. Wang,K., Gheblawi,M. and Oudit,G.Y.
    Angiotensin converting enzyme 2: a double-edged sword
    Circulation142, 426-428. PubMed  Europe PubMed DOI  V
  748. Wang,Q., Sundar,I.K., Li,D., Lucas,J.H., Muthumalage,T., McDonough,S.R. and Rahman,I.
    E-cigarette-induced pulmonary inflammation and dysregulated repair are mediated by nAChR alpha7 receptor: role of nAChR alpha7 in SARS-CoV-2 Covid-19 ACE2 receptor regulation
    Respir Res21, 154-154. PubMed  Europe PubMed DOI
  749. Wang,W., Lv,S., Gan,W., Zeng,Z. and Yang,M.
    A bioinformatics analysis on the potential role of ACE2 in cardiac impairment of patients with coronavirus disease 2019
    Ann Transl Med8, 1403-1403. PubMed  Europe PubMed DOI
  750. Wang,Y., Wang,Y., Luo,W., Huang,L., Xiao,J., Li,F., Qin,S., Song,X., Wu,Y., Zeng,Q., Jin,F. and Wang,Y.
    A comprehensive investigation of the mRNA and protein level of ACE2, the putative receptor of SARS-CoV-2, in human tissues and blood cells
    Int J Med Sci17, 1522-1531. PubMed  Europe PubMed DOI
  751. Warner,F.J., Rajapaksha,H., Shackel,N. and Herath,C.B.
    ACE2: from protection of liver disease to propagation of COVID-19
    Clin Sci (Lond)134, 3137-3158. PubMed  Europe PubMed DOI  V
  752. Weatherbee,B.A.T., Glover,D.M. and Zernicka-Goetz,M.
    Expression of SARS-CoV-2 receptor ACE2 and the protease TMPRSS2 suggests susceptibility of the human embryo in the first trimester
    Open Biol10, 200162-200162. PubMed  Europe PubMed DOI
  753. Wei,S., Duan,S., Liu,X., Wang,H., Ding,S., Chen,Y., Xie,J., Tian,J., Yu,N., Ge,P., Zhang,X., Chen,X., Li,Y. and Meng,Q.
    Chicken Egg Yolk Antibodies (IgYs) block the binding of multiple SARS-CoV-2 spike protein variants to human ACE2
    Int Immunopharmacol107172-107172. PubMed  Europe PubMed DOI
  754. Weir,R.A.P.
    Letter by Weir Regarding Article, "Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2"
    Circ Res127, e44-e44. PubMed  Europe PubMed DOI
  755. Wells,H.L., Letko,M., Lasso,G., Ssebide,B., Nziza,J., Byarugaba,D.K., Navarrete-Macias,I., Liang,E., Cranfield,M., Han,B.A., Tingley,M.W., Diuk-Wasser,M., Goldstein,T., Johnson,C.K., Mazet,J., Chandran,K., Munster,V.J., Gilardi,K. and Anthony,S.J.
    The evolutionary history of ACE2 usage within the coronavirus subgenus Sarbecovirus
    bioRxiv PubMed  Europe PubMed DOI
  756. Wicik,Z., Eyileten,C., Jakubik,D., Simoes,S.N., Martins,D.C., Jr., Pavao,R., Siller-Matula,J.M. and Postula,M.
    ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors
    J Clin Med9, PubMed  Europe PubMed DOI
  757. Wijnant,S.R., Jacobs,M., Van Eeckhoutte,H.P., Lapauw,B., Joos,G.F., Bracke,K.R. and Brusselle,G.G.
    Expression of ACE2, the SARS-CoV-2 Receptor, in Lung Tissue of Patients With Type 2 Diabetes
    Diabetes69, 2691-2699. PubMed  Europe PubMed DOI
  758. Williamson,G. and Kerimi,A.
    Testing of natural products in clinical trials targeting the SARS-CoV-2 (Covid-19) viral spike protein-angiotensin converting enzyme-2 (ACE2) interaction
    Biochem Pharmacol178, 114123-114123. PubMed  Europe PubMed DOI  I
  759. Winkler,E.S., Bailey,A.L., Kafai,N.M., Nair,S., McCune,B.T., Yu,J., Fox,J.M., Chen,R.E., Earnest,J.T., Keeler,S.P., Ritter,J.H., Kang,L.I., Dort,S., Robichaud,A., Head,R., Holtzman,M.J. and Diamond,M.S.
    SARS-CoV-2 infection in the lungs of human ACE2 transgenic mice causes severe inflammation, immune cell infiltration, and compromised respiratory function
    bioRxiv PubMed  Europe PubMed DOI
  760. Winkler,E.S., Bailey,A.L., Kafai,N.M., Nair,S., McCune,B.T., Yu,J., Fox,J.M., Chen,R.E., Earnest,J.T., Keeler,S.P., Ritter,J.H., Kang,L.I., Dort,S., Robichaud,A., Head,R., Holtzman,M.J. and Diamond,M.S.
    SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
    Nat Immunol21, 1327-1335. PubMed  Europe PubMed DOI
  761. Winkler,E.S., Bailey,A.L., Kafai,N.M., Nair,S., McCune,B.T., Yu,J., Fox,J.M., Chen,R.E., Earnest,J.T., Keeler,S.P., Ritter,J.H., Kang,L.I., Dort,S., Robichaud,A., Head,R., Holtzman,M.J. and Diamond,M.S.
    Publisher Correction: SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
    Nat Immunol21, 1470-1470. PubMed  Europe PubMed DOI
  762. Wrobel,A.G., Benton,D.J., Xu,P., Roustan,C., Martin,S.R., Rosenthal,P.B., Skehel,J.J. and Gamblin,S.J.
    SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects
    Nat Struct Mol Biol27, 763-767. PubMed  Europe PubMed DOI
  763. Wruck,W. and Adjaye,J.
    SARS-CoV-2 receptor ACE2 is co-expressed with genes related to transmembrane serine proteases, viral entry, immunity and cellular stress
    Sci Rep10, 21415-21415. PubMed  Europe PubMed DOI
  764. Wu,C., Ye,D., Mullick,A.E., Li,Z., Danser,A.H.J., Daugherty,A. and Lu,H.S.
    Effects of Renin-Angiotensin Inhibition on ACE2 and TMPRSS2 Expression: Insights into COVID-19
    Hypertension76, e29-e30. PubMed  Europe PubMed DOI
  765. Wu,C.Y., Lin,Y.S., Yang,Y.H., Shu,L.H., Cheng,Y.C. and Liu,H.T.
    Potential Simultaneous Inhibitors of Angiotensin-Converting Enzyme 2 and Transmembrane Protease, Serine 2
    Front Pharmacol11, 584158-584158. PubMed  Europe PubMed DOI
  766. Wu,C.Y., Lin,Y.S., Yang,Y.H., Shu,L.H., Cheng,Y.C. and Liu,H.T.
    GB-2 inhibits ACE2 and TMPRSS2 expression: In vivo and in vitro studies
    Biomed Pharmacother132, 110816-110816. PubMed  Europe PubMed DOI
  767. Wu,J.
    A Novel Angiotensin Converting Enzyme 2 (ACE2) Activating Peptide: A Reflection of 10 Years of Research on a Small Peptide Ile-Arg-Trp (IRW)
    J Agric Food Chem68, 14402-14408. PubMed  Europe PubMed DOI
  768. Wu,L., Chen,Q., Liu,K., Wang,J., Han,P., Zhang,Y., Hu,Y., Meng,Y., Pan,X., Qiao,C., Tian,S., Du,P., Song,H., Shi,W., Qi,J., Wang,H.W., Yan,J., Gao,G.F. and Wang,Q.
    Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2
    Cell Discov6, 68-68. PubMed  Europe PubMed DOI
  769. Wysocki,J., Lores,E., Ye,M., Soler,M.J. and Batlle,D.
    Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19
    J Am Soc Nephrol31, 1941-1943. PubMed  Europe PubMed DOI
  770. Xiang,Z., Liu,J., Shi,D., Chen,W., Li,J., Yan,R., Bi,Y., Hu,W., Zhu,Z., Yu,Y. and Yang,Z.
    Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels
    Int J Biol Sci16, 2382-2391. PubMed  Europe PubMed DOI
  771. Xie,Y., Karki,C.B., Du,D., Li,H., Wang,J., Sobitan,A., Teng,S., Tang,Q. and Li,L.
    Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2
    Front Mol Biosci7, 591873-591873. PubMed  Europe PubMed DOI
  772. Xing,Y., Hua,Y.R., Shang,J., Ge,W.H. and Liao,J.
    Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019
    Chin J Nat Med18, 941-951. PubMed  Europe PubMed DOI  I
  773. Xiong,H.L., Wu,Y.T., Cao,J.L., Yang,R., Liu,Y.X., Ma,J., Qiao,X.Y., Yao,X.Y., Zhang,B.H., Zhang,Y.L., Hou,W.H., Shi,Y., Xu,J.J., Zhang,L., Wang,S.J., Fu,B.R., Yang,T., Ge,S.X., Zhang,J., Yuan,Q., Huang,B.Y., Li,Z.Y., Zhang,T.Y. and Xia,N.S.
    Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells
    Emerg Microbes Infect9, 2105-2113. PubMed  Europe PubMed DOI
  774. Xu,F., Gao,J., Munkhsaikhan,U., Li,N., Gu,Q., Pierre,J.F., Starlard-Davenport,A., Towbin,J.A., Cui,Y., Purevjav,E. and Lu,L.
    The Genetic Dissection of Ace2 Expression Variation in the Heart of Murine Genetic Reference Population
    Front Cardiovasc Med7, 582949-582949. PubMed  Europe PubMed DOI
  775. Xu,Y., Liu,S., Zhang,Y. and Zhi,Y.
    Does hereditary angioedema make COVID-19 worse?
    World Allergy Organ J13, 100454-100454. PubMed  Europe PubMed DOI  V
  776. Xu,Y., Liu,S., Zhang,Y. and Zhi,Y.
    Does hereditary angioedema make COVID-19 worse?
    World Allergy Organ J13, 100454-100454. PubMed  Europe PubMed DOI  V
  777. Yamamoto,K., Takeshita,H. and Rakugi,H.
    ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19
    Clin Sci (Lond)134, 3047-3062. PubMed  Europe PubMed DOI
  778. Yan,R., Zhang,Y., Li,Y., Xia,L., Guo,Y. and Zhou,Q.
    Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
    Science367, 1444-1448. PubMed  Europe PubMed DOI  S
  779. Yao,J., Gong,X., Shi,X., Fan,S., Chen,J. and Chen,Q.
    The efficacy of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on insulin resistance in hypertensive patients: A protocol for a systematic review and meta-analysis
    Medicine (Baltimore)99, e20674-e20674. PubMed  Europe PubMed DOI
  780. Yao,Y., Wang,H. and Liu,Z.
    Expression of ACE2 in airways: Implication for COVID-19 risk and disease management in patients with chronic inflammatory respiratory diseases
    Clin Exp Allergy50, 1313-1324. PubMed  Europe PubMed DOI  V
  781. Yu,W., Ou,X., Liu,X., Zhang,S., Gao,X., Cheng,H., Zhu,B. and Yan,J.
    ACE2 contributes to the maintenance of mouse epithelial barrier function
    Biochem Biophys Res Commun533, 1276-1282. PubMed  Europe PubMed DOI
  782. Zamai,L.
    The Yin and Yang of ACE/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients
    Cells9, PubMed  Europe PubMed DOI
  783. Zamorano Cuervo,N. and Grandvaux,N.
    ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
    elife9, PubMed  Europe PubMed DOI
  784. Zhang,H., Quek,K., Chen,R., Chen,J. and Chen,B.
    Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer
    J Cancer11, 5289-5292. PubMed  Europe PubMed DOI
  785. Zhang,H., Quek,K., Chen,R., Chen,J. and Chen,B.
    Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer
    J Cancer11, 5289-5292. PubMed  Europe PubMed DOI
  786. Zhang,S., Liu,Y., Wang,X., Yang,L., Li,H., Wang,Y., Liu,M., Zhao,X., Xie,Y., Yang,Y., Zhang,S., Fan,Z., Dong,J., Yuan,Z., Ding,Z., Zhang,Y. and Hu,L.
    SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
    J Hematol Oncol13, 120-120. PubMed  Europe PubMed DOI
  787. Zhang,T., Zhong,S. and Cao,W.
    COVID-19 and Comorbid Hypertension: Is ACE2 the Culprit?
    Prehosp Disaster Med1-2. PubMed  Europe PubMed DOI
  788. Zhang,X.Y., Huang,H.J., Zhuang,D.L., Nasser,M.I., Yang,M.H., Zhu,P. and Zhao,M.Y.
    Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2
    Infect Dis Poverty9, 99-99. PubMed  Europe PubMed DOI  V
  789. Zhang,Z., Li,L., Li,M. and Wang,X.
    The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression
    Comput Struct Biotechnol J18, 2438-2444. PubMed  Europe PubMed DOI
  790. Zhao,P., Praissman,J.L., Grant,O.C., Cai,Y., Xiao,T., Rosenbalm,K.E., Aoki,K., Kellman,B.P., Bridger,R., Barouch,D.H., Brindley,M.A., Lewis,N.E., Tiemeyer,M., Chen,B., Woods,R.J. and Wells,L.
    Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor
    bioRxiv PubMed  Europe PubMed DOI
  791. Zhao,X., Chen,D., Szabla,R., Zheng,M., Li,G., Du,P., Zheng,S., Li,X., Song,C., Li,R., Guo,J.T., Junop,M., Zeng,H. and Lin,H.
    Broad and differential animal ACE2 receptor usage by SARS-CoV-2
    J Virol94, e00940-20-e00940-20. PubMed  Europe PubMed DOI
  792. Zhao,Y., Zhao,Z., Wang,Y., Zhou,Y., Ma,Y. and Zuo,W.
    Single-cell RNA Expression Profiling of ACE2, The Receptor of SARS-CoV-2
    Am J Respir Crit Care Med202, 756-759. PubMed  Europe PubMed DOI
  793. Zheng,L., Zhang,L., Huang,J., Nandakumar,K.S., Liu,S. and Cheng,K.
    Potential treatment methods targeting 2019-nCoV infection
    Eur J Med Chem205, 112687-112687. PubMed  Europe PubMed DOI  V  I
  794. Zheng,M., Zhao,X., Zheng,S., Chen,D., Du,P., Li,X., Jiang,D., Guo,J.T., Zeng,H. and Lin,H.
    Bat SARS-Like WIV1 coronavirus uses the ACE2 of multiple animal species as receptor and evades IFITM3 restriction via TMPRSS2 activation of membrane fusion
    Emerg Microbes Infect9, 1567-1579. PubMed  Europe PubMed DOI
  795. Zhong,M., Lin,B., Pathak,J.L., Gao,H., Young,A.J., Wang,X., Liu,C., Wu,K., Liu,M., Chen,J.M., Huang,J., Lee,L.H., Qi,C.L., Ge,L. and Wang,L.
    ACE2 and Furin Expressions in Oral Epithelial Cells Possibly Facilitate COVID-19 Infection via Respiratory and Fecal-Oral Routes
    Front Med (Lausanne)7, 580796-580796. PubMed  Europe PubMed DOI
  796. Zhou,L., Huntington,K., Zhang,S., Carlsen,L., So,E.Y., Parker,C., Sahin,I., Safran,H., Kamle,S., Lee,C.M., Geun Lee,C., Elias,A., Campbell,S., Naik,T., Atwood,J., Youssef,E., Pachter,A., Navaraj,A., Seyhan,A., Liang,O. and El-Deiry,W.S.
    MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infection
    Oncotarget11, 4201-4223. PubMed  Europe PubMed DOI
  797. Zhou,L., Xu,Z., Castiglione,G.M., Soiberman,U.S., Eberhart,C.G. and Duh,E.J.
    ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection
    Ocul Surf18, 537-544. PubMed  Europe PubMed DOI
  798. Zhou,L., Huntington,K., Zhang,S., Carlsen,L., So,E.Y., Parker,C., Sahin,I., Safran,H., Kamle,S., Lee,C.M., Lee,C.G., Elias,J.A., Campbell,K.S., Naik,M.T., Atwood,W.J., Youssef,E., Pachter,J.A., Navaraj,A., Seyhan,A.A., Liang,O. and El-Deiry,W.S.
    Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells
    bioRxiv PubMed  Europe PubMed DOI
  799. Zhou,L., Niu,Z., Jiang,X., Zhang,Z., Zheng,Y., Wang,Z., Zhu,Y., Gao,L., Huang,H., Wang,X. and Sun,Q.
    SARS-CoV-2 Targets by the pscRNA Profiling of ACE2, TMPRSS2 and Furin Proteases
    iScience23, 101744-101744. PubMed  Europe PubMed DOI
  800. Zhou,T., Tsybovsky,Y., Gorman,J., Rapp,M., Cerutti,G., Chuang,G.Y., Katsamba,P.S., Sampson,J.M., Schon,A., Bimela,J., Boyington,J.C., Nazzari,A., Olia,A.S., Shi,W., Sastry,M., Stephens,T., Stuckey,J., Teng,I.T., Wang,P., Wang,S., Zhang,B., Friesner,R.A., Ho,D.D., Mascola,J.R., Shapiro,L. and Kwong,P.D.
    Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains
    Cell Host Microbe28, 867-879. PubMed  Europe PubMed DOI
  801. Zipeto,D., Palmeira,J.D.F., Arganaraz,G.A. and Arganaraz,E.R.
    ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19
    Front Immunol11, 576745-576745. PubMed  Europe PubMed DOI  V
  802. Zoufaly,A., Poglitsch,M., Aberle,J.H., Hoepler,W., Seitz,T., Traugott,M., Grieb,A., Pawelka,E., Laferl,H., Wenisch,C., Neuhold,S., Haider,D., Stiasny,K., Bergthaler,A., Puchhammer-Stoeckl,E., Mirazimi,A., Montserrat,N., Zhang,H., Slutsky,A.S. and Penninger,J.M.
    Human recombinant soluble ACE2 in severe COVID-19
    Lancet Respir Med8, 1154-1158. PubMed  Europe PubMed DOI
  803. 2019
  804. Kangussu,L.M., de Almeida,T.C.S., Prestes,T.R.R., de Andrade De Maria,M.L., da Silva Filha,R., Vieira,M.A.R., Silva,A.C.S.E. and Ferreira,A.J.
    Beneficial effects of the angiotensin-converting enzyme 2 activator DIZE in renovascular hypertension
    Protein Pept Lett26, 523-531. PubMed  Europe PubMed DOI  I
  805. Liu,C., Chen,C.Y., Shang,Q.H. and Liu,J.
    [Establishment of Ace2 knockout mouse model with CRISPR/Cas9 gene targeting technology]
    Sheng Li Xue Bao71, 588-596. PubMed  Europe PubMed  K
  806. 2018
  807. Bruce,E.B., Sakarya,Y., Kirichenko,N., Toklu,H.Z., Sumners,C., Morgan,D., Tumer,N., Scarpace,P.J. and Carter,C.S.
    ACE2 activator diminazene aceturate reduces adiposity but preserves lean mass in young and old rats
    Exp Gerontol111, 133-140. PubMed  Europe PubMed DOI  I
  808. Liao,W., Bhullar,K.S., Chakrabarti,S., Davidge,S.T. and Wu,J.
    Egg white-derived tripeptide IRW (Ile-Arg-Trp) is an activator of angiotensin converting enzyme 2
    J Agric Food Chem66, 11330-11336. PubMed  Europe PubMed DOI
  809. Liu,P., Wysocki,J., Souma,T., Ye,M., Ramirez,V., Zhou,B., Wilsbacher,L.D., Quaggin,S.E., Batlle,D. and Jin,J.
    Novel ACE2-Fc chimeric fusion provides long-lasting hypertension control and organ protection in mouse models of systemic renin angiotensin system activation
    Kidney Int94, 114-125. PubMed  Europe PubMed DOI  U
  810. Williams,V.R. and Scholey,J.W.
    Angiotensin-converting enzyme 2 and renal disease
    Curr Opin Nephrol Hypertens27, 35-41. PubMed  Europe PubMed DOI
  811. Zhang,J., Dong,J., Martin,M., He,M., Gongol,B., Marin,T.L., Chen,L., Shi,X., Yin,Y., Shang,F., Wu,Y., Huang,H.Y., Zhang,J., Zhang,Y., Kang,J., Moya,E.A., Huang,H.D., Powell,F.L., Chen,Z., Thistlethwaite,P.A., Yuan,Z.Y. and Shyy,J.Y.
    AMP-activated protein kinase phosphorylation of angiotensin-converting enzyme 2 in endothelium mitigates pulmonary hypertension
    Am J Respir Crit Care Med198, 509-520. PubMed  Europe PubMed DOI
  812. 2017
  813. Bae,E.H., Fang,F., Williams,V.R., Konvalinka,A., Zhou,X., Patel,V.B., Song,X., John,R., Oudit,G.Y., Pei,Y. and Scholey,J.W.
    Murine recombinant angiotensin-converting enzyme 2 attenuates kidney injury in experimental Alport syndrome
    Kidney Int91, 1347-1361. PubMed  Europe PubMed DOI  U
  814. Sriramula,S., Pedersen,K.B., Xia,H. and Lazartigues,E.
    Determining the enzymatic activity of angiotensin-converting enzyme 2 (ACE2) in brain tissue and cerebrospinal fluid using a quenched fluorescent substrate
    Methods Mol Biol1527, 117-126. PubMed  Europe PubMed DOI  A
  815. Wang,Y., Cassis,L.A. and Thatcher,S.E.
    Use of a fluorescent substrate to measure ACE2 activity in the mouse abdominal aorta
    Methods Mol Biol1614, 61-67. PubMed  Europe PubMed DOI  A
  816. Yang,P., Kuc,R.E., Brame,A.L., Dyson,A., Singer,M., Glen,R.C., Cheriyan,J., Wilkinson,I.B., Davenport,A.P. and Maguire,J.J.
    [Pyr1]Apelin-13(1-12) is a biologically active ACE2 metabolite of the endogenous cardiovascular peptide [Pyr1]apelin-13
    Front Neurosci11, 92-92. PubMed  Europe PubMed DOI
  817. 2016
  818. Chen,Y.Y., Liu,D., Zhang,P., Zhong,J.C., Zhang,C.J., Wu,S.L., Zhang,Y.Q., Liu,G.Z., He,M., Jin,L.J. and Yu,H.M.
    Impact of ACE2 gene polymorphism on antihypertensive efficacy of ACE inhibitors
    J Hum Hypertens30, 766-771. PubMed  Europe PubMed DOI  M  I
  819. Joshi,S., Balasubramanian,N., Vasam,G. and Jarajapu,Y.P.
    Angiotensin converting enzyme versus angiotensin converting enzyme-2 selectivity of MLN-4760 and DX600 in human and murine bone marrow-derived cells
    Eur J Pharmacol774, 25-33. PubMed  Europe PubMed DOI  I
  820. Motta-Santos,D., dos Santos,R.A., Oliveira,M., Qadri,F., Poglitsch,M., Mosienko,V., Kappes Becker,L., Campagnole-Santos,M.J., M Penninger,J., Alenina,N. and Bader,M.
    Effects of ACE2 deficiency on physical performance and physiological adaptations of cardiac and skeletal muscle to exercise
    Hypertens Res39, 506-512. PubMed  Europe PubMed DOI  K
  821. Qiu,Y., Tao,L., Zheng,S., Lin,R., Fu,X., Chen,Z., Lei,C., Wang,J., Li,H., Li,Q. and Lei,B.
    AAV8-mediated angiotensin-converting enzyme 2 gene delivery prevents experimental autoimmune uveitis by regulating MAPK, NF-kappaB and STAT3 pathways
    Sci Rep6, 31912-31912. PubMed  Europe PubMed DOI  U
  822. Rabelo,L.A., Todiras,M., Nunes-Souza,V., Qadri,F., Szijarto,I.A., Gollasch,M., Penninger,J.M., Bader,M., Santos,R.A. and Alenina,N.
    Genetic deletion of ACE2 induces vascular dysfunction in C57BL/6 mice: role of nitric oxide imbalance and oxidative stress
    PLoS ONE11, e0150255-e0150255. PubMed  Europe PubMed DOI  K
  823. Tao,L., Qiu,Y., Fu,X., Lin,R., Lei,C., Wang,J. and Lei,B.
    Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-kappaB pathways in human retinal pigment epithelium
    J Neuroinflammation13, 35-35. PubMed  Europe PubMed DOI  I
  824. Velkoska,E., Patel,S.K. and Burrell,L.M.
    Angiotensin converting enzyme 2 and diminazene: role in cardiovascular and blood pressure regulation
    Curr Opin Nephrol Hypertens25, 384-395. PubMed  Europe PubMed DOI
  825. Wang,L., de Kloet,A.D., Pati,D., Hiller,H., Smith,J.A., Pioquinto,D.J., Ludin,J.A., Oh,S.P., Katovich,M.J., Frazier,C.J., Raizada,M.K. and Krause,E.G.
    Increasing brain angiotensin converting enzyme 2 activity decreases anxiety-like behavior in male mice by activating central Mas receptors
    Neuropharmacology105, 114-123. PubMed  Europe PubMed DOI
  826. Wang,W., McKinnie,S.M., Farhan,M., Paul,M., McDonald,T., McLean,B., Llorens-Cortes,C., Hazra,S., Murray,A.G., Vederas,J.C. and Oudit,G.Y.
    Angiotensin-converting enzyme 2 metabolizes and partially inactivates pyr-apelin-13 and apelin-17: physiological effects in the cardiovascular system
    Hypertension68, 365-377. PubMed  Europe PubMed DOI  I
  827. 2015
  828. Bernardi,S., Tikellis,C., Candido,R., Tsorotes,D., Pickering,R.J., Bossi,F., Carretta,R., Fabris,B., Cooper,M.E. and Thomas,M.C.
    ACE2 deficiency shifts energy metabolism towards glucose utilization
    Metabolism64, 406-415. PubMed  Europe PubMed DOI  K
  829. Clayton,D., Hanchapola,I., Thomas,W.G., Widdop,R.E., Smith,A.I., Perlmutter,P. and Aguilar,M.I.
    Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors 1 and 2
    Front Pharmacol6, 5-5. PubMed  Europe PubMed DOI
  830. Liu,C., Xiao,L., Li,F., Zhang,H., Li,Q., Liu,H., Fu,S., Li,C., Zhang,X., Wang,J., Staunstrup,N.H., Li,Y. and Yang,H.
    Generation of outbred Ace2 knockout mice by RNA transfection of TALENs displaying colitis reminiscent pathophysiology and inflammation
    Transgenic Res24, 433-446. PubMed  Europe PubMed DOI  K
  831. Mak,K.Y., Chin,R., Cunningham,S.C., Habib,M.R., Torresi,J., Sharland,A.F., Alexander,I.E., Angus,P.W. and Herath,C.B.
    ACE2 therapy using adeno-associated viral vector inhibits liver fibrosis in mice
    Mol Ther23, 1434-1443. PubMed  Europe PubMed DOI  U
  832. Takahashi,S., Yoshiya,T., Yoshizawa-Kumagaye,K. and Sugiyama,T.
    Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean
    Biomed Res36, 219-224. PubMed  Europe PubMed DOI  A  I
  833. 2014
  834. Jiang,F., Yang,J., Zhang,Y., Dong,M., Wang,S., Zhang,Q., Liu,F.F., Zhang,K. and Zhang,C.
    Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets
    Nat Rev Cardiol11, 413-426. PubMed  Europe PubMed DOI  V
  835. Lambert,D.W., Lambert,L.A., Clarke,N.E., Hooper,N.M., Porter,K.E. and Turner,A.J.
    Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation by miR-421
    Clin Sci (Lond)127, 243-249. PubMed  Europe PubMed DOI
  836. Liu,S., Liu,J., Miura,Y., Tanabe,C., Maeda,T., Terayama,Y., Turner,A.J., Zou,K. and Komano,H.
    Conversion of Abeta43 to Abeta40 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme
    J Neurosci Res92, 1178-1186. PubMed  Europe PubMed DOI  I
  837. Niu,J. and Shi,F.
    The recombinant expression of truncated human ACE2 in E. coli
    Chin J Pharm Biotechnol21, 398-401.  E
  838. Xue,T., Wei,N., Xin,Z. and Qingyu,X.
    Angiotensin-converting enzyme-2 overexpression attenuates inflammation in rat model of chronic obstructive pulmonary disease
    Inhal Toxicol26, 14-22. PubMed  Europe PubMed DOI
  839. Yang,P., Gu,H., Zhao,Z., Wang,W., Cao,B., Lai,C., Yang,X., Zhang,L., Duan,Y., Zhang,S., Chen,W., Zhen,W., Cai,M., Penninger,J.M., Jiang,C. and Wang,X.
    Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury
    Sci Rep4, 7027-7027. PubMed  Europe PubMed DOI
  840. 2013
  841. Chen,J., Xiao,X., Chen,S., Zhang,C., Chen,J., Yi,D., Shenoy,V., Raizada,M.K., Zhao,B. and Chen,Y.
    Angiotensin-converting enzyme 2 priming enhances the function of endothelial progenitor cells and their therapeutic efficacy
    Hypertension61, 681-689. PubMed  Europe PubMed DOI  U
  842. Chhabra,K.H., Xia,H., Pedersen,K.B., Speth,R.C. and Lazartigues,E.
    Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice
    Am J Physiol Endocrinol Metab304, E874-E884. PubMed  Europe PubMed DOI  U
  843. Fraga-Silva,R.A., Costa-Fraga,F.P., Murca,T.M., Moraes,P.L., Martins Lima,A., Lautner,R.Q., Castro,C.H., Soares,C.M., Borges,C.L., Nadu,A.P., Oliveira,M.L., Shenoy,V., Katovich,M.J., Santos,R.A., Raizada,M.K. and Ferreira,A.J.
    Angiotensin-converting enzyme 2 activation improves endothelial function
    Hypertension61, 1233-1238. PubMed  Europe PubMed DOI
  844. Kuba,K., Imai,Y. and Penninger,J.M.
    Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases
    Circ J77, 301-308. PubMed  Europe PubMed DOI
  845. Marian,A.J.
    The discovery of the ACE2 gene
    Circ Res112, 1307-1309. PubMed  Europe PubMed DOI
  846. Takeda,M., Yamamoto,K., Takemura,Y., Takeshita,H., Hongyo,K., Kawai,T., Hanasaki-Yamamoto,H., Oguro,R., Takami,Y., Tatara,Y., Takeya,Y., Sugimoto,K., Kamide,K., Ohishi,M. and Rakugi,H.
    Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice
    Diabetes62, 223-233. PubMed  Europe PubMed DOI
  847. 2012
  848. Batlle,D., Wysocki,J., Soler,M.J. and Ranganath,K.
    Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy
    Kidney Int81, 520-528. PubMed  Europe PubMed DOI
  849. Clarke,N.E., Hooper,N.M. and Turner,A.J.
    Angiotensin-converting enzyme 2
    [ISSN:978-0-12-407744-7]3, 499-504. DOI
  850. Jin,H.Y., Song,B., Oudit,G.Y., Davidge,S.T., Yu,H.M., Jiang,Y.Y., Gao,P.J., Zhu,D.L., Ning,G., Kassiri,Z., Penninger,J.M. and Zhong,J.C.
    ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production
    PLoS ONE7, e38502-e38502. PubMed  Europe PubMed DOI
  851. Kleinsasser,A., Pircher,I., Treml,B., Schwienbacher,M., Schuster,M., Janzek,E., Loibner,H., Penninger,J.M. and Loeckinger,A.
    Recombinant angiotensin-converting enzyme 2 suppresses pulmonary vasoconstriction in acute hypoxia
    Wilderness Environ Med23, 24-30. PubMed  Europe PubMed DOI  U
  852. Murca,T.M., Moraes,P.L., Capuruco,C.A., Santos,S.H., Melo,M.B., Santos,R.A., Shenoy,V., Katovich,M.J., Raizada,M.K. and Ferreira,A.J.
    Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction
    Regul Pept177, 107-115. PubMed  Europe PubMed DOI
  853. Poglitsch,M., Domenig,O., Schwager,C., Stranner,S., Peball,B., Janzek,E., Wagner,B., Jungwirth,H., Loibner,H. and Schuster,M.
    Recombinant expression and characterization of human and murine ACE2: species-specific activation of the alternative renin-angiotensin-system
    Int J Hypertens2012, 428950-428950. PubMed  Europe PubMed DOI  E
  854. Tikellis,C. and Thomas,M.C.
    Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease
    Int J Pept2012, 256294-256294. PubMed  Europe PubMed DOI  K  U
  855. Wang,W., Bodiga,S., Das,S.K., Lo,J., Patel,V. and Oudit,G.Y.
    Role of ACE2 in diastolic and systolic heart failure
    Heart Fail Rev17, 683-691. PubMed  Europe PubMed DOI
  856. Ye,M., Wysocki,J., Gonzalez-Pacheco,F.R., Salem,M., Evora,K., Garcia-Halpin,L., Poglitsch,M., Schuster,M. and Batlle,D.
    Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2
    Hypertension60, 730-740. PubMed  Europe PubMed DOI  I
  857. 2011
  858. Aragao,D.S., Cunha,T.S., Arita,D.Y., Andrade,M.C., Fernandes,A.B., Watanabe,I.K., Mortara,R.A. and Casarini,D.E.
    Purification and characterization of angiotensin converting enzyme 2 (ACE2) from murine model of mesangial cell in culture
    Int J Biol Macromol49, 79-84. PubMed  Europe PubMed DOI
  859. Bharadwaj,M.S., Strawn,W.B., Groban,L., Yamaleyeva,L.M., Chappell,M.C., Horta,C., Atkins,K., Firmes,L., Gurley,S.B. and Brosnihan,K.B.
    Angiotensin-converting enzyme 2 deficiency is associated with impaired gestational weight gain and fetal growth restriction
    Hypertension58, 852-858. PubMed  Europe PubMed DOI  K
  860. Clayton,D., Hanchapola,I., Hausler,N., Unabia,S., Lew,R.A., Widdop,R.E., Smith,A.I., Perlmutter,P. and Aguilar,M.I.
    beta-Amino acid substitution to investigate the recognition of angiotensin II (AngII) by angiotensin converting enzyme 2 (ACE2)
    J Mol Recognit24, 235-244. PubMed  Europe PubMed DOI
  861. Jin,X.Q., Lu,Z.Q. and Lin,X.
    Effect of ACE2 gene transfection on the proliferation of vascular smooth muscle cells in rats
    Zhonghua Yi Xue Za Zhi91, 125-128. DOI
  862. Lai,Z.W., Hanchapola,I., Steer,D.L. and Smith,A.I.
    Angiotensin-converting enzyme 2 ectodomain shedding cleavage-site identification: determinants and constraints
    Biochemistry50, 5182-5194. PubMed  Europe PubMed DOI
  863. Miller,L.K., Hou,X., Rodriguiz,R.M., Gagnidze,K., Sweedler,J.V., Wetsel,W.C. and Devi,L.A.
    Mice deficient in endothelin-converting enzyme-2 exhibit abnormal responses to morphine and altered peptide levels in the spinal cord
    J Neurochem119, 1074-1085. PubMed  Europe PubMed DOI  K
  864. Oudit,G.Y. and Penninger,J.M.
    Recombinant human angiotensin-converting enzyme 2 as a new renin-angiotensin system peptidase for heart failure therapy
    Curr Heart Fail Rep8, 176-183. PubMed  Europe PubMed DOI  U
  865. Pedersen,K.B., Sriramula,S., Chhabra,K.H., Xia,H. and Lazartigues,E.
    Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assays
    Am J Physiol Regul Integr Comp Physiol301, R1293-R1299. PubMed  Europe PubMed DOI  I
  866. Sriramula,S., Cardinale,J.P., Lazartigues,E. and Francis,J.
    ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension
    Cardiovasc Res92, 401-408. PubMed  Europe PubMed DOI  U
  867. Vangjeli,C., Dicker,P., Tregouet,D.A., Shields,D.C., Evans,A. and Stanton,A.V.
    A polymorphism in ACE2 is associated with a lower risk for fatal cardiovascular events in females: the MORGAM project
    J Renin Angiotensin Aldosterone Syst12, 504-509. PubMed  Europe PubMed DOI  M
  868. Wosten-van Asperen,R.M., Lutter,R., Specht,P.A., Moll,G.N., van Woensel,J.B., Van der Loos,C.M., van Goor,H., Kamilic,J., Florquin,S. and Bos,A.P.
    Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist
    J Pathol225, 618-627. PubMed  Europe PubMed DOI  U
  869. Xiao,L., Gao,L., Lazartigues,E. and Zucker,I.H.
    Brain-selective overexpression of angiotensin-converting enzyme 2 attenuates sympathetic nerve activity and enhances baroreflex function in chronic heart failure
    Hypertension58, 1057-1065. PubMed  Europe PubMed DOI  U
  870. 2010
  871. Batlle,D., Wysocki,J. and Khan,M.S.
    Vascular angiotensin-converting enzyme 2: lord of the ring?
    Circ Res107, 822-824. PubMed  Europe PubMed DOI
  872. Feng,Y., Xia,H., Santos,R.A., Speth,R. and Lazartigues,E.
    Angiotensin-converting enzyme 2: a new target for neurogenic hypertension
    Exp Physiol95, 601-606. PubMed  Europe PubMed DOI
  873. Feng,Y., Xia,H., Cai,Y., Halabi,C.M., Becker,L.K., Santos,R.A., Speth,R.C., Sigmund,C.D. and Lazartigues,E.
    Brain-selective overexpression of human angiotensin-converting enzyme type 2 attenuates neurogenic hypertension
    Circ Res106, 373-382. PubMed  Europe PubMed DOI
  874. Fraga-Silva,R.A., Sorg,B.S., Wankhede,M., Dedeugd,C., Jun,J.Y., Baker,M.B., Li,Y., Castellano,R.K., Katovich,M.J., Raizada,M.K. and Ferreira,A.J.
    ACE2 activation promotes antithrombotic activity
    Mol Med16, 210-215. PubMed  Europe PubMed DOI  I
  875. Kuba,K., Imai,Y., Ohto-Nakanishi,T. and Penninger,J.M.
    Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters
    Pharmacol Ther128, 119-128. PubMed  Europe PubMed DOI  V
  876. Lambert,D.W., Clarke,N.E. and Turner,A.J.
    Not just angiotensinases: new roles for the angiotensin-converting enzymes
    Cell Mol Life Sci67, 89-98. PubMed  Europe PubMed DOI  V
  877. Shiota,A., Yamamoto,K., Ohishi,M., Tatara,Y., Ohnishi,M., Maekawa,Y., Iwamoto,Y., Takeda,M. and Rakugi,H.
    Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice
    Hypertens Res33, 298-307. PubMed  Europe PubMed DOI  K
  878. Thomas,M.C., Pickering,R.J., Tsorotes,D., Koitka,A., Sheehy,K., Bernardi,S., Toffoli,B., Nguyen-Huu,T.P., Head,G.A., Fu,Y., Chin-Dusting,J., Cooper,M.E. and Tikellis,C.
    Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse
    Circ Res107, 888-897. PubMed  Europe PubMed DOI  K  I
  879. Trask,A.J., Groban,L., Westwood,B.M., Varagic,J., Ganten,D., Gallagher,P.E., Chappell,M.C. and Ferrario,C.M.
    Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats
    Am J Hypertens23, 687-693. PubMed  Europe PubMed DOI  I
  880. Treml,B., Neu,N., Kleinsasser,A., Gritsch,C., Finsterwalder,T., Geiger,R., Schuster,M., Janzek,E., Loibner,H., Penninger,J. and Loeckinger,A.
    Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets
    Crit Care Med38, 596-601. PubMed  Europe PubMed DOI  U
  881. Wysocki,J., Ye,M., Rodriguez,E., Gonzalez-Pacheco,F.R., Barrios,C., Evora,K., Schuster,M., Loibner,H., Brosnihan,K.B., Ferrario,C.M., Penninger,J.M. and Batlle,D.
    Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension
    Hypertension55, 90-98. PubMed  Europe PubMed DOI  U
  882. Xia,H. and Lazartigues,E.
    Angiotensin-converting enzyme 2: central regulator for cardiovascular function
    Curr Hypertens Rep12, 170-175. PubMed  Europe PubMed DOI
  883. Zhao,Y.X., Yin,H.Q., Yu,Q.T., Qiao,Y., Dai,H.Y., Zhang,M.X., Zhang,L., Liu,Y.F., Wang,L.C., Liu,d.S., Deng,B.P., Zhang,Y.H., Pan,C.M., Song,H.D., Qu,X., Jiang,H., Liu,C.X., Lu,X.T., Liu,B., Gao,F. and Dong,B.
    ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction
    Hum Gene Ther21, 1545-1554. PubMed  Europe PubMed DOI
  884. 2009
  885. Bindom,S.M. and Lazartigues,E.
    The sweeter side of ACE2: physiological evidence for a role in diabetes
    Mol Cell Endocrinol302, 193-202. PubMed  Europe PubMed DOI
  886. Clayton,D., Hanchapola,I., Perlmutter,P., Smith,A.I. and Aguilar,M.I.
    The active site specificity of angiotensin II converting enzyme 2 investigated through single and multiple residue changes and beta-amino acid substrate analogs
    Adv Exp Med Biol611, 559-560. PubMed  Europe PubMed DOI  P
  887. De Mello,W.C.
    Opposite effects of angiotensin II and angiotensin (1-7) on impulse propagation, excitability and cardiac arrhythmias. Is the overexpression of ACE2 arrhythmogenic?
    Regul Pept153, 7-10. PubMed  Europe PubMed DOI
  888. Lai,Z.W., Lew,R.A., Yarski,M.A., Mu,F.T., Andrews,R.K. and Smith,A.I.
    The identification of a calmodulin-binding domain within the cytoplasmic tail of angiotensin-converting enzyme-2
    Endocrinology150, 2376-2381. PubMed  Europe PubMed DOI
  889. Oudit,G.Y., Imai,Y., Kuba,K., Scholey,J.W. and Penninger,J.M.
    The role of ACE2 in pulmonary diseases - relevance for the nephrologist
    Nephrol Dial Transplant24, 1362-1365. PubMed  Europe PubMed DOI
  890. Riviere,G.
    [Angiotensin-converting enzyme: a protein conserved during evolution]
    J Soc Biol203, 281-293. PubMed  Europe PubMed DOI  V
  891. Wu,K., Li,W., Peng,G. and Li,F.
    Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor
    Proc Natl Acad Sci U S A106, 19970-19974. PubMed  Europe PubMed DOI  S
  892. Xu,L., Zhang,Y., Liu,Y., Chen,Z., Deng,H., Ma,Z., Wang,H., Hu,Z. and Deng,F.
    Angiotensin-converting enzyme 2 (ACE2) from raccoon dog can serve as an efficient receptor for the spike protein of severe acute respiratory syndrome coronavirus
    J Gen Virol90, 2695-2703. PubMed  Europe PubMed DOI
  893. 2008
  894. Batlle,D., Soler,M.J. and Wysocki,J.
    New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2 - a potential target for treatment of hypertension and diabetic nephropathy
    Curr Opin Nephrol Hypertens17, 250-257. PubMed  Europe PubMed DOI  T
  895. Deaton,D.N., Graham,K.P., Gross,J.W. and Miller,A.B.
    Thiol-based angiotensin-converting enzyme 2 inhibitors: P1' modifications for the exploration of the S1' subsite
    Bioorg Med Chem Lett18, 1681-1687. PubMed  Europe PubMed DOI  I
  896. Deaton,D.N., Gao,E.N., Graham,K.P., Gross,J.W., Miller,A.B. and Strelow,J.M.
    Thiol-based angiotensin-converting enzyme 2 inhibitors: P1 modifications for the exploration of the S1 subsite
    Bioorg Med Chem Lett18, 732-737. PubMed  Europe PubMed DOI  I
  897. Elased,K.M., Cunha,T.S., Marcondes,F.K. and Morris,M.
    Brain angiotensin-converting enzymes: role of angiotensin-converting enzyme 2 in processing angiotensin II in mice
    Exp Physiol93, 665-675. PubMed  Europe PubMed DOI
  898. Feng,Y., Yue,X., Xia,H., Bindom,S.M., Hickman,P.J., Filipeanu,C.M., Wu,G. and Lazartigues,E.
    Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation
    Circ Res102, 729-736. PubMed  Europe PubMed DOI
  899. Ferreira,A.J. and Raizada,M.K.
    Are we poised to target ACE2 for the next generation of antihypertensives?
    J Mol Med (Berl)86, 685-690. PubMed  Europe PubMed DOI  V  T
  900. Ferreira,A.J., Hernandez Prada,J.A., Ostrov,D.A. and Raizada,M.K.
    Cardiovascular protection by angiotensin-converting enzyme 2: a new paradigm
    Future Cardiol4, 175-182. PubMed  Europe PubMed DOI
  901. Garabelli,P.J., Modrall,J.G., Penninger,J.M., Ferrario,C.M. and Chappell,M.C.
    Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart
    Exp Physiol93, 613-621. PubMed  Europe PubMed DOI  I
  902. Guo,H., Guo,A., Wang,C., Yan,B., Lu,H. and Chen,H.
    Expression of feline angiotensin converting enzyme 2 and its interaction with SARS-CoV S1 protein
    Res Vet Sci84, 494-496. PubMed  Europe PubMed DOI  E
  903. Guo,Y.J., Li,W.H., Wu,R., Xie,Q. and Cui,L.Q.
    ACE2 overexpression inhibits angiotensin II-induced monocyte chemoattractant protein-1 expression in macrophages
    Arch Med Res39, 149-154. PubMed  Europe PubMed DOI
  904. Gurley,S.B. and Coffman,T.M.
    Angiotensin-converting enzyme 2 gene targeting studies in mice: mixed messages
    Exp Physiol93, 538-542. PubMed  Europe PubMed DOI
  905. Hernandez Prada,J.A., Ferreira,A.J., Katovich,M.J., Shenoy,V., Qi,Y., Santos,R.A., Castellano,R.K., Lampkins,A.J., Gubala,V., Ostrov,D.A. and Raizada,M.K.
    Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents
    Hypertension51, 1312-1317. PubMed  Europe PubMed DOI
  906. Imai,Y., Kuba,K. and Penninger,J.M.
    [Lessons from SARS: a new potential therapy for acute respiratory distress syndrome (ARDS) with angiotensin converting enzyme 2 (ACE2)]
    Masui57, 302-310. PubMed  Europe PubMed
  907. Koitka,A., Cooper,M.E., Thomas,M.C. and Tikellis,C.
    Angiotensin converting enzyme 2 in the kidney
    Clin Exp Pharmacol Physiol35, 420-425. PubMed  Europe PubMed DOI
  908. Lambert,D.W., Hooper,N.M. and Turner,A.J.
    Angiotensin-converting enzyme 2 and new insights into the renin-angiotensin system
    Biochem Pharmacol75, 781-786. PubMed  Europe PubMed DOI  V
  909. Lew,R.A., Warner,F.J., Hanchapola,I., Yarski,M.A., Manohar,J., Burrell,L.M. and Smith,A.I.
    Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor
    Exp Physiol93, 685-693. PubMed  Europe PubMed DOI
  910. Lubel,J.S., Herath,C.B., Velkoska,E., Casley,D.J., Burrell,L.M. and Angus,P.W.
    Angiotensin converting enzyme 2 (ACE2) activity in fetal calf serum: implications for cell culture research
    Cytotechnology58, 119-126. PubMed  Europe PubMed DOI
  911. Mores,A., Matziari,M., Beau,F., Cuniasse,P., Yiotakis,A. and Dive,V.
    Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2
    J Med Chem51, 2216-2226. PubMed  Europe PubMed DOI  I
  912. Nakamura,K., Koibuchi,N., Nishimatsu,H., Higashikuni,Y., Hirata,Y., Kugiyama,K., Nagai,R. and Sata,M.
    Candesartan ameliorates cardiac dysfunction observed in Angiotensin-converting enzyme 2-deficient mice
    Hypertens Res31, 1953-1961. PubMed  Europe PubMed DOI  K
  913. Niu,M.J., Yang,J.K., Lin,S.S., Ji,X.J. and Guo,L.M.
    Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice
    Endocrine34, 56-61. PubMed  Europe PubMed DOI  K
  914. Rushworth,C.A., Guy,J.L. and Turner,A.J.
    Residues affecting the chloride regulation and substrate selectivity of the angiotensin-converting enzymes (ACE and ACE2) identified by site-directed mutagenesis
    FEBS J275, 6033-6042. PubMed  Europe PubMed DOI  I
  915. Soler,M.J., Wysocki,J. and Batlle,D.
    Angiotensin-converting enzyme 2 and the kidney
    Exp Physiol93, 549-556. PubMed  Europe PubMed DOI
  916. Tikellis,C., Bialkowski,K., Pete,J., Sheehy,K., Su,Q., Johnston,C., Cooper,M.E. and Thomas,M.C.
    ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes
    Diabetes57, 1018-1025. PubMed  Europe PubMed DOI  I
  917. Zucker,I.H.
    Angiotensin-converting enzyme 2: a new player in central sympathetic regulation?
    Circ Res102, 628-629. PubMed  Europe PubMed DOI
  918. 2007
  919. Burns,K.D.
    The emerging role of angiotensin-converting enzyme-2 in the kidney
    Curr Opin Nephrol Hypertens16, 116-121. PubMed  Europe PubMed DOI
  920. Doobay,M.F., Talman,L.S., Obr,T.D., Tian,X., Davisson,R.L. and Lazartigues,E.
    Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system
    Am J Physiol Regul Integr Comp Physiol292, R373-R381. PubMed  Europe PubMed DOI
  921. Fan,X., Wang,Y., Sun,K., Zhang,W., Yang,X., Wang,S., Zhen,Y., Wang,J., Li,W., Han,Y., Liu,T., Wang,X., Chen,J., Wu,H. and Hui,R.
    Polymorphisms of ACE2 gene are associated with essential hypertension and antihypertensive effects of captopril in women
    Clin Pharmacol Ther82, 187-196. PubMed  Europe PubMed DOI  M
  922. Grobe,J.L., Der Sarkissian,S., Stewart,J.M., Meszaros,J.G., Raizada,M.K. and Katovich,M.J.
    ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts
    Clin Sci (Lond)113, 357-364. PubMed  Europe PubMed DOI  U
  923. Hamming,I., Cooper,M.E., Haagmans,B.L., Hooper,N.M., Korstanje,R., Osterhaus,A.D., Timens,W., Turner,A.J., Navis,G. and van Goor,H.
    The emerging role of ACE2 in physiology and disease
    J Pathol212, 1-11. PubMed  Europe PubMed DOI  V
  924. Keidar,S., Kaplan,M. and Gamliel-Lazarovich,A.
    ACE2 of the heart: from angiotensin I to angiotensin (1-7)
    Cardiovasc Res73, 463-469. PubMed  Europe PubMed DOI
  925. Li,W., Sui,J., Huang,I.C., Kuhn,J.H., Radoshitzky,S.R., Marasco,W.A., Choe,H. and Farzan,M.
    The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2
    Virology367, 367-374. PubMed  Europe PubMed DOI
  926. Oudit,G.Y., Kassiri,Z., Patel,M.P., Chappell,M., Butany,J., Backx,P.H., Tsushima,R.G., Scholey,J.W., Khokha,R. and Penninger,J.M.
    Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice
    Cardiovasc Res75, 29-39. PubMed  Europe PubMed DOI  K
  927. Raizada,M.K. and Ferreira,A.J.
    ACE2: a new target for cardiovascular disease therapeutics
    J Cardiovasc Pharmacol50, 112-119. PubMed  Europe PubMed DOI  V
  928. Shaltout,H.A., Westwood,B.M., Averill,D.B., Ferrario,C.M., Figueroa,J.P., Diz,D.I., Rose,J.C. and Chappell,M.C.
    Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II
    Am J Physiol Renal Physiol292, F82-F91. PubMed  Europe PubMed DOI
  929. Soler,M.J., Wysocki,J., Ye,M., Lloveras,J., Kanwar,Y. and Batlle,D.
    ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice
    Kidney Int72, 614-623. PubMed  Europe PubMed DOI  I
  930. Trask,A.J., Averill,D.B., Ganten,D., Chappell,M.C. and Ferrario,C.M.
    Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats
    Am J Physiol Heart Circ Physiol292, H3019-H3024. PubMed  Europe PubMed DOI  I
  931. Wiener,R.S., Cao,Y.X., Hinds,A., Ramirez,M.I. and Williams,M.C.
    Angiotensin converting enzyme 2 is primarily epithelial and is developmentally regulated in the mouse lung
    J Cell Biochem101, 1278-1291. PubMed  Europe PubMed DOI
  932. Wong,D.W., Oudit,G.Y., Reich,H., Kassiri,Z., Zhou,J., Liu,Q.C., Backx,P.H., Penninger,J.M., Herzenberg,A.M. and Scholey,J.W.
    Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury
    Am J Pathol171, 438-451. PubMed  Europe PubMed DOI  K
  933. Yang,X.H., Deng,W., Tong,Z., Liu,Y.X., Zhang,L.F., Zhu,H., Gao,H., Huang,L., Liu,Y.L., Ma,C.M., Xu,Y.F., Ding,M.X., Deng,H.K. and Qin,C.
    Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection
    Comp Med57, 450-459. PubMed  Europe PubMed
  934. Zhang,Y. and Wada,J.
    Collectrin, a homologue of ACE2, its transcriptional control and functional perspectives
    Biochem Biophys Res Commun363, 1-5. PubMed  Europe PubMed DOI
  935. 2006
  936. [YEAR:5-4-2006]Chou,C.F., Loh,C.B., Foo,Y.K., Shen,S., Fielding,B.C., Tan,T.H., Khan,S., Wang,Y., Lim,S.G., Hong,W., Tan,Y.J. and Fu,J.
    ACE2 orthologues in non-mammalian vertebrates (Danio, Gallus, Fugu, Tetraodon and Xenopus)
    Gene377, 46-55. PubMed  Europe PubMed DOI
  937. [YEAR:3-3-2006]Danilczyk,U. and Penninger,J.M.
    Angiotensin-converting enzyme II in the heart and the kidney
    Circ Res98, 463-471. PubMed  Europe PubMed DOI  K
  938. [YEAR:8-7-2006]Der Sarkissian,S., Huentelman,M.J., Stewart,J., Katovich,M.J. and Raizada,M.K.
    ACE2: a novel therapeutic target for cardiovascular diseases
    Prog Biophys Mol Biol91, 163-198. PubMed  Europe PubMed DOI
  939. [YEAR:20-6-2006]Diez-Freire,C., Vazquez,J., Correa de Adjounian,M.F., Ferrari,M.F., Yuan,L., Silver,X., Torres,R. and Raizada,M.K.
    ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR
    Physiol Genomics27, 12-19. PubMed  Europe PubMed DOI
  940. Elased,K.M., Cunha,T.S., Gurley,S.B., Coffman,T.M. and Morris,M.
    New mass spectrometric assay for angiotensin-converting enzyme 2 activity
    Hypertension47, 1010-1017. PubMed  Europe PubMed DOI  A  I
  941. [YEAR:1-8-2006]Gurley,S.B., Allred,A., Le,T.H., Griffiths,R., Mao,L., Philip,N., Haystead,T.A., Donoghue,M., Breitbart,R.E., Acton,S.L., Rockman,H.A. and Coffman,T.M.
    Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice
    J Clin Invest116, 2218-2225. PubMed  Europe PubMed DOI  K
  942. [YEAR:4-10-2006]Ingelfinger,J.R.
    ACE2: a new target for prevention of diabetic nephropathy?
    J Am Soc Nephrol17, 2957-2959. PubMed  Europe PubMed DOI  T
  943. Kuba,K., Imai,Y., Rao,S., Jiang,C. and Penninger,J.M.
    Lessons from SARS: control of acute lung failure by the SARS receptor ACE2
    J Mol Med (Berl)84, 814-820. PubMed  Europe PubMed DOI
  944. [YEAR:11-11-2006]Lieb,W., Graf,J., Gotz,A., Konig,I.R., Mayer,B., Fischer,M., Stritzke,J., Hengstenberg,C., Holmer,S.R., Doring,A., Lowel,H., Schunkert,H. and Erdmann,J.
    Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men. Results of the MONICA Augsburg echocardiographic substudy
    J Mol Med (Berl)84, 88-96. PubMed  Europe PubMed DOI  M
  945. Rella,M., Rushworth,C.A., Guy,J.L., Turner,A.J., Langer,T. and Jackson,R.M.
    Structure-based pharmacophore design and virtual screening for novel Angiotensin converting enzyme 2 inhibitors
    J Chem Inf Model46, 708-716. PubMed  Europe PubMed DOI  I
  946. [YEAR:25-9-2006]Rice,G.I., Jones,A.L., Grant,P.J., Carter,A.M., Turner,A.J. and Hooper,N.M.
    Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study
    Hypertension48, 914-920. PubMed  Europe PubMed DOI
  947. [YEAR:17-5-2006]Tikellis,C., Cooper,M.E., Bialkowski,K., Johnston,C.I., Burns,W.C., Lew,R.A., Smith,A.I. and Thomas,M.C.
    Developmental expression of ACE2 in the SHR kidney: a role in hypertension?
    Kidney Int70, 34-41. PubMed  Europe PubMed DOI
  948. Yamamoto,K., Ohishi,M., Katsuya,T., Ito,N., Ikushima,M., Kaibe,M., Tatara,Y., Shiota,A., Sugano,S., Takeda,S., Rakugi,H. and Ogihara,T.
    Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II
    Hypertension47, 718-726. PubMed  Europe PubMed DOI  K
  949. 2005
  950. Burrell,L.M., Risvanis,J., Kubota,E., Dean,R.G., MacDonald,P.S., Lu,S., Tikellis,C., Grant,S.L., Lew,R.A., Smith,A.I., Cooper,M.E. and Johnston,C.I.
    Myocardial infarction increases ACE2 expression in rat and humans
    Eur Heart J26, 369-375. PubMed  Europe PubMed DOI
  951. [YEAR:24-5-2005]Ferrario,C.M., Jessup,J., Chappell,M.C., Averill,D.B., Brosnihan,K.B., Tallant,E.A., Diz,D.I. and Gallagher,P.E.
    Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2
    Circulation111, 2605-2610. PubMed  Europe PubMed DOI
  952. [YEAR:15-4-2005]Ferrario,C.M.
    Myocardial infarction increases ACE2 expression in rat and humans
    Eur Heart J26, 1141-1143. PubMed  Europe PubMed DOI
  953. [YEAR:7-10-2005]Frojdo,S., Sjolind,L., Parkkonen,M., Makinen,V.P., Kilpikari,R., Pettersson-Fernholm,K., Forsblom,C., Fagerudd,J., Tikellis,C., Cooper,M.E., Wessman,M. and Groop,P.H.
    Polymorphisms in the gene encoding angiotensin I converting enzyme 2 and diabetic nephropathy
    Diabetologia48, 2278-2281. PubMed  Europe PubMed DOI
  954. Gembardt,F., Sterner-Kock,A., Imboden,H., Spalteholz,M., Reibitz,F., Schultheiss,H.P., Siems,W.E. and Walther,T.
    Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents
    Peptides26, 1270-1277. PubMed  Europe PubMed DOI
  955. [YEAR:1-8-2005]Guy,J.L., Lambert,D.W., Warner,F.J., Hooper,N.M. and Turner,A.J.
    Membrane-associated zinc peptidase families: comparing ACE and ACE2
    Biochim Biophys Acta1751, 2-8. PubMed  Europe PubMed DOI
  956. Guy,J.L., Jackson,R.M., Jensen,H.A., Hooper,N.M. and Turner,A.J.
    Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis
    FEBS J272, 3512-3520. PubMed  Europe PubMed DOI
  957. [YEAR:7-7-2005]Imai,Y., Kuba,K., Rao,S., Huan,Y., Guo,F., Guan,B., Yang,P., Sarao,R., Wada,T., Leong-Poi,H., Crackower,M.A., Fukamizu,A., Hui,C.C., Hein,L., Uhlig,S., Slutsky,A.S., Jiang,C. and Penninger,J.M.
    Angiotensin-converting enzyme 2 protects from severe acute lung failure
    Nature436, 112-116. PubMed  Europe PubMed DOI
  958. [YEAR:1-7-2005]Itoyama,S., Keicho,N., Hijikata,M., Quy,T., Phi,N.C., Long,H.T., Ha,L.D., Ban,V.V., Matsushita,I., Yanai,H., Kirikae,F., Kirikae,T., Kuratsuji,T. and Sasazuki,T.
    Identification of an alternative 5'-untranslated exon and new polymorphisms of angiotensin-converting enzyme 2 gene: lack of association with SARS in the Vietnamese population
    Am J Med Genet A136, 52-57. PubMed  Europe PubMed DOI
  959. [YEAR:7-1-2005]Katovich,M.J., Grobe,J.L., Huentelman,M. and Raizada,M.K.
    Angiotensin-converting enzyme 2 as a novel target for gene therapy for hypertension
    Exp Physiol90, 299-305. PubMed  Europe PubMed DOI
  960. Kruit,A., Ruven,H.J., Grutters,J.C. and van den Bosch,J.M.
    Angiotensin-converting enzyme 2 (ACE2) haplotypes are associated with pulmonary disease phenotypes in sarcoidosis patients
    Sarcoidosis Vasc Diffuse Lung Dis22, 195-203. PubMed  Europe PubMed  M
  961. [YEAR:10-7-2005]Kuba,K., Imai,Y., Rao,S., Gao,H., Guo,F., Guan,B., Huan,Y., Yang,P., Zhang,Y., Deng,W., Bao,L., Zhang,B., Liu,G., Wang,Z., Chappell,M., Liu,Y., Zheng,D., Leibbrandt,A., Wada,T., Slutsky,A.S., Liu,D., Qin,C., Jiang,C. and Penninger,J.M.
    A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
    Nat Med11, 875-879. PubMed  Europe PubMed DOI
  962. [YEAR:27-6-2005]Lambert,D.W., Yarski,M., Warner,F.J., Thornhill,P., Parkin,E.T., Smith,A.I., Hooper,N.M. and Turner,A.J.
    Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)
    J Biol Chem280, 30113-30119. PubMed  Europe PubMed DOI
  963. Leckie,B.J.
    Targeting the renin-angiotensin system: what's new?
    Curr Med Chem Cardiovasc Hematol Agents3, 23-32. PubMed  Europe PubMed DOI  V
  964. [YEAR:16-9-2005]Li,F., Li,W., Farzan,M. and Harrison,S.C.
    Structure of SARS coronavirus spike receptor-binding domain complexed with receptor
    Science309, 1864-1868. PubMed  Europe PubMed DOI  S
  965. [YEAR:5-10-2005]Li,N., Zimpelmann,J., Cheng,K., Wilkins,J.A. and Burns,K.D.
    The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules
    Am J Physiol Renal Physiol288, F353-F362. PubMed  Europe PubMed DOI  I
  966. [YEAR:20-4-2005]Li,W., Zhang,C., Sui,J., Kuhn,J.H., Moore,M.J., Luo,S., Wong,S.K., Huang,I.C., Xu,K., Vasilieva,N., Murakami,A., He,Y., Marasco,W.A., Guan,Y., Choe,H. and Farzan,M.
    Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2
    EMBO J24, 1634-1643. PubMed  Europe PubMed DOI
  967. Mossel,E.C., Huang,C., Narayanan,K., Makino,S., Tesh,R.B. and Peters,C.J.
    Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication
    J Virol79, 3846-3850. PubMed  Europe PubMed DOI
  968. [YEAR:15-9-2005]Paizis,G., Tikellis,C., Cooper,M.E., Schembri,J.M., Lew,R.A., Smith,A.I., Shaw,T., Warner,F.J., Zuilli,A., Burrell,L.M. and Angus,P.W.
    Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2
    Gut54, 1790-1796. PubMed  Europe PubMed DOI
  969. [YEAR:15-9-2005]Warner,F.J., Lew,R.A., Smith,A.I., Lambert,D.W., Hooper,N.M. and Turner,A.J.
    Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells
    J Biol Chem280, 39353-39362. PubMed  Europe PubMed DOI
  970. Zhang,Y., Zheng,N., Hao,P., Cao,Y. and Zhong,Y.
    A molecular docking model of SARS-CoV S1 protein in complex with its receptor, human ACE2
    Comput Biol Chem29, 254-257. PubMed  Europe PubMed DOI
  971. 2004
  972. Benjafield,A.V., Wang,W.Y. and Morris,B.J.
    No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension
    Am J Hypertens17, 624-628. PubMed  Europe PubMed DOI  M
  973. Burrell,L.M., Johnston,C.I., Tikellis,C. and Cooper,M.E.
    ACE2, a new regulator of the renin-angiotensin system
    Trends Endocrinol Metab15, 166-169. PubMed  Europe PubMed DOI
  974. Campbell,D.J., Zeitz,C.J., Esler,M.D. and Horowitz,J.D.
    Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation
    J Hypertens22, 1971-1976. PubMed  Europe PubMed DOI
  975. Chiu,R.W., Tang,N.L., Hui,D.S., Chung,G.T., Chim,S.S., Chan,K.C., Sung,Y.M., Chan,L.Y., Tong,Y.K., Lee,W.S., Chan,P.K. and Lo,Y.M.
    ACE2 gene polymorphisms do not affect outcome of severe acute respiratory syndrome
    Clin Chem50, 1683-1686. PubMed  Europe PubMed DOI  M
  976. Danilczyk,U., Eriksson,U., Oudit,G.Y. and Penninger,J.M.
    Physiological roles of angiotensin-converting enzyme 2
    Cell Mol Life Sci61, 2714-2719. PubMed  Europe PubMed DOI
  977. [YEAR:1-7-2004]Douglas,G.C., O'Bryan,M.K., Hedger,M.P., Lee,D.K., Yarski,M.A., Smith,A.I. and Lew,R.A.
    The novel angiotensin-converting enzyme (ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis
    Endocrinology145, 4703-4711. PubMed  Europe PubMed DOI
  978. Hamming,I., Timens,W., Bulthuis,M.L., Lely,A.T., Navis,G.J. and van Goor,H.
    Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
    J Pathol203, 631-637. PubMed  Europe PubMed DOI
  979. [YEAR:9-7-2004]Hofmann,H., Geier,M., Marzi,A., Krumbiegel,M., Peipp,M., Fey,G.H., Gramberg,T. and Pohlmann,S.
    Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor
    Biochem Biophys Res Commun319, 1216-1221. PubMed  Europe PubMed DOI
  980. Huentelman,M.J., Zubcevic,J., Hernandez Prada,J.A., Xiao,X., Dimitrov,D.S., Raizada,M.K. and Ostrov,D.A.
    Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor
    Hypertension44, 903-906. PubMed  Europe PubMed DOI  I
  981. [YEAR:15-10-2004]Huentelman,M.J., Zubcevic,J., Katovich,M.J. and Raizada,M.K.
    Cloning and characterization of a secreted form of angiotensin-converting enzyme 2
    Regul Pept122, 61-67. PubMed  Europe PubMed DOI
  982. Kuhn,J.H., Li,W., Choe,H. and Farzan,M.
    Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus
    Cell Mol Life Sci61, 2738-2743. PubMed  Europe PubMed DOI
  983. Lely,A.T., Hamming,I., van Goor,H. and Navis,G.J.
    Renal ACE2 expression in human kidney disease
    J Pathol204, 587-593. PubMed  Europe PubMed DOI
  984. Li,W., Greenough,T.C., Moore,M.J., Vasilieva,N., Somasundaran,M., Sullivan,J.L., Farzan,M. and Choe,H.
    Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2
    J Virol78, 11429-11433. PubMed  Europe PubMed DOI
  985. [YEAR:4-8-2004]Lin,Q., Keller,R.S., Weaver,B. and Zisman,L.S.
    Interaction of ACE2 and integrin beta1 in failing human heart
    Biochim Biophys Acta1689, 175-178. PubMed  Europe PubMed DOI
  986. Moore,M.J., Dorfman,T., Li,W., Wong,S.K., Li,Y., Kuhn,J.H., Coderre,J., Vasilieva,N., Han,Z., Greenough,T.C., Farzan,M. and Choe,H.
    Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2
    J Virol78, 10628-10635. PubMed  Europe PubMed DOI
  987. [YEAR:29-7-2004]Rice,G.I., Thomas,D.A., Grant,P.J., Turner,A.J. and Hooper,N.M.
    Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism
    Biochem J383, 45-51. PubMed  Europe PubMed DOI
  988. Towler,P., Staker,B., Prasad,S.G., Menon,S., Tang,J., Parsons,T., Ryan,D., Fisher,M., Williams,D., Dales,N.A., Patane,M.A. and Pantoliano,M.W.
    ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis
    J Biol Chem279, 17996-18007. PubMed  Europe PubMed DOI  S  I
  989. Turner,A.J. and Hooper,N.M.
    Angiotensin-converting enzyme 2
    [ISSN:0-12-079610-4]2, 349-352.  V
  990. Turner,A.J., Hiscox,J.A. and Hooper,N.M.
    ACE2: from vasopeptidase to SARS virus receptor
    Trends Pharmacol Sci25, 291-294. PubMed  Europe PubMed DOI
  991. Warner,F.J., Smith,A.I., Hooper,N.M. and Turner,A.J.
    Angiotensin-converting enzyme-2: a molecular and cellular perspective
    Cell Mol Life Sci61, 2704-2713. PubMed  Europe PubMed DOI  V
  992. 2003
  993. Danilczyk,U., Eriksson,U., Crackower,M.A. and Penninger,J.M.
    A story of two ACEs
    J Mol Med81, 227-234. PubMed  Europe PubMed DOI
  994. [YEAR:18-11-2003]Guy,J.L., Jackson,R.M., Acharya,K.R., Sturrock,E.D., Hooper,N.M. and Turner,A.J.
    Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence
    Biochemistry42, 13185-13192. PubMed  Europe PubMed DOI
  995. [YEAR:2-5-2003]Huang,L., Sexton,D.J., Skogerson,K., Devlin,M., Smith,R., Sanyal,I., Parry,T., Kent,R., Enright,J., Wu,Q.L., Conley,G., DeOliveira,D., Morganelli,L., Ducar,M., Wescott,C.R. and Ladner,R.C.
    Novel peptide inhibitors of angiotensin-converting enzyme 2
    J Biol Chem278, 15532-15540. PubMed  Europe PubMed DOI  I
  996. Tikellis,C., Johnston,C.I., Forbes,J.M., Burns,W.C., Burrell,L.M., Risvanis,J. and Cooper,M.E.
    Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy
    Hypertension41, 392-397. PubMed  Europe PubMed DOI  I
  997. [YEAR:15-1-2003]Yan,Z.H., Ren,K.J., Wang,Y., Chen,S., Brock,T.A. and Rege,A.A.
    Development of intramolecularly quenched fluorescent peptides as substrates of angiotensin-converting enzyme 2
    Anal Biochem312, 141-147. PubMed  Europe PubMed DOI
  998. 2002
  999. [YEAR:20-6-2002]Crackower,M.A., Sarao,R., Oudit,G.Y., Yagil,C., Kozieradzki,I., Scanga,S.E., Oliveira-dos-Santos,A.J., da Costa,J., Zhang,L., Pei,Y., Scholey,J., Ferrario,C.M., Manoukian,A.S., Chappell,M.C., Backx,P.H., Yagil,Y. and Penninger,J.M.
    Angiotensin-converting enzyme 2 is an essential regulator of heart function
    Nature417, 822-828. PubMed  Europe PubMed DOI
  1000. [YEAR:9-10-2002]Dales,N.A., Gould,A.E., Brown,J.A., Calderwood,E.F., Guan,B., Minor,C.A., Gavin,J.M., Hales,P., Kaushik,V.K., Stewart,M., Tummino,P.J., Vickers,C.S., Ocain,T.D. and Patane,M.A.
    Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors
    J Am Chem Soc124, 11852-11853. PubMed  Europe PubMed DOI  I
  1001. [YEAR:29-10-2002]Eriksson,U., Danilczyk,U. and Penninger,J.M.
    Just the beginning: novel functions for angiotensin-converting enzymes
    Curr Biol12, R745-R752. PubMed  Europe PubMed DOI
  1002. [YEAR:4-12-2002]Harmer,D., Gilbert,M., Borman,R. and Clark,K.L.
    Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme
    FEBS Lett532, 107-110. PubMed  Europe PubMed DOI
  1003. Turner,A.J., Tipnis,S.R., Guy,J.L., Rice,G. and Hooper,N.M.
    ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors
    Can J Physiol Pharmacol80, 346-353. PubMed  Europe PubMed DOI
  1004. Turner,A.J. and Hooper,N.M.
    The angiotensin-converting enzyme gene family: genomics and pharmacology
    Trends Pharmacol Sci23, 177-183. PubMed  Europe PubMed DOI
  1005. [YEAR:26-4-2002]Vickers,C., Hales,P., Kaushik,V., Dick,L., Gavin,J., Tang,J., Godbout,K., Parsons,T., Baronas,E., Hsieh,F., Acton,S., Patane,M., Nichols,A. and Tummino,P.
    Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase
    J Biol Chem277, 14838-14843. PubMed  Europe PubMed DOI
  1006. 2000
  1007. Buchatskii,A.G., Kazachenko,K.Y. and Alexandrov,A.A.
    Hypothetical 92.3-kD human protein homologous to angiotensin-converting enzyme: a new member of the zinc metalloprotease family?
    Biochemistry (Mosc)65, 1019-1022. PubMed  Europe PubMed
  1008. [YEAR:1-9-2000]Donoghue,M., Hsieh,F., Baronas,E., Godbout,K., Gosselin,M., Stagliano,N., Donovan,M., Woolf,B., Robison,K., Jeyaseelan,R., Breitbart,R.E. and Acton,S.
    A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9
    Circ Res87, E1-E9. PubMed  Europe PubMed  I
  1009. [YEAR:27-10-2000]Tipnis,S.R., Hooper,N.M., Hyde,R., Karran,E., Christie,G. and Turner,A.J.
    A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase
    J Biol Chem275, 33238-33243. PubMed  Europe PubMed DOI  E  I